data_2epq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2epq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.881 0.372 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 48.0 t -144.87 168.35 20.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.7 t -113.66 74.29 2.33 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.617 0.722 . . . . 0.0 110.888 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -11.29 30.47 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.671 2.247 . . . . 0.0 112.356 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.66 -43.56 98.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.43 -25.55 7.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.14 77.18 1.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 4.0 tp -168.06 108.64 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.919 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 50.0 mtt85 -66.68 163.81 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -148.26 147.64 29.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -98.15 -34.06 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -90.15 144.9 25.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.863 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp -89.11 -26.23 21.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -84.15 -28.96 27.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.881 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -80.01 -38.38 32.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -28.61 67.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 23.2 t -70.23 -25.64 63.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.825 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -86.41 -26.01 24.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -89.15 -56.63 3.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 92.0 t -52.67 -35.46 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.111 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 -68.0 -31.26 70.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 9.6 m -52.05 -30.18 24.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.893 0.378 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.8 p -132.79 179.77 5.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.852 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 10.6 t -127.43 74.69 77.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.631 0.729 . . . . 0.0 110.883 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -8.99 25.01 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.696 2.264 . . . . 0.0 112.354 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.0 t -67.39 -41.41 86.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.131 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.44 -25.51 7.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.38 73.75 0.94 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.481 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 5.3 tt -168.53 106.06 0.46 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.782 0.325 . . . . 0.0 110.919 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -64.87 164.8 11.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -139.51 151.87 46.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -103.98 -29.76 10.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -91.75 147.14 23.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -86.95 -25.93 24.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -85.78 -51.6 6.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -57.06 -46.94 82.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -53.92 -36.57 62.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.933 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 29.0 t -70.0 -25.66 63.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.839 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -82.94 -25.96 31.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -90.81 -55.59 3.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 93.8 t -52.84 -29.89 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -76.94 -32.44 57.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 59.0 m -52.01 -30.12 23.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.851 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.898 0.38 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 9.6 p -123.75 173.2 8.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.857 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.0 t -113.51 74.75 2.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.704 . . . . 0.0 110.862 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -8.61 24.04 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.691 2.261 . . . . 0.0 112.389 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 91.5 t -66.72 -43.92 89.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.2 p -116.46 -25.4 7.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.36 77.27 1.08 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.506 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 9.9 tp -167.72 109.81 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.793 0.33 . . . . 0.0 110.934 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -69.05 163.98 23.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -151.13 141.69 22.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.2 tttp -91.84 -35.38 14.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -83.05 143.07 30.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.02 -25.88 21.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -83.91 -47.74 10.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 33.8 mmt-85 -60.2 -48.01 83.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.49 -27.97 51.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 6.3 t -70.35 -25.54 63.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.851 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -85.94 -25.92 25.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -89.5 -55.98 3.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.837 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 73.8 t -54.04 -27.31 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -77.27 -30.54 54.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 8.7 t -52.09 -30.16 24.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.829 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.914 0.388 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.8 p -138.92 169.55 17.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.916 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.5 t -113.87 74.7 2.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.594 0.712 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -8.63 24.1 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.651 2.234 . . . . 0.0 112.357 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.7 t -67.56 -41.88 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.55 -25.52 7.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.74 74.65 0.94 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.439 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 3.3 tp -168.73 105.7 0.43 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.787 0.327 . . . . 0.0 110.98 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -67.18 163.5 20.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -139.48 149.33 43.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.853 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -100.91 -29.68 12.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -93.01 144.82 24.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.64 -25.98 23.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -90.13 -28.23 19.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.856 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -82.71 -30.2 29.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -32.61 68.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 60.1 p -69.16 -25.39 64.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -80.85 -25.99 37.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -92.03 -54.71 3.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.866 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 94.9 t -51.98 -39.62 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.124 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -70.56 -28.84 65.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.839 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 9.3 t -52.11 -30.12 24.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 179.959 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.871 0.367 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 67.1 m -117.58 170.52 8.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.864 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 9.6 t -113.48 75.05 2.34 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.685 0.755 . . . . 0.0 110.919 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -8.7 24.28 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.679 2.253 . . . . 0.0 112.37 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.8 t -67.32 -41.43 86.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.12 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 20.8 p -116.83 -26.64 6.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.85 74.57 0.93 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.537 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 5.2 tt -169.03 112.42 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.901 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -65.97 159.47 25.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.841 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -140.15 140.44 35.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -92.44 -28.92 16.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 44.8 mmt-85 -93.89 143.05 26.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -88.57 -26.1 22.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -89.18 -37.19 15.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -70.35 -34.02 72.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.896 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.38 -26.23 62.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 56.1 m -70.03 -26.31 63.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -85.86 -26.15 25.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -88.47 -56.5 3.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.865 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 64.8 t -53.99 -27.38 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.098 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -75.06 -31.31 61.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.4 t -52.15 -30.07 24.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 179.983 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.861 0.362 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 12.9 p -132.06 179.6 5.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.822 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.9 t -124.63 74.74 63.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.599 0.714 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -8.67 24.2 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.693 2.262 . . . . 0.0 112.341 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 81.5 t -67.19 -42.81 88.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -116.47 -25.57 7.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.35 76.07 1.0 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.494 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 4.1 tp -168.98 106.33 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.901 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 62.5 mtt85 -70.05 160.58 31.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -137.6 160.96 37.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 32.7 mmtm -103.91 -37.92 7.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 23.5 mmt85 -87.29 146.08 26.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -89.1 -26.93 21.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -90.3 -27.91 19.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -83.7 -35.86 24.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -30.59 65.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 15.4 m -68.54 -42.58 78.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.838 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -54.53 -27.28 37.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -95.77 -57.43 2.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.802 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 95.8 t -53.55 -56.79 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -54.43 -33.42 59.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.6 t -52.04 -30.16 24.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.888 179.936 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.909 0.385 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 48.1 t -143.16 168.8 18.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.7 t -113.54 74.65 2.3 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.615 0.721 . . . . 0.0 110.832 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -8.65 24.14 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.745 2.297 . . . . 0.0 112.309 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 47.3 t -67.21 -43.33 88.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -116.31 -25.48 7.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.57 77.61 1.13 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 5.6 tp -168.61 112.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 110.883 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -72.52 167.0 21.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -150.66 146.67 26.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.76 -35.47 10.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -86.28 146.29 26.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -88.8 -26.02 21.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.12 -38.28 20.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.878 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -69.37 -45.31 69.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.72 -32.15 67.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 31.0 t -71.2 -24.28 62.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.857 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -84.28 -21.78 30.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.948 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -96.37 -55.79 2.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.833 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 64.5 t -54.07 -27.17 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -36.9 85.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 6.5 t -51.91 -30.31 23.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.845 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.952 0.406 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 4.5 p -153.16 172.67 16.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.857 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 19.2 t -117.44 74.94 8.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.593 0.711 . . . . 0.0 110.895 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -8.65 24.14 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.642 2.228 . . . . 0.0 112.371 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 99.7 t -66.43 -44.32 90.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.16 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.4 p -116.51 -25.49 7.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 107.49 77.35 1.04 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.527 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 8.4 tp -168.01 104.11 0.47 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.832 0.349 . . . . 0.0 110.939 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -66.54 167.4 10.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -150.71 177.61 9.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -125.15 -37.39 2.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -92.32 134.9 34.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.92 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -79.07 -24.43 43.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -85.0 -28.62 25.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -85.77 -46.24 10.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -58.78 -33.49 70.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 12.7 p -63.7 -44.59 93.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -59.72 -26.13 65.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.937 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -88.46 -59.4 2.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.837 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 38.8 t -51.66 -38.36 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.127 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -57.63 -32.21 67.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 8.4 t -54.08 -29.03 42.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.853 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.938 0.399 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 45.6 t -126.66 169.41 13.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.854 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 29.3 t -113.37 75.25 2.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.623 0.725 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -8.55 23.88 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.656 2.237 . . . . 0.0 112.323 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 23.8 t -65.99 -46.0 89.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.134 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -116.42 -25.55 7.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 107.11 80.53 1.31 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.53 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 11.0 tp -168.43 110.88 0.56 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.797 0.332 . . . . 0.0 110.956 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -71.55 164.33 26.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -151.44 134.1 15.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -89.84 -26.14 20.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 29.0 mtm-85 -88.03 148.71 24.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.93 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -89.02 -25.15 22.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.56 -55.5 3.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -52.08 -46.74 65.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.46 -36.47 64.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 40.0 t -72.02 -23.47 61.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -82.51 -22.85 34.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.908 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -96.53 -55.52 2.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.816 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 64.7 t -53.31 -28.03 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.36 -37.61 88.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 8.4 m -51.72 -31.04 24.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 179.982 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.87 0.366 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 53.0 p -165.53 -179.75 5.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.8 t -124.59 74.12 62.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.639 0.733 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 -12.3 32.74 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.694 2.263 . . . . 0.0 112.361 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 91.8 t -62.7 -43.16 98.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.134 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.38 -25.5 7.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.926 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.32 75.48 0.97 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 6.3 tp -165.81 108.4 0.78 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.909 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -73.74 161.57 30.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -142.52 170.09 16.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.88 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -110.96 -45.53 3.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -82.83 148.77 27.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -89.11 -25.87 21.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -88.79 -26.2 21.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -84.41 -33.72 23.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -28.75 68.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.82 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.1 t -68.49 -44.49 74.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.824 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -55.41 -26.26 40.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.934 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -95.24 -58.87 2.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.828 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 92.2 t -52.67 -56.86 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -53.47 -34.58 58.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.5 t -52.09 -30.13 24.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.828 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.95 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.893 0.377 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 45.2 p -124.28 173.51 8.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.859 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 25.0 t -113.36 75.87 2.49 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.663 0.744 . . . . 0.0 110.889 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -8.56 23.91 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.729 2.286 . . . . 0.0 112.356 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.61 -44.64 89.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.2 p -116.36 -25.3 7.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.63 77.39 1.07 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.493 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 13.1 tp -167.57 106.69 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.771 0.32 . . . . 0.0 110.92 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 39.0 mtt180 -68.05 164.79 19.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -152.78 159.14 43.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.19 -32.06 5.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.94 109.52 16.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -59.82 -25.42 64.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -84.79 -42.08 15.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.879 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -68.55 -46.91 68.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.82 -29.83 60.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 5.5 p -70.86 -23.96 62.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -86.75 -25.46 24.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -91.26 -56.53 3.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 96.9 t -51.8 -40.48 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.164 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -70.26 -28.96 65.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.9 t -52.3 -29.73 24.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.835 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 179.984 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.906 0.384 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 24.3 p -143.77 167.45 22.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.1 t -114.75 74.23 3.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.59 0.709 . . . . 0.0 110.907 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -12.81 33.67 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.63 2.22 . . . . 0.0 112.396 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.18 -42.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.075 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 19.0 p -116.51 -25.89 7.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.95 75.55 1.02 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.495 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 5.2 tt -166.68 110.3 0.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.817 0.342 . . . . 0.0 110.894 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -65.28 161.65 19.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.837 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -140.62 153.4 46.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.852 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -105.68 -29.27 10.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 27.6 mtt-85 -101.32 148.96 24.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -89.04 -26.15 21.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -83.86 -35.49 24.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.848 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -73.01 -38.9 66.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.91 -27.19 64.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.4 t -69.82 -26.42 64.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.847 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -87.7 -26.26 23.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.957 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -87.58 -57.77 2.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 66.5 t -52.3 -36.72 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -66.14 -31.58 72.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.1 t -52.13 -30.1 25.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.84 0.353 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 82.8 p -161.1 170.56 20.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.6 t -113.66 74.16 2.3 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.571 0.7 . . . . 0.0 110.857 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -11.72 31.43 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.712 2.275 . . . . 0.0 112.334 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.36 -43.13 98.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.138 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.7 p -116.48 -25.56 7.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.38 75.83 0.99 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 7.4 tp -167.23 104.71 0.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.819 0.342 . . . . 0.0 110.919 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 12.4 mtp85 -72.77 161.47 30.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -142.77 173.38 11.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -109.92 -48.02 3.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.926 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 10.4 mmp_? -78.26 150.62 33.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -89.09 -29.12 19.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.832 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -89.81 -26.67 20.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.54 -33.55 36.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -29.72 68.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 37.5 t -66.86 -42.87 84.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -55.68 -26.2 43.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -95.35 -55.27 3.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.854 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 73.6 t -53.55 -32.83 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.139 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -68.73 -29.97 68.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.82 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 5.0 m -52.09 -30.13 24.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.816 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.854 179.994 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.918 0.389 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 91.2 p -152.64 171.37 18.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.819 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.5 t -115.17 74.25 3.79 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.666 0.746 . . . . 0.0 110.91 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -11.33 30.66 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.707 2.272 . . . . 0.0 112.346 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.89 -43.16 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.8 p -116.44 -25.71 7.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.58 76.54 1.06 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.487 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 4.1 tp -166.83 113.36 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.786 0.326 . . . . 0.0 110.907 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -73.96 160.03 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -142.51 164.17 30.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.826 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -113.63 -37.27 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -83.75 144.48 29.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.822 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -27.77 20.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -85.41 -27.83 25.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -80.87 -48.45 12.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.64 -30.74 61.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 32.9 t -69.7 -26.31 64.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -81.89 -26.36 34.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.845 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -90.24 -54.98 3.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 91.9 t -53.65 -27.79 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.172 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -78.07 -31.3 50.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.845 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.7 t -52.17 -30.04 25.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.927 0.394 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 44.2 t -160.09 167.55 27.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.6 t -113.63 74.37 2.32 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.602 0.715 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -11.76 31.45 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.657 2.238 . . . . 0.0 112.324 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.5 t -63.66 -42.43 96.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.7 p -116.47 -25.56 7.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.22 75.06 0.98 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.5 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 4.5 tp -166.58 109.51 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.846 0.355 . . . . 0.0 110.89 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 39.9 mtp85 -72.66 160.67 31.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.878 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -143.64 154.23 43.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -99.67 -38.24 8.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -83.94 145.21 28.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -89.05 -27.99 20.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.893 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -86.81 -26.2 24.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -81.83 -35.62 29.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.858 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.98 -28.79 64.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 2.3 t -68.73 -26.29 65.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -82.89 -26.32 31.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.93 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -89.12 -54.31 4.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 89.5 t -53.19 -35.68 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.147 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 27.9 mtm-85 -68.5 -29.24 67.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.898 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 5.6 m -52.01 -30.11 23.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.852 179.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.884 0.373 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 2.3 p -157.94 164.91 36.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.849 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.7 t -115.38 74.23 4.14 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.638 0.733 . . . . 0.0 110.876 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -11.15 30.24 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.656 2.237 . . . . 0.0 112.323 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.01 -43.1 97.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.153 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 18.5 p -116.51 -25.81 7.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.71 77.0 1.12 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.471 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 5.4 tp -167.6 121.8 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 0.0 110.888 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -83.11 162.72 21.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.841 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -144.14 169.58 17.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -113.87 -42.12 3.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 -83.98 151.71 24.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -89.12 -28.3 20.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.58 -26.58 23.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.878 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 14.5 tpt85 -81.94 -33.08 30.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -29.97 64.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 95.9 p -67.58 -49.79 61.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.884 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -56.22 -26.19 50.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.947 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -88.9 -60.57 1.92 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.856 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 91.2 t -52.0 -38.07 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.128 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -68.14 -31.17 70.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 21.0 t -52.06 -30.67 26.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.859 179.982 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.897 0.38 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 35.8 p -159.61 174.19 14.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.832 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.9 t -117.25 74.25 7.68 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.653 0.74 . . . . 0.0 110.929 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -11.21 30.44 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.717 2.278 . . . . 0.0 112.353 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 93.4 t -64.23 -42.9 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.101 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.41 -25.53 7.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.46 76.02 1.03 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.481 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 4.4 tp -166.88 113.54 0.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.805 0.336 . . . . 0.0 110.962 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 76.9 mtt-85 -72.78 165.73 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.811 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -148.14 164.76 32.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -116.1 -34.94 4.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -91.01 130.33 36.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -73.62 -29.77 62.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -82.6 -26.44 32.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.884 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -82.46 -38.45 23.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -28.63 66.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 2.2 t -69.57 -26.14 64.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -84.05 -26.14 29.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -89.32 -55.49 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 92.1 t -52.99 -34.63 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.142 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -68.23 -30.8 69.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.1 t -52.03 -30.18 24.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.971 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.861 0.362 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 41.9 p -147.15 156.49 43.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 14.2 t -116.13 74.32 5.45 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.652 0.739 . . . . 0.0 110.851 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -10.28 28.18 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.686 2.257 . . . . 0.0 112.342 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.8 -43.84 96.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.096 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.7 p -116.48 -25.58 7.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.868 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 103.51 78.31 1.26 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.498 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 5.6 tp -168.61 134.32 1.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.801 0.334 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -93.38 163.28 13.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -146.11 169.87 17.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.91 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -116.61 -38.77 3.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -84.48 152.67 23.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.825 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.1 -31.17 18.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -82.73 -26.98 31.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -80.95 -40.69 24.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -31.65 72.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 70.3 p -68.15 -56.71 7.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -55.43 -26.27 40.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.937 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -82.94 -63.39 1.37 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.893 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 96.1 t -52.05 -34.98 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 44.3 mtm-85 -62.41 -34.07 76.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 7.3 m -52.08 -31.97 32.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.868 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.819 -179.938 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.892 0.377 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 83.1 p -131.34 161.54 32.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 15.0 t -114.36 74.21 2.92 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.655 0.741 . . . . 0.0 110.915 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -9.74 26.87 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 0.0 112.38 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.23 -44.21 95.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.108 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.8 p -116.42 -25.57 7.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 103.69 78.58 1.27 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.499 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 3.7 tp -168.59 135.29 1.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.803 0.335 . . . . 0.0 110.89 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -91.85 165.08 13.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -148.6 161.44 41.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.9 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -110.38 -35.26 6.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -88.73 151.01 22.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -89.08 -28.22 20.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -85.06 -26.41 26.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.921 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 15.0 ttp85 -81.89 -34.81 29.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.22 -29.39 62.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 28.3 t -67.99 -58.62 4.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.801 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -54.82 -26.98 38.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -82.38 -65.07 1.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 94.8 t -52.29 -29.57 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 16.0 mmt85 -76.89 -35.26 57.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 15.7 t -52.59 -29.61 26.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.853 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.899 0.381 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -157.12 168.23 28.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.887 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.2 t -115.62 74.31 4.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.615 0.721 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.85 -10.44 28.48 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.687 2.258 . . . . 0.0 112.322 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.4 t -64.76 -43.38 96.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.127 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 18.1 p -116.48 -25.7 7.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.61 77.34 1.11 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 3.6 tp -168.06 115.61 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.923 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -72.36 165.51 24.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.849 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -148.35 152.7 37.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -105.54 -32.39 8.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -93.7 146.3 23.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.11 -32.15 17.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -75.51 -26.78 58.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.61 -51.78 7.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.7 -28.86 57.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 30.9 t -70.65 -25.53 63.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -88.24 -25.62 22.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -88.89 -56.15 3.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 92.2 t -53.97 -57.59 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.111 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -52.93 -33.71 51.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.6 t -52.05 -30.11 24.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.893 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 179.974 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 91.5 p -129.95 118.42 21.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.918 0.39 . . . . 0.0 110.834 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 4.9 t -60.18 -70.14 0.18 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.861 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 103.18 51.15 1.01 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.517 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 66.1 p -149.23 133.2 17.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.891 0.377 . . . . 0.0 110.836 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 4.7 m -58.7 -31.78 68.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 173.41 89.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.529 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -144.77 140.5 28.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.893 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp 59.63 73.69 0.64 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.575 0.702 . . . . 0.0 110.848 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -13.1 34.13 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.662 2.241 . . . . 0.0 112.36 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -123.32 108.74 13.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 48.0 t -144.87 168.35 20.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.7 t -113.66 74.29 2.33 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.617 0.722 . . . . 0.0 110.888 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -11.29 30.47 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.671 2.247 . . . . 0.0 112.356 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.66 -43.56 98.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.43 -25.55 7.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.14 77.18 1.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 4.0 tp -168.06 108.64 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.919 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 50.0 mtt85 -66.68 163.81 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -148.26 147.64 29.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -98.15 -34.06 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -90.15 144.9 25.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.863 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp -89.11 -26.23 21.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -84.15 -28.96 27.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.881 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -80.01 -38.38 32.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -28.61 67.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 23.2 t -70.23 -25.64 63.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.825 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -86.41 -26.01 24.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -89.15 -56.63 3.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 92.0 t -52.67 -35.46 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.111 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 -68.0 -31.26 70.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 9.6 m -52.05 -30.18 24.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -79.27 -64.86 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -79.3 85.51 5.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -82.67 126.25 7.36 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 12.6 t -156.48 132.3 9.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.872 0.368 . . . . 0.0 110.895 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 11.2 p -172.16 147.36 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.14 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 170.82 59.98 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.462 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.05 160.22 0.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.772 0.32 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 72.7 p -72.43 163.34 28.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -74.33 170.97 53.23 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.476 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 107.11 1.78 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.644 2.229 . . . . 0.0 112.344 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 4.8 m -72.48 153.42 41.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.871 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 7.4 t -56.24 158.86 3.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 CA-C-O 119.141 -0.81 . . . . 0.0 112.471 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 38.8 m -89.87 177.41 6.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.902 0.382 . . . . 0.0 110.843 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 1.3 t -127.75 169.48 13.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.906 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 107.78 -48.71 0.92 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 37.7 m -103.48 44.44 1.02 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 0.0 110.834 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 74.9 m -87.68 98.52 11.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.864 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 172.68 156.9 13.27 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.482 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -79.12 137.24 37.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.935 0.398 . . . . 0.0 110.914 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.04 73.72 12.1 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.53 0.681 . . . . 0.0 110.843 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -15.6 37.18 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.709 2.273 . . . . 0.0 112.344 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -111.42 76.27 0.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.935 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.8 p -132.79 179.77 5.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.852 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 10.6 t -127.43 74.69 77.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.631 0.729 . . . . 0.0 110.883 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -8.99 25.01 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.696 2.264 . . . . 0.0 112.354 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.0 t -67.39 -41.41 86.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.131 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.44 -25.51 7.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.38 73.75 0.94 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.481 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 5.3 tt -168.53 106.06 0.46 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.782 0.325 . . . . 0.0 110.919 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -64.87 164.8 11.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -139.51 151.87 46.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -103.98 -29.76 10.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -91.75 147.14 23.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -86.95 -25.93 24.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -85.78 -51.6 6.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -57.06 -46.94 82.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -53.92 -36.57 62.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.933 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 29.0 t -70.0 -25.66 63.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.839 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -82.94 -25.96 31.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -90.81 -55.59 3.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 93.8 t -52.84 -29.89 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -76.94 -32.44 57.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 59.0 m -52.01 -30.12 23.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -75.02 -60.78 2.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.851 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -76.87 80.92 3.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.812 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -88.63 -107.93 1.06 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.521 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 80.6 p -119.32 47.61 1.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.871 0.367 . . . . 0.0 110.813 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 76.0 t -119.55 94.49 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.16 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -139.08 116.62 1.27 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.482 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -90.65 -45.75 8.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.893 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 78.0 p -62.43 145.79 53.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.839 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 93.8 167.69 37.83 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.427 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -45.08 1.71 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.691 2.26 . . . . 0.0 112.332 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 20.1 t -100.58 139.99 35.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.843 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 39.5 t -63.17 -31.9 73.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.861 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 CA-C-O 119.151 -0.805 . . . . 0.0 112.503 180.0 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 11.2 p -98.81 138.97 35.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.833 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 48.2 m -88.24 86.47 7.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 71.08 92.31 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.499 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 67.2 p -77.3 152.85 34.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.853 0.358 . . . . 0.0 110.904 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 3.0 t -113.38 170.27 8.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.868 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 73.5 -151.46 44.91 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.488 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -159.73 114.25 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 110.889 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -154.56 73.74 5.97 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.577 0.703 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -16.48 37.32 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.696 2.264 . . . . 0.0 112.356 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -107.47 80.9 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 9.6 p -123.75 173.2 8.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.857 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.0 t -113.51 74.75 2.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.704 . . . . 0.0 110.862 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -8.61 24.04 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.691 2.261 . . . . 0.0 112.389 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 91.5 t -66.72 -43.92 89.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.2 p -116.46 -25.4 7.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.36 77.27 1.08 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.506 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 9.9 tp -167.72 109.81 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.793 0.33 . . . . 0.0 110.934 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -69.05 163.98 23.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -151.13 141.69 22.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.2 tttp -91.84 -35.38 14.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -83.05 143.07 30.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.02 -25.88 21.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -83.91 -47.74 10.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 33.8 mmt-85 -60.2 -48.01 83.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.49 -27.97 51.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 6.3 t -70.35 -25.54 63.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.851 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -85.94 -25.92 25.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -89.5 -55.98 3.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.837 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 73.8 t -54.04 -27.31 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -77.27 -30.54 54.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 8.7 t -52.09 -30.16 24.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -79.37 -48.53 13.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.829 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -87.3 74.44 9.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.862 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -110.09 -104.63 2.86 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.487 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 3.9 t -52.05 -38.08 55.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.891 0.377 . . . . 0.0 110.841 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 65.6 t -82.21 142.66 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.143 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 111.4 -35.27 4.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.479 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -132.18 178.25 6.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.799 0.333 . . . . 0.0 110.879 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 3.0 m 54.19 27.99 8.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -160.62 -75.25 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.473 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 128.12 15.58 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.697 2.264 . . . . 0.0 112.352 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 11.2 p -89.42 74.47 7.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 31.8 t -97.15 -59.22 1.84 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 CA-C-O 119.157 -0.802 . . . . 0.0 112.499 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 11.4 t -164.62 127.4 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.888 0.375 . . . . 0.0 110.832 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 4.1 m -106.51 -42.09 5.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.88 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 173.18 -107.09 0.24 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.511 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 26.5 m -142.75 160.45 40.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.846 0.355 . . . . 0.0 110.854 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 68.6 p -156.19 128.77 7.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 79.99 -139.36 21.21 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.487 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -126.84 53.41 1.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.76 74.12 63.91 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 0.0 110.866 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -14.08 35.34 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.676 2.251 . . . . 0.0 112.31 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -112.73 84.84 2.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.8 p -138.92 169.55 17.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.916 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.5 t -113.87 74.7 2.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.594 0.712 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -8.63 24.1 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.651 2.234 . . . . 0.0 112.357 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.7 t -67.56 -41.88 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.55 -25.52 7.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.74 74.65 0.94 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.439 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 3.3 tp -168.73 105.7 0.43 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.787 0.327 . . . . 0.0 110.98 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -67.18 163.5 20.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -139.48 149.33 43.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.853 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -100.91 -29.68 12.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -93.01 144.82 24.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.64 -25.98 23.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -90.13 -28.23 19.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.856 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -82.71 -30.2 29.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -32.61 68.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 60.1 p -69.16 -25.39 64.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -80.85 -25.99 37.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -92.03 -54.71 3.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.866 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 94.9 t -51.98 -39.62 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.124 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -70.56 -28.84 65.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.839 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 9.3 t -52.11 -30.12 24.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -80.01 -56.26 4.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -53.61 -37.6 63.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -87.79 156.94 28.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.523 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 24.5 m -116.74 72.54 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.936 0.398 . . . . 0.0 110.843 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.7 p -54.18 -27.85 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.171 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 168.82 -162.47 36.24 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.502 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -119.8 34.46 5.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.785 0.326 . . . . 0.0 110.837 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 1.5 t -71.16 96.01 1.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.843 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 93.87 -178.13 37.5 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 178.04 4.96 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.719 2.28 . . . . 0.0 112.316 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 7.5 t -102.41 143.22 32.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 66.8 p -94.47 164.28 13.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.862 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 119.158 -0.801 . . . . 0.0 112.526 -179.965 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 3.6 t 56.04 30.67 16.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 0.0 110.825 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 22.0 t -126.52 32.9 5.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 89.34 121.99 2.09 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.491 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 13.7 m -114.5 66.31 0.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.836 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 2.3 m -97.51 -41.66 8.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.9 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 75.67 -177.31 49.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.449 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -97.23 75.53 2.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.924 0.393 . . . . 0.0 110.937 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -160.7 74.03 2.77 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.603 0.716 . . . . 0.0 110.886 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -16.01 37.13 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.639 2.226 . . . . 0.0 112.358 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -105.04 80.69 1.64 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 67.1 m -117.58 170.52 8.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.864 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 9.6 t -113.48 75.05 2.34 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.685 0.755 . . . . 0.0 110.919 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -8.7 24.28 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.679 2.253 . . . . 0.0 112.37 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.8 t -67.32 -41.43 86.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.12 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 20.8 p -116.83 -26.64 6.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.85 74.57 0.93 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.537 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 5.2 tt -169.03 112.42 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.901 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -65.97 159.47 25.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.841 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -140.15 140.44 35.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -92.44 -28.92 16.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 44.8 mmt-85 -93.89 143.05 26.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -88.57 -26.1 22.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -89.18 -37.19 15.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -70.35 -34.02 72.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.896 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.38 -26.23 62.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 56.1 m -70.03 -26.31 63.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -85.86 -26.15 25.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -88.47 -56.5 3.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.865 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 64.8 t -53.99 -27.38 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.098 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -75.06 -31.31 61.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.4 t -52.15 -30.07 24.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -77.5 -63.9 1.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -86.46 71.04 10.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -76.9 -64.07 2.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.492 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 2.6 p -80.46 100.31 8.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 0.0 110.866 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.83 93.83 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.144 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -158.62 48.71 0.42 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.472 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -59.69 99.13 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.761 0.315 . . . . 0.0 110.881 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.87 126.9 16.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 176.61 -75.41 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.489 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 93.79 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.654 2.236 . . . . 0.0 112.362 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 19.5 t -89.42 83.09 6.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.806 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 1.3 t -77.78 175.85 9.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.833 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 CA-C-O 119.172 -0.793 . . . . 0.0 112.506 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 8.5 t -117.58 116.34 26.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.853 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 1.7 p -79.63 146.8 32.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.845 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -179.33 -134.99 2.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.49 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 1.9 t -115.98 -39.75 3.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.888 0.375 . . . . 0.0 110.87 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 3.1 m -97.04 -45.68 6.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.845 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 84.48 164.87 38.55 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.487 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -84.86 -26.83 27.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.894 0.378 . . . . 0.0 110.882 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.08 74.44 58.05 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.576 0.703 . . . . 0.0 110.915 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 -8.77 24.43 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.65 2.233 . . . . 0.0 112.31 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -112.46 68.33 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.901 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 12.9 p -132.06 179.6 5.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.822 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.9 t -124.63 74.74 63.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.599 0.714 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -8.67 24.2 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.693 2.262 . . . . 0.0 112.341 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 81.5 t -67.19 -42.81 88.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -116.47 -25.57 7.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.35 76.07 1.0 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.494 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 4.1 tp -168.98 106.33 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.901 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 62.5 mtt85 -70.05 160.58 31.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -137.6 160.96 37.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 32.7 mmtm -103.91 -37.92 7.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 23.5 mmt85 -87.29 146.08 26.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -89.1 -26.93 21.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -90.3 -27.91 19.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -83.7 -35.86 24.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -30.59 65.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 15.4 m -68.54 -42.58 78.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.838 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -54.53 -27.28 37.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -95.77 -57.43 2.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.802 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 95.8 t -53.55 -56.79 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -54.43 -33.42 59.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.6 t -52.04 -30.16 24.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -72.03 -38.93 69.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -80.18 72.92 7.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.822 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 178.99 134.43 2.13 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.471 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 35.8 t -96.69 145.5 25.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.882 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.24 28.41 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.161 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -104.0 -75.14 1.03 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.38 175.12 8.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 0.0 110.886 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 3.5 p -73.06 -58.99 2.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.866 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 155.85 73.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.481 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 168.37 21.68 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.713 2.275 . . . . 0.0 112.313 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 12.9 p 52.19 34.9 15.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.822 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 3.0 m -76.63 -26.62 55.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.844 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 CA-C-O 119.125 -0.819 . . . . 0.0 112.494 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.456 -0.257 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 5.4 p -74.78 144.44 43.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.879 0.371 . . . . 0.0 110.868 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 46.8 t -131.78 -68.7 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.837 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 166.6 96.41 0.11 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.531 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 4.7 m -64.47 139.05 58.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 0.0 110.883 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.6 t -74.29 80.51 1.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -139.7 23.21 2.8 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.475 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -69.99 120.62 15.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.927 0.394 . . . . 0.0 110.868 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 4.4 mmtm 56.79 73.71 0.77 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.589 0.709 . . . . 0.0 110.854 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -13.74 35.01 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.641 2.227 . . . . 0.0 112.344 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -122.22 101.91 7.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 48.1 t -143.16 168.8 18.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.7 t -113.54 74.65 2.3 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.615 0.721 . . . . 0.0 110.832 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -8.65 24.14 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.745 2.297 . . . . 0.0 112.309 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 47.3 t -67.21 -43.33 88.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -116.31 -25.48 7.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.57 77.61 1.13 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 5.6 tp -168.61 112.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 110.883 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -72.52 167.0 21.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -150.66 146.67 26.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.76 -35.47 10.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -86.28 146.29 26.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -88.8 -26.02 21.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.12 -38.28 20.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.878 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -69.37 -45.31 69.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.72 -32.15 67.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 31.0 t -71.2 -24.28 62.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.857 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -84.28 -21.78 30.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.948 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -96.37 -55.79 2.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.833 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 64.5 t -54.07 -27.17 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -36.9 85.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 6.5 t -51.91 -30.31 23.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -91.24 46.68 1.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.845 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -75.64 160.64 29.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.845 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 143.91 126.08 1.94 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.528 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 30.0 m -58.41 158.29 7.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 0.0 110.871 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 39.9 t -93.75 120.21 42.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.102 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 102.99 58.56 0.75 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -90.08 119.81 30.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.839 0.352 . . . . 0.0 110.897 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 7.7 t 57.84 31.84 21.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -84.11 166.35 42.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.494 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 139.26 39.74 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.735 2.29 . . . . 0.0 112.302 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 41.9 t -91.05 -36.19 14.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 19.8 p -72.71 -65.7 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 CA-C-O 119.123 -0.821 . . . . 0.0 112.513 179.996 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.471 -0.251 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 9.9 m -73.53 114.78 12.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.87 0.367 . . . . 0.0 110.899 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 44.4 m -87.78 72.44 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 86.41 -144.06 19.68 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.473 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 12.2 m -103.08 163.89 11.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.9 0.381 . . . . 0.0 110.824 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 12.0 t -93.18 151.77 19.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 110.26 161.81 18.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.488 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -63.77 130.85 45.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.908 0.385 . . . . 0.0 110.881 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -120.14 74.0 20.57 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.562 0.696 . . . . 0.0 110.929 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 -14.31 36.05 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.692 2.261 . . . . 0.0 112.334 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -119.68 108.53 14.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 4.5 p -153.16 172.67 16.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.857 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 19.2 t -117.44 74.94 8.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.593 0.711 . . . . 0.0 110.895 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -8.65 24.14 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.642 2.228 . . . . 0.0 112.371 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 99.7 t -66.43 -44.32 90.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.16 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.4 p -116.51 -25.49 7.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 107.49 77.35 1.04 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.527 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 8.4 tp -168.01 104.11 0.47 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.832 0.349 . . . . 0.0 110.939 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -66.54 167.4 10.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -150.71 177.61 9.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -125.15 -37.39 2.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -92.32 134.9 34.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.92 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -79.07 -24.43 43.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -85.0 -28.62 25.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -85.77 -46.24 10.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -58.78 -33.49 70.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 12.7 p -63.7 -44.59 93.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -59.72 -26.13 65.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.937 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -88.46 -59.4 2.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.837 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 38.8 t -51.66 -38.36 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.127 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -57.63 -32.21 67.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 8.4 t -54.08 -29.03 42.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.853 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -85.75 -50.12 7.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -71.27 82.12 0.74 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -99.27 -143.42 14.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.442 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 49.7 m -103.05 86.7 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 0.0 110.894 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 47.9 t -146.82 136.15 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.145 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 80.04 -164.27 48.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.467 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -89.17 152.55 21.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.786 0.327 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 1.2 p -103.99 -60.22 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.803 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -156.93 -173.42 25.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.492 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -175.32 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.662 2.241 . . . . 0.0 112.345 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 4.7 p 55.24 26.89 8.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.82 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 11.6 m -128.27 159.31 35.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 CA-C-O 119.143 -0.809 . . . . 0.0 112.468 -179.948 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 30.0 t -155.13 107.87 2.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.869 0.366 . . . . 0.0 110.835 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 48.8 m -87.08 -68.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -162.16 -94.63 0.1 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.486 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 58.9 p -80.49 -32.23 37.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 110.833 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 51.3 m -156.84 146.35 20.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -112.89 160.99 12.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.431 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -101.52 100.47 10.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.923 0.392 . . . . 0.0 110.935 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -168.46 73.57 0.83 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.559 0.695 . . . . 0.0 110.87 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -16.29 37.57 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.722 2.281 . . . . 0.0 112.33 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -110.93 89.43 3.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 45.6 t -126.66 169.41 13.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.854 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 29.3 t -113.37 75.25 2.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.623 0.725 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -8.55 23.88 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.656 2.237 . . . . 0.0 112.323 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 23.8 t -65.99 -46.0 89.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.134 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -116.42 -25.55 7.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 107.11 80.53 1.31 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.53 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 11.0 tp -168.43 110.88 0.56 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.797 0.332 . . . . 0.0 110.956 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -71.55 164.33 26.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -151.44 134.1 15.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -89.84 -26.14 20.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 29.0 mtm-85 -88.03 148.71 24.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.93 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -89.02 -25.15 22.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.56 -55.5 3.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -52.08 -46.74 65.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.46 -36.47 64.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 40.0 t -72.02 -23.47 61.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -82.51 -22.85 34.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.908 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -96.53 -55.52 2.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.816 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 64.7 t -53.31 -28.03 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.36 -37.61 88.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 8.4 m -51.72 -31.04 24.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -92.03 -28.86 16.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -67.92 -42.86 80.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -111.92 -179.14 19.97 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 5.1 t -121.9 53.32 1.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.923 0.392 . . . . 0.0 110.896 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.53 -26.96 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.132 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -100.84 -93.52 2.16 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.45 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -106.25 166.82 10.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.776 0.322 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 29.5 p -83.08 92.53 7.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -68.48 -168.95 5.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.515 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -17.54 37.75 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.647 2.231 . . . . 0.0 112.355 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 12.9 p -161.71 142.71 10.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.835 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 88.6 p -103.42 81.92 1.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.837 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 CA-C-O 119.145 -0.808 . . . . 0.0 112.475 -179.982 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 6.2 m -66.98 -62.11 1.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.927 0.394 . . . . 0.0 110.855 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 3.6 p -76.47 170.83 15.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -171.83 -114.84 0.34 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.503 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 2.2 p -84.35 -42.97 15.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.921 0.391 . . . . 0.0 110.891 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 7.4 m -73.4 163.56 27.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.892 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -90.16 -159.56 35.65 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.51 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -95.81 -57.5 2.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.914 0.388 . . . . 0.0 110.872 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -83.82 160.69 57.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.611 0.72 . . . . 0.0 110.873 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -17.15 37.61 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.645 2.23 . . . . 0.0 112.36 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -141.48 128.53 20.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.957 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 53.0 p -165.53 -179.75 5.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.8 t -124.59 74.12 62.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.639 0.733 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 -12.3 32.74 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.694 2.263 . . . . 0.0 112.361 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 91.8 t -62.7 -43.16 98.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.134 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.38 -25.5 7.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.926 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.32 75.48 0.97 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 6.3 tp -165.81 108.4 0.78 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.909 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -73.74 161.57 30.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -142.52 170.09 16.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.88 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -110.96 -45.53 3.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -82.83 148.77 27.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -89.11 -25.87 21.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -88.79 -26.2 21.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -84.41 -33.72 23.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -28.75 68.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.82 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.1 t -68.49 -44.49 74.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.824 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -55.41 -26.26 40.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.934 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -95.24 -58.87 2.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.828 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 92.2 t -52.67 -56.86 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -53.47 -34.58 58.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.5 t -52.09 -30.13 24.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.828 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -69.77 -64.53 0.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -79.1 112.89 16.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 168.81 97.61 0.11 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.472 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 1.6 m -75.18 85.01 2.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.371 . . . . 0.0 110.861 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 12.2 p -97.76 -30.41 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -111.07 -68.5 0.56 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.454 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.81 81.39 8.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.763 0.316 . . . . 0.0 110.896 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 5.3 t -68.15 -35.96 78.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.861 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 131.67 -73.16 0.47 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.494 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 102.43 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.708 2.272 . . . . 0.0 112.319 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.1 m -142.61 144.88 33.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 38.9 m -54.31 131.79 42.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.819 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.464 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 8.6 m -151.88 139.79 20.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.874 0.369 . . . . 0.0 110.881 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 11.4 t -56.65 -51.29 69.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.899 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 138.25 127.38 2.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 3.0 m -103.97 108.84 20.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 0.0 110.872 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 17.4 p -100.4 68.29 1.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -137.28 178.49 18.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.509 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -82.17 109.13 16.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -142.2 73.92 21.34 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.58 0.705 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -15.68 37.27 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.662 2.241 . . . . 0.0 112.31 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -101.59 77.02 1.71 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.872 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 45.2 p -124.28 173.51 8.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.859 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 25.0 t -113.36 75.87 2.49 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.663 0.744 . . . . 0.0 110.889 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -8.56 23.91 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.729 2.286 . . . . 0.0 112.356 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.61 -44.64 89.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.2 p -116.36 -25.3 7.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.63 77.39 1.07 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.493 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 13.1 tp -167.57 106.69 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.771 0.32 . . . . 0.0 110.92 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 39.0 mtt180 -68.05 164.79 19.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -152.78 159.14 43.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.19 -32.06 5.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.94 109.52 16.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -59.82 -25.42 64.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -84.79 -42.08 15.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.879 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -68.55 -46.91 68.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.82 -29.83 60.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 5.5 p -70.86 -23.96 62.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -86.75 -25.46 24.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -91.26 -56.53 3.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 96.9 t -51.8 -40.48 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.164 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -70.26 -28.96 65.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.9 t -52.3 -29.73 24.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.835 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -77.58 -65.94 0.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -76.01 108.54 8.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -135.1 -42.52 0.12 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.449 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 10.4 p -59.1 143.51 48.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.899 0.38 . . . . 0.0 110.872 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 10.1 p -62.66 140.82 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.132 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -166.02 -58.38 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.504 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 33.2 tttm 58.37 37.48 25.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.778 0.323 . . . . 0.0 110.873 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 6.1 p -112.47 108.98 18.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.829 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 139.67 -71.56 0.44 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.496 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 143.3 50.17 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.732 2.288 . . . . 0.0 112.305 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 67.3 m -102.11 62.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.855 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 16.2 p -162.34 171.59 16.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 CA-C-O 119.18 -0.789 . . . . 0.0 112.453 -179.966 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 2.8 p -61.61 -55.98 24.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.389 . . . . 0.0 110.858 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 72.8 m -90.51 -179.31 5.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.825 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -162.28 -43.57 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.478 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 18.9 t -153.39 142.9 21.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.894 0.378 . . . . 0.0 110.876 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 37.6 t -98.82 -43.38 6.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 165.69 71.18 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.452 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -56.61 132.9 53.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 110.927 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -104.43 160.7 25.15 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.613 0.72 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -20.7 34.3 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.638 2.225 . . . . 0.0 112.332 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -126.98 110.5 13.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.951 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 24.3 p -143.77 167.45 22.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.1 t -114.75 74.23 3.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.59 0.709 . . . . 0.0 110.907 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -12.81 33.67 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.63 2.22 . . . . 0.0 112.396 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.18 -42.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.075 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 19.0 p -116.51 -25.89 7.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.95 75.55 1.02 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.495 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 5.2 tt -166.68 110.3 0.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.817 0.342 . . . . 0.0 110.894 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -65.28 161.65 19.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.837 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -140.62 153.4 46.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.852 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -105.68 -29.27 10.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 27.6 mtt-85 -101.32 148.96 24.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -89.04 -26.15 21.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -83.86 -35.49 24.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.848 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -73.01 -38.9 66.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.91 -27.19 64.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.4 t -69.82 -26.42 64.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.847 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -87.7 -26.26 23.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.957 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -87.58 -57.77 2.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 66.5 t -52.3 -36.72 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -66.14 -31.58 72.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.1 t -52.13 -30.1 25.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -79.09 -46.8 17.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -57.85 -34.98 70.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -80.78 -35.85 23.97 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.444 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 6.1 m -71.86 136.71 47.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 110.852 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.78 142.73 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.121 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -137.2 -111.15 1.04 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.481 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -91.91 -51.76 5.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.759 0.314 . . . . 0.0 110.897 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.83 178.93 0.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -132.17 -167.51 11.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.464 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 138.83 38.89 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.678 2.252 . . . . 0.0 112.372 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 3.6 m -131.89 92.35 3.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 96.5 p -63.74 123.6 19.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 CA-C-O 119.168 -0.795 . . . . 0.0 112.475 -179.98 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 86.4 p -71.8 -33.76 68.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 110.842 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 17.9 p -90.35 63.17 5.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.816 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 168.24 -115.01 0.59 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.432 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 30.2 m -159.67 162.36 35.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.855 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 4.4 m -97.66 -65.29 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 111.47 -156.33 15.63 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.551 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -129.48 126.41 38.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 0.0 110.906 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -81.37 160.72 64.37 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.616 0.722 . . . . 0.0 110.859 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -16.77 37.45 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.69 2.26 . . . . 0.0 112.315 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -133.83 124.11 25.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 82.8 p -161.1 170.56 20.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.6 t -113.66 74.16 2.3 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.571 0.7 . . . . 0.0 110.857 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -11.72 31.43 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.712 2.275 . . . . 0.0 112.334 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.36 -43.13 98.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.138 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.7 p -116.48 -25.56 7.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.38 75.83 0.99 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 7.4 tp -167.23 104.71 0.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.819 0.342 . . . . 0.0 110.919 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 12.4 mtp85 -72.77 161.47 30.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -142.77 173.38 11.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -109.92 -48.02 3.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.926 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 10.4 mmp_? -78.26 150.62 33.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -89.09 -29.12 19.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.832 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -89.81 -26.67 20.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.54 -33.55 36.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -29.72 68.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 37.5 t -66.86 -42.87 84.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -55.68 -26.2 43.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -95.35 -55.27 3.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.854 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 73.6 t -53.55 -32.83 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.139 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -68.73 -29.97 68.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.82 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 5.0 m -52.09 -30.13 24.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.816 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -85.35 54.03 2.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -88.24 135.42 33.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 135.21 -49.08 0.91 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.534 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 4.2 m 54.59 28.61 10.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.899 0.381 . . . . 0.0 110.852 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.52 142.25 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.123 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 97.1 71.38 1.06 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.501 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -118.69 124.48 47.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.0 110.926 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 12.9 t -127.99 120.65 28.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.861 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 89.6 72.19 1.26 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.464 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 143.23 50.36 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.7 2.267 . . . . 0.0 112.322 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 73.6 m -104.04 -33.42 8.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 48.1 p -122.89 -176.47 3.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.838 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 CA-C-O 119.158 -0.801 . . . . 0.0 112.522 179.981 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 4.6 m -136.99 127.76 27.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.918 0.389 . . . . 0.0 110.836 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 5.7 t -115.38 130.04 56.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.832 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -146.7 78.12 0.24 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.477 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 60.5 p -53.37 126.6 21.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 0.0 110.878 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 2.7 t -113.79 95.49 5.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 97.93 133.45 7.93 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.529 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -124.39 132.84 53.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.916 0.389 . . . . 0.0 110.926 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 30.1 mttp -87.68 160.64 46.94 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.542 0.687 . . . . 0.0 110.936 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -18.41 37.17 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.681 2.254 . . . . 0.0 112.336 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -136.06 120.11 17.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.876 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 91.2 p -152.64 171.37 18.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.819 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.5 t -115.17 74.25 3.79 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.666 0.746 . . . . 0.0 110.91 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -11.33 30.66 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.707 2.272 . . . . 0.0 112.346 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.89 -43.16 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.8 p -116.44 -25.71 7.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.58 76.54 1.06 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.487 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 4.1 tp -166.83 113.36 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.786 0.326 . . . . 0.0 110.907 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -73.96 160.03 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -142.51 164.17 30.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.826 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -113.63 -37.27 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -83.75 144.48 29.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.822 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -27.77 20.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -85.41 -27.83 25.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -80.87 -48.45 12.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.64 -30.74 61.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 32.9 t -69.7 -26.31 64.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -81.89 -26.36 34.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.845 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -90.24 -54.98 3.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 91.9 t -53.65 -27.79 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.172 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -78.07 -31.3 50.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.845 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.7 t -52.17 -30.04 25.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -76.83 -35.72 57.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.88 111.11 4.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.892 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 91.6 106.49 1.49 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.456 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 8.6 t -81.34 161.59 23.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.912 0.387 . . . . 0.0 110.836 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.9 p -84.87 -31.5 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.132 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -58.49 -64.08 4.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.474 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -77.46 -179.74 5.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.753 0.311 . . . . 0.0 110.899 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 1.4 t -122.87 167.04 14.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.862 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -154.07 176.64 31.88 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.51 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 91.82 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.637 2.225 . . . . 0.0 112.356 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.6 p -126.72 106.26 9.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.868 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 3.5 m -133.47 109.1 9.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 CA-C-O 119.138 -0.812 . . . . 0.0 112.477 -179.943 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 1.2 m -86.92 144.15 27.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.92 0.39 . . . . 0.0 110.883 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 63.3 p -172.6 160.08 4.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.832 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 80.4 60.52 2.35 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.481 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 3.6 t -112.59 -39.72 4.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.37 . . . . 0.0 110.892 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 16.2 m -80.53 93.23 6.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.855 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 168.33 65.93 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.499 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.23 139.23 35.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 110.868 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 36.0 mttm -108.49 160.65 26.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.557 0.694 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -16.98 37.91 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.655 2.236 . . . . 0.0 112.372 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -137.44 125.23 22.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 44.2 t -160.09 167.55 27.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.6 t -113.63 74.37 2.32 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.602 0.715 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -11.76 31.45 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.657 2.238 . . . . 0.0 112.324 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.5 t -63.66 -42.43 96.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.7 p -116.47 -25.56 7.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.22 75.06 0.98 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.5 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 4.5 tp -166.58 109.51 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.846 0.355 . . . . 0.0 110.89 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 39.9 mtp85 -72.66 160.67 31.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.878 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -143.64 154.23 43.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -99.67 -38.24 8.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -83.94 145.21 28.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -89.05 -27.99 20.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.893 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -86.81 -26.2 24.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -81.83 -35.62 29.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.858 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.98 -28.79 64.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 2.3 t -68.73 -26.29 65.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -82.89 -26.32 31.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.93 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -89.12 -54.31 4.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 89.5 t -53.19 -35.68 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.147 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 27.9 mtm-85 -68.5 -29.24 67.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.898 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 5.6 m -52.01 -30.11 23.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -85.21 -32.61 22.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.852 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -69.38 112.65 6.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.816 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -163.8 -94.62 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.474 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 3.3 p -118.74 64.99 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.902 0.382 . . . . 0.0 110.847 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 17.6 m -131.69 156.19 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 168.87 -131.3 2.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -129.29 -44.07 1.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.789 0.328 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 25.8 m 60.45 26.67 16.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.851 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -110.53 -175.13 20.54 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.467 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 103.41 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.692 2.261 . . . . 0.0 112.352 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 3.0 t -129.66 113.23 14.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.854 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 58.1 p -124.08 29.03 6.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.871 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 CA-C-O 119.171 -0.794 . . . . 0.0 112.476 -179.946 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 26.8 t -110.83 66.65 0.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.83 0.348 . . . . 0.0 110.833 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 5.3 m -78.22 -50.92 11.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 137.32 -143.89 15.22 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.549 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 9.5 m -76.79 163.98 26.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.862 0.363 . . . . 0.0 110.829 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.8 p -86.63 -47.32 9.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -104.71 19.59 41.26 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.448 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 55.92 32.72 20.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.909 0.385 . . . . 0.0 110.88 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -150.27 160.65 32.76 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.623 0.725 . . . . 0.0 110.858 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -20.26 34.85 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.671 2.247 . . . . 0.0 112.34 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -142.87 134.71 26.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.952 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 2.3 p -157.94 164.91 36.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.849 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.7 t -115.38 74.23 4.14 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.638 0.733 . . . . 0.0 110.876 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -11.15 30.24 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.656 2.237 . . . . 0.0 112.323 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.01 -43.1 97.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.153 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 18.5 p -116.51 -25.81 7.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.71 77.0 1.12 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.471 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 5.4 tp -167.6 121.8 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 0.0 110.888 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -83.11 162.72 21.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.841 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -144.14 169.58 17.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -113.87 -42.12 3.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 -83.98 151.71 24.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -89.12 -28.3 20.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.58 -26.58 23.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.878 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 14.5 tpt85 -81.94 -33.08 30.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -29.97 64.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 95.9 p -67.58 -49.79 61.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.884 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -56.22 -26.19 50.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.947 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -88.9 -60.57 1.92 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.856 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 91.2 t -52.0 -38.07 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.128 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -68.14 -31.17 70.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 21.0 t -52.06 -30.67 26.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -75.89 -37.71 58.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -71.2 -61.44 1.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -78.72 66.5 3.32 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.505 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 26.7 p -170.15 176.97 4.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.932 0.396 . . . . 0.0 110.892 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 34.8 m -74.08 141.03 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.098 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -83.81 106.63 2.87 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.512 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 86.22 1.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.805 0.336 . . . . 0.0 110.91 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 12.9 p -87.05 60.12 6.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -73.14 -70.11 1.28 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.502 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 121.23 7.93 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.677 2.251 . . . . 0.0 112.334 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 22.3 t -77.01 133.15 39.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 17.6 m -127.82 177.68 6.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.531 179.951 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 1.8 t -53.18 -62.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 0.0 110.871 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 54.4 m -54.34 113.62 1.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.852 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 143.68 -133.82 5.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 35.3 p -133.9 144.4 48.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 0.0 110.855 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.7 t -96.1 65.49 2.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.916 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -175.32 166.54 38.09 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.476 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -124.51 163.81 21.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.9 0.381 . . . . 0.0 110.859 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -105.86 160.67 25.33 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.568 0.699 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -19.64 36.03 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.686 2.257 . . . . 0.0 112.356 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -140.27 129.28 23.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 35.8 p -159.61 174.19 14.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.832 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.9 t -117.25 74.25 7.68 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.653 0.74 . . . . 0.0 110.929 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -11.21 30.44 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.717 2.278 . . . . 0.0 112.353 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 93.4 t -64.23 -42.9 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.101 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.41 -25.53 7.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.46 76.02 1.03 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.481 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 4.4 tp -166.88 113.54 0.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.805 0.336 . . . . 0.0 110.962 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 76.9 mtt-85 -72.78 165.73 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.811 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -148.14 164.76 32.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -116.1 -34.94 4.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -91.01 130.33 36.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -73.62 -29.77 62.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -82.6 -26.44 32.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.884 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -82.46 -38.45 23.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -28.63 66.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 2.2 t -69.57 -26.14 64.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -84.05 -26.14 29.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -89.32 -55.49 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 92.1 t -52.99 -34.63 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.142 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -68.23 -30.8 69.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.1 t -52.03 -30.18 24.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -82.84 -53.99 5.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -57.24 116.6 3.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.856 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 150.8 -54.03 0.48 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.514 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 58.6 m -52.4 109.06 0.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.924 0.393 . . . . 0.0 110.878 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 29.1 m -99.25 139.85 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.16 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 82.6 120.49 0.64 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.509 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -104.08 -65.03 1.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 0.0 110.891 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 45.5 t -72.26 -65.98 0.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 168.55 -74.28 0.13 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.483 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -18.78 36.51 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.669 2.246 . . . . 0.0 112.342 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 67.1 m -99.95 62.75 1.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.862 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 61.9 p -56.93 132.08 51.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 CA-C-O 119.135 -0.814 . . . . 0.0 112.475 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 1.9 m -83.26 136.02 34.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.858 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 6.9 t -83.68 -31.17 26.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 93.01 -152.49 21.0 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.51 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 71.5 m -104.19 -46.26 4.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.358 . . . . 0.0 110.882 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 4.3 p -125.99 156.3 40.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.866 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -153.68 65.65 0.33 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.438 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -170.95 137.25 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.917 0.389 . . . . 0.0 110.901 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -146.12 160.65 42.3 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.551 0.691 . . . . 0.0 110.918 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -17.31 37.81 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.699 2.266 . . . . 0.0 112.362 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -129.48 122.18 28.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.907 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 41.9 p -147.15 156.49 43.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 14.2 t -116.13 74.32 5.45 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.652 0.739 . . . . 0.0 110.851 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -10.28 28.18 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.686 2.257 . . . . 0.0 112.342 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.8 -43.84 96.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.096 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.7 p -116.48 -25.58 7.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.868 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 103.51 78.31 1.26 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.498 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 5.6 tp -168.61 134.32 1.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.801 0.334 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -93.38 163.28 13.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -146.11 169.87 17.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.91 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -116.61 -38.77 3.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -84.48 152.67 23.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.825 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.1 -31.17 18.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -82.73 -26.98 31.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -80.95 -40.69 24.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -31.65 72.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 70.3 p -68.15 -56.71 7.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -55.43 -26.27 40.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.937 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -82.94 -63.39 1.37 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.893 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 96.1 t -52.05 -34.98 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 44.3 mtm-85 -62.41 -34.07 76.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 7.3 m -52.08 -31.97 32.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.868 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -79.86 -49.74 11.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.819 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -74.28 80.31 1.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.838 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -108.5 -65.9 0.58 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.508 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 29.0 t -88.12 130.29 35.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 0.0 110.892 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.28 173.98 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.138 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 110.66 -115.24 3.97 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.553 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -77.08 138.51 39.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.812 0.339 . . . . 0.0 110.895 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 3.7 p -160.18 176.65 11.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 79.61 173.23 44.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.452 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 174.08 10.07 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.686 2.257 . . . . 0.0 112.317 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 2.6 p -117.19 87.38 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.843 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 66.4 m -106.51 173.24 6.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.822 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 CA-C-O 119.1 -0.833 . . . . 0.0 112.54 -179.961 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 4.9 t -95.29 -65.56 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 0.0 110.857 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 75.6 m -78.8 -59.34 2.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.88 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 105.3 -178.89 23.64 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.507 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 23.0 p -171.34 137.75 1.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 110.831 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 36.5 t -103.23 83.93 2.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.875 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -129.52 150.56 18.98 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.545 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -157.25 143.56 17.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 110.871 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 4.7 mttm 63.1 160.6 0.12 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.516 0.674 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -18.35 37.12 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.701 2.267 . . . . 0.0 112.335 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -137.93 109.27 6.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.974 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 83.1 p -131.34 161.54 32.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 15.0 t -114.36 74.21 2.92 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.655 0.741 . . . . 0.0 110.915 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -9.74 26.87 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 0.0 112.38 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.23 -44.21 95.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.108 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.8 p -116.42 -25.57 7.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 103.69 78.58 1.27 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.499 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 3.7 tp -168.59 135.29 1.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.803 0.335 . . . . 0.0 110.89 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -91.85 165.08 13.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -148.6 161.44 41.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.9 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -110.38 -35.26 6.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -88.73 151.01 22.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -89.08 -28.22 20.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -85.06 -26.41 26.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.921 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 15.0 ttp85 -81.89 -34.81 29.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.22 -29.39 62.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 28.3 t -67.99 -58.62 4.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.801 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -54.82 -26.98 38.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -82.38 -65.07 1.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 94.8 t -52.29 -29.57 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 16.0 mmt85 -76.89 -35.26 57.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 15.7 t -52.59 -29.61 26.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -65.1 -69.53 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.853 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.92 -29.1 59.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -97.69 54.3 1.24 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.476 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 11.7 t -171.96 152.81 3.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.952 0.406 . . . . 0.0 110.849 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 30.9 m -72.3 -176.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.135 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 110.58 -76.37 0.22 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.9 139.08 45.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.802 0.334 . . . . 0.0 110.898 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 63.8 p -113.65 77.05 1.02 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 64.01 173.83 3.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.461 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -29.0 24.48 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.696 2.264 . . . . 0.0 112.373 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 2.2 m 58.47 37.5 25.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.871 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 93.3 p -145.68 153.04 40.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.811 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 CA-C-O 119.107 -0.829 . . . . 0.0 112.484 -179.971 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 88.8 p -130.06 175.01 9.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.909 0.385 . . . . 0.0 110.861 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 1.4 p -164.34 155.05 15.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.826 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 93.93 151.39 28.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.53 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 58.1 43.27 21.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.943 0.402 . . . . 0.0 110.879 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 6.0 m -90.66 -29.99 17.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.863 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -129.2 90.24 0.31 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.476 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -101.74 30.29 4.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 110.927 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 37.0 mttt -89.49 160.66 41.54 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.589 0.709 . . . . 0.0 110.89 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -19.69 35.92 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.639 2.226 . . . . 0.0 112.358 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -138.17 123.04 18.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -157.12 168.23 28.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.887 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.2 t -115.62 74.31 4.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.615 0.721 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.85 -10.44 28.48 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.687 2.258 . . . . 0.0 112.322 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.4 t -64.76 -43.38 96.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.127 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 18.1 p -116.48 -25.7 7.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.61 77.34 1.11 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 3.6 tp -168.06 115.61 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.923 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -72.36 165.51 24.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.849 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -148.35 152.7 37.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -105.54 -32.39 8.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -93.7 146.3 23.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.11 -32.15 17.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -75.51 -26.78 58.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.61 -51.78 7.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.7 -28.86 57.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 30.9 t -70.65 -25.53 63.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -88.24 -25.62 22.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -88.89 -56.15 3.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 92.2 t -53.97 -57.59 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.111 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -52.93 -33.71 51.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.6 t -52.05 -30.11 24.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.893 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -70.67 -41.03 72.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -71.34 96.87 1.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 150.53 -29.84 1.05 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.559 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 17.1 t -78.12 -26.96 48.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.905 0.383 . . . . 0.0 110.855 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 32.8 t 58.54 70.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.104 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -147.14 40.11 1.02 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.537 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -139.8 155.77 47.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 110.937 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 17.3 t -94.4 74.47 3.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 167.27 69.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.513 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 101.71 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.683 2.256 . . . . 0.0 112.352 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 7.1 t -103.29 68.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.826 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 1.9 t -90.04 -50.36 6.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 CA-C-O 119.13 -0.817 . . . . 0.0 112.492 179.998 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.881 0.372 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 48.0 t -144.87 168.35 20.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.405 ' SG ' HG22 ' A' ' 402' ' ' VAL . 12.7 t -113.66 74.29 2.33 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.617 0.722 . . . . 0.0 110.888 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -11.29 30.47 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.671 2.247 . . . . 0.0 112.356 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.66 -43.56 98.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.43 -25.55 7.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.14 77.18 1.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.698 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 4.0 tp -168.06 108.64 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.919 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 50.0 mtt85 -66.68 163.81 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.698 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 42.4 m-85 -148.26 147.64 29.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -98.15 -34.06 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -90.15 144.9 25.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.863 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp -89.11 -26.23 21.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -84.15 -28.96 27.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.881 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -80.01 -38.38 32.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.47 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -68.53 -28.61 67.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 23.2 t -70.23 -25.64 63.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.825 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -86.41 -26.01 24.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -89.15 -56.63 3.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 398' ' ' MET . 92.0 t -52.67 -35.46 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.111 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 -68.0 -31.26 70.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 9.6 m -52.05 -30.18 24.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.893 0.378 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.8 p -132.79 179.77 5.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.852 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 10.6 t -127.43 74.69 77.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.631 0.729 . . . . 0.0 110.883 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -8.99 25.01 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.696 2.264 . . . . 0.0 112.354 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.0 t -67.39 -41.41 86.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.131 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.44 -25.51 7.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.38 73.75 0.94 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.481 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.627 HD23 ' O ' ' A' ' 391' ' ' ARG . 5.3 tt -168.53 106.06 0.46 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.782 0.325 . . . . 0.0 110.919 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.627 ' O ' HD23 ' A' ' 390' ' ' LEU . 56.6 mtm180 -64.87 164.8 11.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.607 ' CE1' HD22 ' A' ' 390' ' ' LEU . 7.6 m-85 -139.51 151.87 46.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -103.98 -29.76 10.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -91.75 147.14 23.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -86.95 -25.93 24.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -85.78 -51.6 6.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -57.06 -46.94 82.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.501 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.3 OUTLIER -53.92 -36.57 62.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.933 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 29.0 t -70.0 -25.66 63.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.839 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -82.94 -25.96 31.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -90.81 -55.59 3.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 398' ' ' MET . 93.8 t -52.84 -29.89 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -76.94 -32.44 57.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 59.0 m -52.01 -30.12 23.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.851 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.898 0.38 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 9.6 p -123.75 173.2 8.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.857 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.0 t -113.51 74.75 2.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.704 . . . . 0.0 110.862 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -8.61 24.04 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.691 2.261 . . . . 0.0 112.389 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 91.5 t -66.72 -43.92 89.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.2 p -116.46 -25.4 7.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.36 77.27 1.08 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.506 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.706 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 9.9 tp -167.72 109.81 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.793 0.33 . . . . 0.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -69.05 163.98 23.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.706 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 53.0 m-85 -151.13 141.69 22.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.2 tttp -91.84 -35.38 14.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -83.05 143.07 30.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.02 -25.88 21.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -83.91 -47.74 10.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 33.8 mmt-85 -60.2 -48.01 83.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.473 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -55.49 -27.97 51.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 6.3 t -70.35 -25.54 63.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.851 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -85.94 -25.92 25.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -89.5 -55.98 3.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.837 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 398' ' ' MET . 73.8 t -54.04 -27.31 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -77.27 -30.54 54.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 8.7 t -52.09 -30.16 24.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.829 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.914 0.388 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.8 p -138.92 169.55 17.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.916 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.5 t -113.87 74.7 2.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.594 0.712 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -8.63 24.1 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.651 2.234 . . . . 0.0 112.357 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.7 t -67.56 -41.88 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.55 -25.52 7.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.74 74.65 0.94 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.439 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.597 HD23 ' CE1' ' A' ' 392' ' ' PHE . 3.3 tp -168.73 105.7 0.43 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.787 0.327 . . . . 0.0 110.98 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -67.18 163.5 20.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.597 ' CE1' HD23 ' A' ' 390' ' ' LEU . 7.7 m-85 -139.48 149.33 43.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.853 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -100.91 -29.68 12.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -93.01 144.82 24.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.64 -25.98 23.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -90.13 -28.23 19.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.856 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -82.71 -30.2 29.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.523 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.2 OUTLIER -71.28 -32.61 68.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 60.1 p -69.16 -25.39 64.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -80.85 -25.99 37.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -92.03 -54.71 3.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.866 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 398' ' ' MET . 94.9 t -51.98 -39.62 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -70.56 -28.84 65.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.839 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 9.3 t -52.11 -30.12 24.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 179.959 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.871 0.367 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 67.1 m -117.58 170.52 8.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.864 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.545 ' SG ' HG22 ' A' ' 402' ' ' VAL . 9.6 t -113.48 75.05 2.34 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.685 0.755 . . . . 0.0 110.919 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -8.7 24.28 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.679 2.253 . . . . 0.0 112.37 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.8 t -67.32 -41.43 86.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.12 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 20.8 p -116.83 -26.64 6.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.85 74.57 0.93 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.537 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 391' ' ' ARG . 5.2 tt -169.03 112.42 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.901 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.657 ' O ' HD23 ' A' ' 390' ' ' LEU . 34.0 mtp180 -65.97 159.47 25.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.841 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.639 ' CE1' HD22 ' A' ' 390' ' ' LEU . 7.4 m-85 -140.15 140.44 35.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -92.44 -28.92 16.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 44.8 mmt-85 -93.89 143.05 26.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -88.57 -26.1 22.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -89.18 -37.19 15.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -70.35 -34.02 72.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.896 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.478 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.2 OUTLIER -71.38 -26.23 62.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 56.1 m -70.03 -26.31 63.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -85.86 -26.15 25.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -88.47 -56.5 3.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.865 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.545 HG22 ' SG ' ' A' ' 385' ' ' CYS . 64.8 t -53.99 -27.38 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.098 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -75.06 -31.31 61.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.4 t -52.15 -30.07 24.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 179.983 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.861 0.362 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 12.9 p -132.06 179.6 5.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.822 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.9 t -124.63 74.74 63.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.599 0.714 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -8.67 24.2 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.693 2.262 . . . . 0.0 112.341 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 81.5 t -67.19 -42.81 88.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -116.47 -25.57 7.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.35 76.07 1.0 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.494 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.629 HD23 ' CE1' ' A' ' 392' ' ' PHE . 4.1 tp -168.98 106.33 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.901 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 62.5 mtt85 -70.05 160.58 31.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.629 ' CE1' HD23 ' A' ' 390' ' ' LEU . 13.5 m-85 -137.6 160.96 37.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 32.7 mmtm -103.91 -37.92 7.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 23.5 mmt85 -87.29 146.08 26.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -89.1 -26.93 21.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -90.3 -27.91 19.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -83.7 -35.86 24.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.517 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -57.71 -30.59 65.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 15.4 m -68.54 -42.58 78.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.838 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -54.53 -27.28 37.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -95.77 -57.43 2.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.802 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 398' ' ' MET . 95.8 t -53.55 -56.79 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -54.43 -33.42 59.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.6 t -52.04 -30.16 24.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.888 179.936 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.909 0.385 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 48.1 t -143.16 168.8 18.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.7 t -113.54 74.65 2.3 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.615 0.721 . . . . 0.0 110.832 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -8.65 24.14 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.745 2.297 . . . . 0.0 112.309 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 405' ' ' HIS . 47.3 t -67.21 -43.33 88.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -116.31 -25.48 7.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.57 77.61 1.13 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.727 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 5.6 tp -168.61 112.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 110.883 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -72.52 167.0 21.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.727 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 53.6 m-85 -150.66 146.67 26.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.76 -35.47 10.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -86.28 146.29 26.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -88.8 -26.02 21.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.12 -38.28 20.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.878 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -69.37 -45.31 69.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.479 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -57.72 -32.15 67.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 31.0 t -71.2 -24.28 62.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.857 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -84.28 -21.78 30.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.948 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -96.37 -55.79 2.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.833 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 398' ' ' MET . 64.5 t -54.07 -27.17 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -36.9 85.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 6.5 t -51.91 -30.31 23.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.595 ' HB3' HG11 ' A' ' 387' ' ' VAL . 65.6 m-70 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.845 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.952 0.406 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 4.5 p -153.16 172.67 16.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.857 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.409 ' SG ' HG22 ' A' ' 402' ' ' VAL . 19.2 t -117.44 74.94 8.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.593 0.711 . . . . 0.0 110.895 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -8.65 24.14 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.642 2.228 . . . . 0.0 112.371 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 99.7 t -66.43 -44.32 90.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.16 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.4 p -116.51 -25.49 7.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 107.49 77.35 1.04 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.527 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.681 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 8.4 tp -168.01 104.11 0.47 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.832 0.349 . . . . 0.0 110.939 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -66.54 167.4 10.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.681 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 57.8 m-85 -150.71 177.61 9.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -125.15 -37.39 2.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -92.32 134.9 34.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.92 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -79.07 -24.43 43.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -85.0 -28.62 25.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -85.77 -46.24 10.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.655 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.4 OUTLIER -58.78 -33.49 70.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 12.7 p -63.7 -44.59 93.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -59.72 -26.13 65.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.937 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -88.46 -59.4 2.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.837 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 398' ' ' MET . 38.8 t -51.66 -38.36 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.127 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -57.63 -32.21 67.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 8.4 t -54.08 -29.03 42.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.853 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.938 0.399 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 45.6 t -126.66 169.41 13.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.854 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 29.3 t -113.37 75.25 2.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.623 0.725 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -8.55 23.88 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.656 2.237 . . . . 0.0 112.323 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' VAL . . . . . 0.617 HG11 ' HB3' ' A' ' 405' ' ' HIS . 23.8 t -65.99 -46.0 89.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.134 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -116.42 -25.55 7.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 107.11 80.53 1.31 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.53 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.677 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 11.0 tp -168.43 110.88 0.56 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.797 0.332 . . . . 0.0 110.956 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -71.55 164.33 26.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.677 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 54.6 m-85 -151.44 134.1 15.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -89.84 -26.14 20.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 29.0 mtm-85 -88.03 148.71 24.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.93 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -89.02 -25.15 22.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.56 -55.5 3.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -52.08 -46.74 65.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.502 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.3 OUTLIER -54.46 -36.47 64.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 40.0 t -72.02 -23.47 61.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -82.51 -22.85 34.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.908 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -96.53 -55.52 2.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.816 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 398' ' ' MET . 64.7 t -53.31 -28.03 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.36 -37.61 88.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 8.4 m -51.72 -31.04 24.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.617 ' HB3' HG11 ' A' ' 387' ' ' VAL . 55.2 m-70 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.87 0.366 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 53.0 p -165.53 -179.75 5.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.8 t -124.59 74.12 62.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.639 0.733 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 -12.3 32.74 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.694 2.263 . . . . 0.0 112.361 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 91.8 t -62.7 -43.16 98.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.134 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.38 -25.5 7.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.926 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.32 75.48 0.97 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.734 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 6.3 tp -165.81 108.4 0.78 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.909 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -73.74 161.57 30.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.734 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 60.7 m-85 -142.52 170.09 16.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.88 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -110.96 -45.53 3.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -82.83 148.77 27.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -89.11 -25.87 21.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -88.79 -26.2 21.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -84.41 -33.72 23.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.553 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -66.36 -28.75 68.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.82 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.1 t -68.49 -44.49 74.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.824 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -55.41 -26.26 40.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.934 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -95.24 -58.87 2.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.828 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 398' ' ' MET . 92.2 t -52.67 -56.86 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -53.47 -34.58 58.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.5 t -52.09 -30.13 24.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.828 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.95 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.893 0.377 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 45.2 p -124.28 173.51 8.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.859 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 25.0 t -113.36 75.87 2.49 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.663 0.744 . . . . 0.0 110.889 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -8.56 23.91 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.729 2.286 . . . . 0.0 112.356 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.61 -44.64 89.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.2 p -116.36 -25.3 7.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.63 77.39 1.07 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.493 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.648 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 13.1 tp -167.57 106.69 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.771 0.32 . . . . 0.0 110.92 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 39.0 mtt180 -68.05 164.79 19.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.648 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 65.8 m-85 -152.78 159.14 43.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.19 -32.06 5.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.94 109.52 16.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -59.82 -25.42 64.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -84.79 -42.08 15.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.879 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -68.55 -46.91 68.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.461 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -55.82 -29.83 60.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 5.5 p -70.86 -23.96 62.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -86.75 -25.46 24.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -91.26 -56.53 3.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 398' ' ' MET . 96.9 t -51.8 -40.48 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.164 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -70.26 -28.96 65.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.9 t -52.3 -29.73 24.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.835 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 179.984 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.906 0.384 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 24.3 p -143.77 167.45 22.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.459 ' SG ' HG22 ' A' ' 402' ' ' VAL . 11.1 t -114.75 74.23 3.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.59 0.709 . . . . 0.0 110.907 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -12.81 33.67 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.63 2.22 . . . . 0.0 112.396 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.18 -42.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.075 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 19.0 p -116.51 -25.89 7.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.95 75.55 1.02 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.495 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 391' ' ' ARG . 5.2 tt -166.68 110.3 0.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.817 0.342 . . . . 0.0 110.894 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.635 ' O ' HD23 ' A' ' 390' ' ' LEU . 49.7 mtm180 -65.28 161.65 19.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.837 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.618 ' CE1' HD22 ' A' ' 390' ' ' LEU . 7.3 m-85 -140.62 153.4 46.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.852 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -105.68 -29.27 10.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 27.6 mtt-85 -101.32 148.96 24.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -89.04 -26.15 21.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -83.86 -35.49 24.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.848 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -73.01 -38.9 66.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.458 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -69.91 -27.19 64.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.4 t -69.82 -26.42 64.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.847 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -87.7 -26.26 23.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.957 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -87.58 -57.77 2.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.459 HG22 ' SG ' ' A' ' 385' ' ' CYS . 66.5 t -52.3 -36.72 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -66.14 -31.58 72.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.1 t -52.13 -30.1 25.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.84 0.353 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 82.8 p -161.1 170.56 20.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.417 ' SG ' HG22 ' A' ' 402' ' ' VAL . 12.6 t -113.66 74.16 2.3 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.571 0.7 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -11.72 31.43 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.712 2.275 . . . . 0.0 112.334 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.36 -43.13 98.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.138 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.7 p -116.48 -25.56 7.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.38 75.83 0.99 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.681 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 7.4 tp -167.23 104.71 0.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.819 0.342 . . . . 0.0 110.919 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 12.4 mtp85 -72.77 161.47 30.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.681 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 56.1 m-85 -142.77 173.38 11.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -109.92 -48.02 3.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.926 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 10.4 mmp_? -78.26 150.62 33.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -89.09 -29.12 19.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.832 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -89.81 -26.67 20.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.54 -33.55 36.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.598 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -68.88 -29.72 68.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 37.5 t -66.86 -42.87 84.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -55.68 -26.2 43.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -95.35 -55.27 3.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.854 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 398' ' ' MET . 73.6 t -53.55 -32.83 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.139 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -68.73 -29.97 68.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.82 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 5.0 m -52.09 -30.13 24.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.816 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.854 179.994 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.918 0.389 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 91.2 p -152.64 171.37 18.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.819 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.5 t -115.17 74.25 3.79 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.666 0.746 . . . . 0.0 110.91 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -11.33 30.66 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.707 2.272 . . . . 0.0 112.346 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.89 -43.16 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.8 p -116.44 -25.71 7.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.58 76.54 1.06 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.487 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.692 HD23 ' CE1' ' A' ' 392' ' ' PHE . 4.1 tp -166.83 113.36 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.786 0.326 . . . . 0.0 110.907 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -73.96 160.03 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.692 ' CE1' HD23 ' A' ' 390' ' ' LEU . 46.3 m-85 -142.51 164.17 30.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.826 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -113.63 -37.27 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -83.75 144.48 29.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.822 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -27.77 20.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -85.41 -27.83 25.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -80.87 -48.45 12.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.508 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -55.64 -30.74 61.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 32.9 t -69.7 -26.31 64.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -81.89 -26.36 34.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.845 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -90.24 -54.98 3.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 398' ' ' MET . 91.9 t -53.65 -27.79 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.172 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -78.07 -31.3 50.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.845 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.7 t -52.17 -30.04 25.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.927 0.394 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 44.2 t -160.09 167.55 27.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.6 t -113.63 74.37 2.32 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.602 0.715 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -11.76 31.45 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.657 2.238 . . . . 0.0 112.324 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.5 t -63.66 -42.43 96.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.7 p -116.47 -25.56 7.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.22 75.06 0.98 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.5 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.779 HD23 ' CE1' ' A' ' 392' ' ' PHE . 4.5 tp -166.58 109.51 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.846 0.355 . . . . 0.0 110.89 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 39.9 mtp85 -72.66 160.67 31.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.878 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.779 ' CE1' HD23 ' A' ' 390' ' ' LEU . 40.0 m-85 -143.64 154.23 43.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -99.67 -38.24 8.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -83.94 145.21 28.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -89.05 -27.99 20.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.893 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -86.81 -26.2 24.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -81.83 -35.62 29.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.858 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.521 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -70.98 -28.79 64.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 2.3 t -68.73 -26.29 65.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -82.89 -26.32 31.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.93 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -89.12 -54.31 4.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 398' ' ' MET . 89.5 t -53.19 -35.68 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.147 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 27.9 mtm-85 -68.5 -29.24 67.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.898 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 5.6 m -52.01 -30.11 23.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.852 179.985 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.884 0.373 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 2.3 p -157.94 164.91 36.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.849 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.48 ' SG ' HG22 ' A' ' 402' ' ' VAL . 11.7 t -115.38 74.23 4.14 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.638 0.733 . . . . 0.0 110.876 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -11.15 30.24 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.656 2.237 . . . . 0.0 112.323 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.01 -43.1 97.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.153 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 18.5 p -116.51 -25.81 7.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.71 77.0 1.12 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.471 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.719 HD23 ' CE1' ' A' ' 392' ' ' PHE . 5.4 tp -167.6 121.8 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 0.0 110.888 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -83.11 162.72 21.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.841 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.719 ' CE1' HD23 ' A' ' 390' ' ' LEU . 45.3 m-85 -144.14 169.58 17.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -113.87 -42.12 3.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 -83.98 151.71 24.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -89.12 -28.3 20.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.58 -26.58 23.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.878 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 14.5 tpt85 -81.94 -33.08 30.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.569 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -72.41 -29.97 64.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 95.9 p -67.58 -49.79 61.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.884 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -56.22 -26.19 50.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.947 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -88.9 -60.57 1.92 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.856 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 398' ' ' MET . 91.2 t -52.0 -38.07 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.128 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -68.14 -31.17 70.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 21.0 t -52.06 -30.67 26.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.859 179.982 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.897 0.38 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 35.8 p -159.61 174.19 14.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.832 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.9 t -117.25 74.25 7.68 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.653 0.74 . . . . 0.0 110.929 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -11.21 30.44 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.717 2.278 . . . . 0.0 112.353 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 93.4 t -64.23 -42.9 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.101 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.41 -25.53 7.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.46 76.02 1.03 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.481 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.669 HD23 ' CE1' ' A' ' 392' ' ' PHE . 4.4 tp -166.88 113.54 0.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.805 0.336 . . . . 0.0 110.962 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 76.9 mtt-85 -72.78 165.73 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.811 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.669 ' CE1' HD23 ' A' ' 390' ' ' LEU . 34.5 m-85 -148.14 164.76 32.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -116.1 -34.94 4.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -91.01 130.33 36.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -73.62 -29.77 62.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -82.6 -26.44 32.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.884 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -82.46 -38.45 23.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.501 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -69.39 -28.63 66.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 2.2 t -69.57 -26.14 64.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -84.05 -26.14 29.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -89.32 -55.49 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 398' ' ' MET . 92.1 t -52.99 -34.63 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.142 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -68.23 -30.8 69.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.1 t -52.03 -30.18 24.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.971 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.861 0.362 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 41.9 p -147.15 156.49 43.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.621 ' SG ' HG22 ' A' ' 402' ' ' VAL . 14.2 t -116.13 74.32 5.45 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.652 0.739 . . . . 0.0 110.851 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -10.28 28.18 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.686 2.257 . . . . 0.0 112.342 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' VAL . . . . . 0.582 HG11 ' CB ' ' A' ' 405' ' ' HIS . 75.1 t -64.8 -43.84 96.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.096 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.7 p -116.48 -25.58 7.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.868 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 103.51 78.31 1.26 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.498 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.803 HD23 ' CE1' ' A' ' 392' ' ' PHE . 5.6 tp -168.61 134.32 1.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.801 0.334 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -93.38 163.28 13.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.803 ' CE1' HD23 ' A' ' 390' ' ' LEU . 39.1 m-85 -146.11 169.87 17.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.91 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -116.61 -38.77 3.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -84.48 152.67 23.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.825 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.1 -31.17 18.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -82.73 -26.98 31.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -80.95 -40.69 24.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.554 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -67.27 -31.65 72.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 70.3 p -68.15 -56.71 7.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -55.43 -26.27 40.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.937 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -82.94 -63.39 1.37 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.893 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.621 HG22 ' SG ' ' A' ' 385' ' ' CYS . 96.1 t -52.05 -34.98 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 44.3 mtm-85 -62.41 -34.07 76.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 7.3 m -52.08 -31.97 32.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.868 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' HIS . . . . . 0.582 ' CB ' HG11 ' A' ' 387' ' ' VAL . 45.3 m-70 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.819 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.892 0.377 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 83.1 p -131.34 161.54 32.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.626 ' SG ' HG22 ' A' ' 402' ' ' VAL . 15.0 t -114.36 74.21 2.92 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.655 0.741 . . . . 0.0 110.915 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -9.74 26.87 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 0.0 112.38 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.23 -44.21 95.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.108 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.8 p -116.42 -25.57 7.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 103.69 78.58 1.27 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.499 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.793 HD23 ' CE1' ' A' ' 392' ' ' PHE . 3.7 tp -168.59 135.29 1.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.803 0.335 . . . . 0.0 110.89 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -91.85 165.08 13.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.793 ' CE1' HD23 ' A' ' 390' ' ' LEU . 34.6 m-85 -148.6 161.44 41.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.9 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -110.38 -35.26 6.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -88.73 151.01 22.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -89.08 -28.22 20.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -85.06 -26.41 26.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.921 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 15.0 ttp85 -81.89 -34.81 29.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.523 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -73.22 -29.39 62.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 28.3 t -67.99 -58.62 4.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.801 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -54.82 -26.98 38.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -82.38 -65.07 1.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.626 HG22 ' SG ' ' A' ' 385' ' ' CYS . 94.8 t -52.29 -29.57 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 16.0 mmt85 -76.89 -35.26 57.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 15.7 t -52.59 -29.61 26.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.853 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.899 0.381 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -157.12 168.23 28.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.887 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.2 t -115.62 74.31 4.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.615 0.721 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.85 -10.44 28.48 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.687 2.258 . . . . 0.0 112.322 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.4 t -64.76 -43.38 96.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.127 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 18.1 p -116.48 -25.7 7.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.61 77.34 1.11 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.65 HD23 ' CE1' ' A' ' 392' ' ' PHE . 3.6 tp -168.06 115.61 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -72.36 165.51 24.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.849 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.65 ' CE1' HD23 ' A' ' 390' ' ' LEU . 36.5 m-85 -148.35 152.7 37.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -105.54 -32.39 8.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -93.7 146.3 23.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.11 -32.15 17.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -75.51 -26.78 58.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.61 -51.78 7.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.447 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -55.7 -28.86 57.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 30.9 t -70.65 -25.53 63.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -88.24 -25.62 22.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -88.89 -56.15 3.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 398' ' ' MET . 92.2 t -53.97 -57.59 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.111 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -52.93 -33.71 51.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.6 t -52.05 -30.11 24.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.893 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 179.974 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 91.5 p -129.95 118.42 21.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.918 0.39 . . . . 0.0 110.834 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 4.9 t -60.18 -70.14 0.18 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.861 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 103.18 51.15 1.01 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.517 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 66.1 p -149.23 133.2 17.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.891 0.377 . . . . 0.0 110.836 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 4.7 m -58.7 -31.78 68.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 173.41 89.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.529 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -144.77 140.5 28.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.893 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp 59.63 73.69 0.64 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.575 0.702 . . . . 0.0 110.848 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -13.1 34.13 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.662 2.241 . . . . 0.0 112.36 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -123.32 108.74 13.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 48.0 t -144.87 168.35 20.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.405 ' SG ' HG22 ' A' ' 402' ' ' VAL . 12.7 t -113.66 74.29 2.33 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.617 0.722 . . . . 0.0 110.888 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -11.29 30.47 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.671 2.247 . . . . 0.0 112.356 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.66 -43.56 98.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.43 -25.55 7.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.14 77.18 1.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.698 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 4.0 tp -168.06 108.64 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.919 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 50.0 mtt85 -66.68 163.81 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.698 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 42.4 m-85 -148.26 147.64 29.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -98.15 -34.06 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -90.15 144.9 25.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.863 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp -89.11 -26.23 21.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -84.15 -28.96 27.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.881 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -80.01 -38.38 32.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.47 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -68.53 -28.61 67.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 23.2 t -70.23 -25.64 63.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.825 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -86.41 -26.01 24.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -89.15 -56.63 3.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 398' ' ' MET . 92.0 t -52.67 -35.46 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.111 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 -68.0 -31.26 70.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 9.6 m -52.05 -30.18 24.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -79.27 -64.86 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -79.3 85.51 5.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -82.67 126.25 7.36 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 12.6 t -156.48 132.3 9.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.872 0.368 . . . . 0.0 110.895 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 11.2 p -172.16 147.36 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.14 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 170.82 59.98 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.462 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.05 160.22 0.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.772 0.32 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 72.7 p -72.43 163.34 28.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -74.33 170.97 53.23 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.476 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 107.11 1.78 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.644 2.229 . . . . 0.0 112.344 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 4.8 m -72.48 153.42 41.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.871 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 7.4 t -56.24 158.86 3.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 CA-C-O 119.141 -0.81 . . . . 0.0 112.471 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 38.8 m -89.87 177.41 6.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.902 0.382 . . . . 0.0 110.843 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 1.3 t -127.75 169.48 13.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.906 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 107.78 -48.71 0.92 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 37.7 m -103.48 44.44 1.02 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 0.0 110.834 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 74.9 m -87.68 98.52 11.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.864 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 172.68 156.9 13.27 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.482 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -79.12 137.24 37.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.935 0.398 . . . . 0.0 110.914 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.04 73.72 12.1 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.53 0.681 . . . . 0.0 110.843 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -15.6 37.18 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.709 2.273 . . . . 0.0 112.344 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -111.42 76.27 0.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.935 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.8 p -132.79 179.77 5.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.852 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 10.6 t -127.43 74.69 77.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.631 0.729 . . . . 0.0 110.883 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -8.99 25.01 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.696 2.264 . . . . 0.0 112.354 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.0 t -67.39 -41.41 86.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.131 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.44 -25.51 7.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.38 73.75 0.94 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.481 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.627 HD23 ' O ' ' A' ' 391' ' ' ARG . 5.3 tt -168.53 106.06 0.46 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.782 0.325 . . . . 0.0 110.919 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.627 ' O ' HD23 ' A' ' 390' ' ' LEU . 56.6 mtm180 -64.87 164.8 11.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.607 ' CE1' HD22 ' A' ' 390' ' ' LEU . 7.6 m-85 -139.51 151.87 46.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -103.98 -29.76 10.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -91.75 147.14 23.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -86.95 -25.93 24.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -85.78 -51.6 6.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -57.06 -46.94 82.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.501 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.3 OUTLIER -53.92 -36.57 62.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.933 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 29.0 t -70.0 -25.66 63.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.839 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -82.94 -25.96 31.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -90.81 -55.59 3.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 398' ' ' MET . 93.8 t -52.84 -29.89 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -76.94 -32.44 57.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 59.0 m -52.01 -30.12 23.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -75.02 -60.78 2.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.851 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -76.87 80.92 3.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.812 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -88.63 -107.93 1.06 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.521 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 80.6 p -119.32 47.61 1.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.871 0.367 . . . . 0.0 110.813 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 76.0 t -119.55 94.49 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.16 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -139.08 116.62 1.27 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.482 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -90.65 -45.75 8.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.893 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 78.0 p -62.43 145.79 53.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.839 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 93.8 167.69 37.83 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.427 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -45.08 1.71 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.691 2.26 . . . . 0.0 112.332 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 20.1 t -100.58 139.99 35.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.843 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 39.5 t -63.17 -31.9 73.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.861 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 CA-C-O 119.151 -0.805 . . . . 0.0 112.503 180.0 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 11.2 p -98.81 138.97 35.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.833 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 48.2 m -88.24 86.47 7.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 71.08 92.31 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.499 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 67.2 p -77.3 152.85 34.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.853 0.358 . . . . 0.0 110.904 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 3.0 t -113.38 170.27 8.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.868 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 73.5 -151.46 44.91 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.488 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -159.73 114.25 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 110.889 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -154.56 73.74 5.97 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.577 0.703 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -16.48 37.32 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.696 2.264 . . . . 0.0 112.356 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -107.47 80.9 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 9.6 p -123.75 173.2 8.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.857 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.0 t -113.51 74.75 2.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.704 . . . . 0.0 110.862 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -8.61 24.04 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.691 2.261 . . . . 0.0 112.389 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 91.5 t -66.72 -43.92 89.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.2 p -116.46 -25.4 7.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.36 77.27 1.08 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.506 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.706 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 9.9 tp -167.72 109.81 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.793 0.33 . . . . 0.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -69.05 163.98 23.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.706 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 53.0 m-85 -151.13 141.69 22.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.2 tttp -91.84 -35.38 14.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -83.05 143.07 30.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.02 -25.88 21.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -83.91 -47.74 10.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 33.8 mmt-85 -60.2 -48.01 83.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.473 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -55.49 -27.97 51.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 6.3 t -70.35 -25.54 63.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.851 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -85.94 -25.92 25.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -89.5 -55.98 3.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.837 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 398' ' ' MET . 73.8 t -54.04 -27.31 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -77.27 -30.54 54.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 8.7 t -52.09 -30.16 24.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -79.37 -48.53 13.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.829 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -87.3 74.44 9.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.862 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -110.09 -104.63 2.86 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.487 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 3.9 t -52.05 -38.08 55.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.891 0.377 . . . . 0.0 110.841 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 65.6 t -82.21 142.66 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.143 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 111.4 -35.27 4.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.479 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -132.18 178.25 6.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.799 0.333 . . . . 0.0 110.879 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 3.0 m 54.19 27.99 8.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -160.62 -75.25 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.473 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 128.12 15.58 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.697 2.264 . . . . 0.0 112.352 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 11.2 p -89.42 74.47 7.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 31.8 t -97.15 -59.22 1.84 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 CA-C-O 119.157 -0.802 . . . . 0.0 112.499 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 11.4 t -164.62 127.4 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.888 0.375 . . . . 0.0 110.832 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 4.1 m -106.51 -42.09 5.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.88 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 173.18 -107.09 0.24 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.511 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 26.5 m -142.75 160.45 40.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.846 0.355 . . . . 0.0 110.854 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 68.6 p -156.19 128.77 7.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 79.99 -139.36 21.21 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.487 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -126.84 53.41 1.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.76 74.12 63.91 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 0.0 110.866 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -14.08 35.34 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.676 2.251 . . . . 0.0 112.31 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -112.73 84.84 2.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.8 p -138.92 169.55 17.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.916 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.5 t -113.87 74.7 2.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.594 0.712 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -8.63 24.1 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.651 2.234 . . . . 0.0 112.357 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.7 t -67.56 -41.88 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.55 -25.52 7.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.74 74.65 0.94 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.439 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.597 HD23 ' CE1' ' A' ' 392' ' ' PHE . 3.3 tp -168.73 105.7 0.43 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.787 0.327 . . . . 0.0 110.98 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -67.18 163.5 20.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.597 ' CE1' HD23 ' A' ' 390' ' ' LEU . 7.7 m-85 -139.48 149.33 43.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.853 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -100.91 -29.68 12.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -93.01 144.82 24.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.64 -25.98 23.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -90.13 -28.23 19.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.856 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -82.71 -30.2 29.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.523 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.2 OUTLIER -71.28 -32.61 68.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 60.1 p -69.16 -25.39 64.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -80.85 -25.99 37.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -92.03 -54.71 3.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.866 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 398' ' ' MET . 94.9 t -51.98 -39.62 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -70.56 -28.84 65.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.839 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 9.3 t -52.11 -30.12 24.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -80.01 -56.26 4.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -53.61 -37.6 63.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -87.79 156.94 28.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.523 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 24.5 m -116.74 72.54 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.936 0.398 . . . . 0.0 110.843 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.7 p -54.18 -27.85 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.171 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 168.82 -162.47 36.24 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.502 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -119.8 34.46 5.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.785 0.326 . . . . 0.0 110.837 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 1.5 t -71.16 96.01 1.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.843 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 93.87 -178.13 37.5 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 178.04 4.96 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.719 2.28 . . . . 0.0 112.316 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 7.5 t -102.41 143.22 32.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 66.8 p -94.47 164.28 13.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.862 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 119.158 -0.801 . . . . 0.0 112.526 -179.965 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 3.6 t 56.04 30.67 16.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 0.0 110.825 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 22.0 t -126.52 32.9 5.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 89.34 121.99 2.09 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.491 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 13.7 m -114.5 66.31 0.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.836 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 2.3 m -97.51 -41.66 8.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.9 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 75.67 -177.31 49.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.449 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -97.23 75.53 2.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.924 0.393 . . . . 0.0 110.937 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -160.7 74.03 2.77 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.603 0.716 . . . . 0.0 110.886 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -16.01 37.13 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.639 2.226 . . . . 0.0 112.358 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -105.04 80.69 1.64 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 67.1 m -117.58 170.52 8.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.864 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.545 ' SG ' HG22 ' A' ' 402' ' ' VAL . 9.6 t -113.48 75.05 2.34 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.685 0.755 . . . . 0.0 110.919 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -8.7 24.28 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.679 2.253 . . . . 0.0 112.37 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.8 t -67.32 -41.43 86.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.12 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 20.8 p -116.83 -26.64 6.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.85 74.57 0.93 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.537 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 391' ' ' ARG . 5.2 tt -169.03 112.42 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.901 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.657 ' O ' HD23 ' A' ' 390' ' ' LEU . 34.0 mtp180 -65.97 159.47 25.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.841 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.639 ' CE1' HD22 ' A' ' 390' ' ' LEU . 7.4 m-85 -140.15 140.44 35.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -92.44 -28.92 16.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 44.8 mmt-85 -93.89 143.05 26.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -88.57 -26.1 22.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -89.18 -37.19 15.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -70.35 -34.02 72.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.896 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.478 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.2 OUTLIER -71.38 -26.23 62.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 56.1 m -70.03 -26.31 63.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -85.86 -26.15 25.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -88.47 -56.5 3.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.865 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.545 HG22 ' SG ' ' A' ' 385' ' ' CYS . 64.8 t -53.99 -27.38 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.098 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -75.06 -31.31 61.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.4 t -52.15 -30.07 24.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -77.5 -63.9 1.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -86.46 71.04 10.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -76.9 -64.07 2.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.492 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 2.6 p -80.46 100.31 8.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 0.0 110.866 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.83 93.83 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.144 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -158.62 48.71 0.42 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.472 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -59.69 99.13 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.761 0.315 . . . . 0.0 110.881 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.87 126.9 16.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 176.61 -75.41 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.489 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 93.79 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.654 2.236 . . . . 0.0 112.362 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 19.5 t -89.42 83.09 6.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.806 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 1.3 t -77.78 175.85 9.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.833 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 CA-C-O 119.172 -0.793 . . . . 0.0 112.506 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 8.5 t -117.58 116.34 26.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.853 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 1.7 p -79.63 146.8 32.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.845 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -179.33 -134.99 2.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.49 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 1.9 t -115.98 -39.75 3.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.888 0.375 . . . . 0.0 110.87 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 3.1 m -97.04 -45.68 6.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.845 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 84.48 164.87 38.55 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.487 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -84.86 -26.83 27.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.894 0.378 . . . . 0.0 110.882 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.08 74.44 58.05 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.576 0.703 . . . . 0.0 110.915 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 -8.77 24.43 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.65 2.233 . . . . 0.0 112.31 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -112.46 68.33 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.901 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 12.9 p -132.06 179.6 5.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.822 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.9 t -124.63 74.74 63.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.599 0.714 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -8.67 24.2 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.693 2.262 . . . . 0.0 112.341 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 81.5 t -67.19 -42.81 88.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -116.47 -25.57 7.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.35 76.07 1.0 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.494 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.629 HD23 ' CE1' ' A' ' 392' ' ' PHE . 4.1 tp -168.98 106.33 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.901 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 62.5 mtt85 -70.05 160.58 31.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.629 ' CE1' HD23 ' A' ' 390' ' ' LEU . 13.5 m-85 -137.6 160.96 37.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 32.7 mmtm -103.91 -37.92 7.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 23.5 mmt85 -87.29 146.08 26.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -89.1 -26.93 21.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -90.3 -27.91 19.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -83.7 -35.86 24.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.517 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -57.71 -30.59 65.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 15.4 m -68.54 -42.58 78.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.838 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -54.53 -27.28 37.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -95.77 -57.43 2.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.802 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 398' ' ' MET . 95.8 t -53.55 -56.79 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -54.43 -33.42 59.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.6 t -52.04 -30.16 24.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -72.03 -38.93 69.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -80.18 72.92 7.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.822 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 178.99 134.43 2.13 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.471 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 35.8 t -96.69 145.5 25.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.882 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.24 28.41 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.161 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -104.0 -75.14 1.03 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.38 175.12 8.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 0.0 110.886 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 3.5 p -73.06 -58.99 2.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.866 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 155.85 73.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.481 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 168.37 21.68 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.713 2.275 . . . . 0.0 112.313 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 12.9 p 52.19 34.9 15.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.822 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 3.0 m -76.63 -26.62 55.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.844 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 CA-C-O 119.125 -0.819 . . . . 0.0 112.494 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.456 -0.257 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 5.4 p -74.78 144.44 43.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.879 0.371 . . . . 0.0 110.868 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 46.8 t -131.78 -68.7 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.837 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 166.6 96.41 0.11 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.531 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 4.7 m -64.47 139.05 58.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 0.0 110.883 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.6 t -74.29 80.51 1.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -139.7 23.21 2.8 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.475 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -69.99 120.62 15.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.927 0.394 . . . . 0.0 110.868 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 4.4 mmtm 56.79 73.71 0.77 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.589 0.709 . . . . 0.0 110.854 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -13.74 35.01 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.641 2.227 . . . . 0.0 112.344 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -122.22 101.91 7.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 48.1 t -143.16 168.8 18.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.7 t -113.54 74.65 2.3 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.615 0.721 . . . . 0.0 110.832 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -8.65 24.14 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.745 2.297 . . . . 0.0 112.309 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 405' ' ' HIS . 47.3 t -67.21 -43.33 88.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -116.31 -25.48 7.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.57 77.61 1.13 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.727 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 5.6 tp -168.61 112.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 110.883 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -72.52 167.0 21.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.727 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 53.6 m-85 -150.66 146.67 26.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.76 -35.47 10.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -86.28 146.29 26.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -88.8 -26.02 21.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.12 -38.28 20.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.878 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -69.37 -45.31 69.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.479 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -57.72 -32.15 67.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 31.0 t -71.2 -24.28 62.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.857 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -84.28 -21.78 30.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.948 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -96.37 -55.79 2.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.833 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 398' ' ' MET . 64.5 t -54.07 -27.17 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -36.9 85.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 6.5 t -51.91 -30.31 23.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.595 ' HB3' HG11 ' A' ' 387' ' ' VAL . 65.6 m-70 -91.24 46.68 1.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.845 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -75.64 160.64 29.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.845 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 143.91 126.08 1.94 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.528 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 30.0 m -58.41 158.29 7.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 0.0 110.871 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 39.9 t -93.75 120.21 42.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.102 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 102.99 58.56 0.75 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -90.08 119.81 30.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.839 0.352 . . . . 0.0 110.897 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 7.7 t 57.84 31.84 21.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -84.11 166.35 42.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.494 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 139.26 39.74 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.735 2.29 . . . . 0.0 112.302 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 41.9 t -91.05 -36.19 14.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 19.8 p -72.71 -65.7 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 CA-C-O 119.123 -0.821 . . . . 0.0 112.513 179.996 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.471 -0.251 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 9.9 m -73.53 114.78 12.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.87 0.367 . . . . 0.0 110.899 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 44.4 m -87.78 72.44 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 86.41 -144.06 19.68 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.473 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 12.2 m -103.08 163.89 11.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.9 0.381 . . . . 0.0 110.824 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 12.0 t -93.18 151.77 19.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 110.26 161.81 18.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.488 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -63.77 130.85 45.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.908 0.385 . . . . 0.0 110.881 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -120.14 74.0 20.57 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.562 0.696 . . . . 0.0 110.929 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 -14.31 36.05 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.692 2.261 . . . . 0.0 112.334 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -119.68 108.53 14.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 4.5 p -153.16 172.67 16.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.857 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.409 ' SG ' HG22 ' A' ' 402' ' ' VAL . 19.2 t -117.44 74.94 8.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.593 0.711 . . . . 0.0 110.895 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -8.65 24.14 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.642 2.228 . . . . 0.0 112.371 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 99.7 t -66.43 -44.32 90.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.16 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.4 p -116.51 -25.49 7.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 107.49 77.35 1.04 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.527 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.681 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 8.4 tp -168.01 104.11 0.47 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.832 0.349 . . . . 0.0 110.939 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -66.54 167.4 10.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.681 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 57.8 m-85 -150.71 177.61 9.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -125.15 -37.39 2.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -92.32 134.9 34.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.92 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -79.07 -24.43 43.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -85.0 -28.62 25.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -85.77 -46.24 10.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.655 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.4 OUTLIER -58.78 -33.49 70.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 12.7 p -63.7 -44.59 93.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -59.72 -26.13 65.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.937 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -88.46 -59.4 2.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.837 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 398' ' ' MET . 38.8 t -51.66 -38.36 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.127 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -57.63 -32.21 67.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 8.4 t -54.08 -29.03 42.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.853 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -85.75 -50.12 7.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -71.27 82.12 0.74 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -99.27 -143.42 14.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.442 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 49.7 m -103.05 86.7 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 0.0 110.894 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 47.9 t -146.82 136.15 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.145 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 80.04 -164.27 48.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.467 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -89.17 152.55 21.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.786 0.327 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 1.2 p -103.99 -60.22 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.803 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -156.93 -173.42 25.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.492 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -175.32 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.662 2.241 . . . . 0.0 112.345 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 4.7 p 55.24 26.89 8.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.82 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 11.6 m -128.27 159.31 35.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 CA-C-O 119.143 -0.809 . . . . 0.0 112.468 -179.948 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 30.0 t -155.13 107.87 2.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.869 0.366 . . . . 0.0 110.835 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 48.8 m -87.08 -68.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -162.16 -94.63 0.1 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.486 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 58.9 p -80.49 -32.23 37.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 110.833 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 51.3 m -156.84 146.35 20.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -112.89 160.99 12.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.431 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -101.52 100.47 10.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.923 0.392 . . . . 0.0 110.935 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -168.46 73.57 0.83 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.559 0.695 . . . . 0.0 110.87 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -16.29 37.57 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.722 2.281 . . . . 0.0 112.33 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -110.93 89.43 3.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 45.6 t -126.66 169.41 13.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.854 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 29.3 t -113.37 75.25 2.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.623 0.725 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -8.55 23.88 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.656 2.237 . . . . 0.0 112.323 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' VAL . . . . . 0.617 HG11 ' HB3' ' A' ' 405' ' ' HIS . 23.8 t -65.99 -46.0 89.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.134 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -116.42 -25.55 7.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 107.11 80.53 1.31 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.53 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.677 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 11.0 tp -168.43 110.88 0.56 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.797 0.332 . . . . 0.0 110.956 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -71.55 164.33 26.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.677 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 54.6 m-85 -151.44 134.1 15.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -89.84 -26.14 20.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 29.0 mtm-85 -88.03 148.71 24.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.93 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -89.02 -25.15 22.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.56 -55.5 3.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -52.08 -46.74 65.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.502 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.3 OUTLIER -54.46 -36.47 64.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 40.0 t -72.02 -23.47 61.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -82.51 -22.85 34.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.908 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -96.53 -55.52 2.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.816 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 398' ' ' MET . 64.7 t -53.31 -28.03 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.36 -37.61 88.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 8.4 m -51.72 -31.04 24.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.617 ' HB3' HG11 ' A' ' 387' ' ' VAL . 55.2 m-70 -92.03 -28.86 16.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -67.92 -42.86 80.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -111.92 -179.14 19.97 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 5.1 t -121.9 53.32 1.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.923 0.392 . . . . 0.0 110.896 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.53 -26.96 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.132 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -100.84 -93.52 2.16 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.45 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -106.25 166.82 10.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.776 0.322 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 29.5 p -83.08 92.53 7.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -68.48 -168.95 5.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.515 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -17.54 37.75 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.647 2.231 . . . . 0.0 112.355 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 12.9 p -161.71 142.71 10.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.835 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 88.6 p -103.42 81.92 1.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.837 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 CA-C-O 119.145 -0.808 . . . . 0.0 112.475 -179.982 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 6.2 m -66.98 -62.11 1.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.927 0.394 . . . . 0.0 110.855 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 3.6 p -76.47 170.83 15.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -171.83 -114.84 0.34 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.503 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 2.2 p -84.35 -42.97 15.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.921 0.391 . . . . 0.0 110.891 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 7.4 m -73.4 163.56 27.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.892 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -90.16 -159.56 35.65 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.51 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -95.81 -57.5 2.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.914 0.388 . . . . 0.0 110.872 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -83.82 160.69 57.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.611 0.72 . . . . 0.0 110.873 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -17.15 37.61 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.645 2.23 . . . . 0.0 112.36 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -141.48 128.53 20.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.957 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 53.0 p -165.53 -179.75 5.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.8 t -124.59 74.12 62.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.639 0.733 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 -12.3 32.74 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.694 2.263 . . . . 0.0 112.361 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 91.8 t -62.7 -43.16 98.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.134 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.38 -25.5 7.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.926 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.32 75.48 0.97 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.734 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 6.3 tp -165.81 108.4 0.78 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.909 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -73.74 161.57 30.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.734 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 60.7 m-85 -142.52 170.09 16.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.88 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -110.96 -45.53 3.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -82.83 148.77 27.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -89.11 -25.87 21.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -88.79 -26.2 21.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -84.41 -33.72 23.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.553 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -66.36 -28.75 68.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.82 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.1 t -68.49 -44.49 74.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.824 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -55.41 -26.26 40.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.934 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -95.24 -58.87 2.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.828 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 398' ' ' MET . 92.2 t -52.67 -56.86 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -53.47 -34.58 58.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.5 t -52.09 -30.13 24.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.828 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -69.77 -64.53 0.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -79.1 112.89 16.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 168.81 97.61 0.11 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.472 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 1.6 m -75.18 85.01 2.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.371 . . . . 0.0 110.861 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 12.2 p -97.76 -30.41 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -111.07 -68.5 0.56 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.454 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.81 81.39 8.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.763 0.316 . . . . 0.0 110.896 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 5.3 t -68.15 -35.96 78.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.861 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 131.67 -73.16 0.47 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.494 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 102.43 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.708 2.272 . . . . 0.0 112.319 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.1 m -142.61 144.88 33.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 38.9 m -54.31 131.79 42.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.819 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.464 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 8.6 m -151.88 139.79 20.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.874 0.369 . . . . 0.0 110.881 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 11.4 t -56.65 -51.29 69.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.899 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 138.25 127.38 2.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 3.0 m -103.97 108.84 20.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 0.0 110.872 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 17.4 p -100.4 68.29 1.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -137.28 178.49 18.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.509 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -82.17 109.13 16.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -142.2 73.92 21.34 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.58 0.705 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -15.68 37.27 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.662 2.241 . . . . 0.0 112.31 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -101.59 77.02 1.71 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.872 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 45.2 p -124.28 173.51 8.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.859 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 25.0 t -113.36 75.87 2.49 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.663 0.744 . . . . 0.0 110.889 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -8.56 23.91 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.729 2.286 . . . . 0.0 112.356 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.61 -44.64 89.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.2 p -116.36 -25.3 7.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.63 77.39 1.07 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.493 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.648 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 13.1 tp -167.57 106.69 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.771 0.32 . . . . 0.0 110.92 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 39.0 mtt180 -68.05 164.79 19.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.648 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 65.8 m-85 -152.78 159.14 43.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.19 -32.06 5.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.94 109.52 16.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -59.82 -25.42 64.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -84.79 -42.08 15.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.879 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -68.55 -46.91 68.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.461 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -55.82 -29.83 60.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 5.5 p -70.86 -23.96 62.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -86.75 -25.46 24.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -91.26 -56.53 3.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 398' ' ' MET . 96.9 t -51.8 -40.48 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.164 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -70.26 -28.96 65.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.9 t -52.3 -29.73 24.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.835 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -77.58 -65.94 0.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -76.01 108.54 8.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -135.1 -42.52 0.12 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.449 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 10.4 p -59.1 143.51 48.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.899 0.38 . . . . 0.0 110.872 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 10.1 p -62.66 140.82 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.132 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -166.02 -58.38 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.504 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 33.2 tttm 58.37 37.48 25.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.778 0.323 . . . . 0.0 110.873 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 6.1 p -112.47 108.98 18.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.829 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 139.67 -71.56 0.44 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.496 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 143.3 50.17 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.732 2.288 . . . . 0.0 112.305 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 67.3 m -102.11 62.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.855 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 16.2 p -162.34 171.59 16.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 CA-C-O 119.18 -0.789 . . . . 0.0 112.453 -179.966 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 2.8 p -61.61 -55.98 24.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.389 . . . . 0.0 110.858 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 72.8 m -90.51 -179.31 5.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.825 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -162.28 -43.57 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.478 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 18.9 t -153.39 142.9 21.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.894 0.378 . . . . 0.0 110.876 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 37.6 t -98.82 -43.38 6.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 165.69 71.18 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.452 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -56.61 132.9 53.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 110.927 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -104.43 160.7 25.15 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.613 0.72 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -20.7 34.3 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.638 2.225 . . . . 0.0 112.332 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -126.98 110.5 13.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.951 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 24.3 p -143.77 167.45 22.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.459 ' SG ' HG22 ' A' ' 402' ' ' VAL . 11.1 t -114.75 74.23 3.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.59 0.709 . . . . 0.0 110.907 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -12.81 33.67 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.63 2.22 . . . . 0.0 112.396 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.18 -42.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.075 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 19.0 p -116.51 -25.89 7.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.95 75.55 1.02 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.495 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 391' ' ' ARG . 5.2 tt -166.68 110.3 0.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.817 0.342 . . . . 0.0 110.894 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.635 ' O ' HD23 ' A' ' 390' ' ' LEU . 49.7 mtm180 -65.28 161.65 19.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.837 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.618 ' CE1' HD22 ' A' ' 390' ' ' LEU . 7.3 m-85 -140.62 153.4 46.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.852 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -105.68 -29.27 10.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 27.6 mtt-85 -101.32 148.96 24.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -89.04 -26.15 21.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -83.86 -35.49 24.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.848 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -73.01 -38.9 66.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.458 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -69.91 -27.19 64.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.4 t -69.82 -26.42 64.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.847 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -87.7 -26.26 23.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.957 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -87.58 -57.77 2.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.459 HG22 ' SG ' ' A' ' 385' ' ' CYS . 66.5 t -52.3 -36.72 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -66.14 -31.58 72.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.1 t -52.13 -30.1 25.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -79.09 -46.8 17.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -57.85 -34.98 70.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -80.78 -35.85 23.97 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.444 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 6.1 m -71.86 136.71 47.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 110.852 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.78 142.73 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.121 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -137.2 -111.15 1.04 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.481 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -91.91 -51.76 5.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.759 0.314 . . . . 0.0 110.897 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.83 178.93 0.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -132.17 -167.51 11.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.464 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 138.83 38.89 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.678 2.252 . . . . 0.0 112.372 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 3.6 m -131.89 92.35 3.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 96.5 p -63.74 123.6 19.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 CA-C-O 119.168 -0.795 . . . . 0.0 112.475 -179.98 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 86.4 p -71.8 -33.76 68.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 110.842 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 17.9 p -90.35 63.17 5.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.816 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 168.24 -115.01 0.59 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.432 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 30.2 m -159.67 162.36 35.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.855 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 4.4 m -97.66 -65.29 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 111.47 -156.33 15.63 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.551 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -129.48 126.41 38.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 0.0 110.906 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -81.37 160.72 64.37 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.616 0.722 . . . . 0.0 110.859 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -16.77 37.45 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.69 2.26 . . . . 0.0 112.315 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -133.83 124.11 25.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 82.8 p -161.1 170.56 20.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.417 ' SG ' HG22 ' A' ' 402' ' ' VAL . 12.6 t -113.66 74.16 2.3 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.571 0.7 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -11.72 31.43 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.712 2.275 . . . . 0.0 112.334 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.36 -43.13 98.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.138 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.7 p -116.48 -25.56 7.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.38 75.83 0.99 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.681 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 7.4 tp -167.23 104.71 0.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.819 0.342 . . . . 0.0 110.919 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 12.4 mtp85 -72.77 161.47 30.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.681 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 56.1 m-85 -142.77 173.38 11.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -109.92 -48.02 3.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.926 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 10.4 mmp_? -78.26 150.62 33.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -89.09 -29.12 19.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.832 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -89.81 -26.67 20.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.54 -33.55 36.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.598 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -68.88 -29.72 68.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 37.5 t -66.86 -42.87 84.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -55.68 -26.2 43.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -95.35 -55.27 3.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.854 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 398' ' ' MET . 73.6 t -53.55 -32.83 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.139 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -68.73 -29.97 68.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.82 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 5.0 m -52.09 -30.13 24.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.816 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -85.35 54.03 2.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -88.24 135.42 33.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 135.21 -49.08 0.91 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.534 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 4.2 m 54.59 28.61 10.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.899 0.381 . . . . 0.0 110.852 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.52 142.25 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.123 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 97.1 71.38 1.06 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.501 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -118.69 124.48 47.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.0 110.926 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 12.9 t -127.99 120.65 28.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.861 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 89.6 72.19 1.26 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.464 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 143.23 50.36 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.7 2.267 . . . . 0.0 112.322 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 73.6 m -104.04 -33.42 8.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 48.1 p -122.89 -176.47 3.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.838 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 CA-C-O 119.158 -0.801 . . . . 0.0 112.522 179.981 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 4.6 m -136.99 127.76 27.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.918 0.389 . . . . 0.0 110.836 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 5.7 t -115.38 130.04 56.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.832 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -146.7 78.12 0.24 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.477 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 60.5 p -53.37 126.6 21.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 0.0 110.878 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 2.7 t -113.79 95.49 5.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 97.93 133.45 7.93 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.529 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -124.39 132.84 53.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.916 0.389 . . . . 0.0 110.926 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 30.1 mttp -87.68 160.64 46.94 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.542 0.687 . . . . 0.0 110.936 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -18.41 37.17 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.681 2.254 . . . . 0.0 112.336 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -136.06 120.11 17.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.876 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 91.2 p -152.64 171.37 18.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.819 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.5 t -115.17 74.25 3.79 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.666 0.746 . . . . 0.0 110.91 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -11.33 30.66 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.707 2.272 . . . . 0.0 112.346 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.89 -43.16 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.8 p -116.44 -25.71 7.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.58 76.54 1.06 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.487 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.692 HD23 ' CE1' ' A' ' 392' ' ' PHE . 4.1 tp -166.83 113.36 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.786 0.326 . . . . 0.0 110.907 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -73.96 160.03 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.692 ' CE1' HD23 ' A' ' 390' ' ' LEU . 46.3 m-85 -142.51 164.17 30.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.826 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -113.63 -37.27 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -83.75 144.48 29.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.822 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -27.77 20.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -85.41 -27.83 25.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -80.87 -48.45 12.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.508 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -55.64 -30.74 61.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 32.9 t -69.7 -26.31 64.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -81.89 -26.36 34.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.845 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -90.24 -54.98 3.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 398' ' ' MET . 91.9 t -53.65 -27.79 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.172 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -78.07 -31.3 50.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.845 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.7 t -52.17 -30.04 25.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -76.83 -35.72 57.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.88 111.11 4.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.892 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 91.6 106.49 1.49 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.456 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 8.6 t -81.34 161.59 23.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.912 0.387 . . . . 0.0 110.836 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.9 p -84.87 -31.5 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.132 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -58.49 -64.08 4.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.474 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -77.46 -179.74 5.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.753 0.311 . . . . 0.0 110.899 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 1.4 t -122.87 167.04 14.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.862 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -154.07 176.64 31.88 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.51 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 91.82 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.637 2.225 . . . . 0.0 112.356 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.6 p -126.72 106.26 9.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.868 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 3.5 m -133.47 109.1 9.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 CA-C-O 119.138 -0.812 . . . . 0.0 112.477 -179.943 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 1.2 m -86.92 144.15 27.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.92 0.39 . . . . 0.0 110.883 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 63.3 p -172.6 160.08 4.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.832 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 80.4 60.52 2.35 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.481 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 3.6 t -112.59 -39.72 4.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.37 . . . . 0.0 110.892 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 16.2 m -80.53 93.23 6.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.855 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 168.33 65.93 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.499 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.23 139.23 35.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 110.868 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 36.0 mttm -108.49 160.65 26.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.557 0.694 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -16.98 37.91 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.655 2.236 . . . . 0.0 112.372 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -137.44 125.23 22.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 44.2 t -160.09 167.55 27.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.6 t -113.63 74.37 2.32 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.602 0.715 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -11.76 31.45 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.657 2.238 . . . . 0.0 112.324 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.5 t -63.66 -42.43 96.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.7 p -116.47 -25.56 7.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.22 75.06 0.98 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.5 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.779 HD23 ' CE1' ' A' ' 392' ' ' PHE . 4.5 tp -166.58 109.51 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.846 0.355 . . . . 0.0 110.89 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 39.9 mtp85 -72.66 160.67 31.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.878 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.779 ' CE1' HD23 ' A' ' 390' ' ' LEU . 40.0 m-85 -143.64 154.23 43.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -99.67 -38.24 8.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -83.94 145.21 28.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -89.05 -27.99 20.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.893 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -86.81 -26.2 24.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -81.83 -35.62 29.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.858 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.521 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -70.98 -28.79 64.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 2.3 t -68.73 -26.29 65.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -82.89 -26.32 31.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.93 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -89.12 -54.31 4.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 398' ' ' MET . 89.5 t -53.19 -35.68 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.147 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 27.9 mtm-85 -68.5 -29.24 67.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.898 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 5.6 m -52.01 -30.11 23.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -85.21 -32.61 22.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.852 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -69.38 112.65 6.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.816 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -163.8 -94.62 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.474 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 3.3 p -118.74 64.99 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.902 0.382 . . . . 0.0 110.847 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 17.6 m -131.69 156.19 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 168.87 -131.3 2.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -129.29 -44.07 1.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.789 0.328 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 25.8 m 60.45 26.67 16.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.851 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -110.53 -175.13 20.54 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.467 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 103.41 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.692 2.261 . . . . 0.0 112.352 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 3.0 t -129.66 113.23 14.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.854 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 58.1 p -124.08 29.03 6.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.871 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 CA-C-O 119.171 -0.794 . . . . 0.0 112.476 -179.946 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 26.8 t -110.83 66.65 0.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.83 0.348 . . . . 0.0 110.833 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 5.3 m -78.22 -50.92 11.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 137.32 -143.89 15.22 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.549 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 9.5 m -76.79 163.98 26.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.862 0.363 . . . . 0.0 110.829 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.8 p -86.63 -47.32 9.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -104.71 19.59 41.26 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.448 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 55.92 32.72 20.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.909 0.385 . . . . 0.0 110.88 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -150.27 160.65 32.76 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.623 0.725 . . . . 0.0 110.858 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -20.26 34.85 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.671 2.247 . . . . 0.0 112.34 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -142.87 134.71 26.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.952 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 2.3 p -157.94 164.91 36.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.849 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.48 ' SG ' HG22 ' A' ' 402' ' ' VAL . 11.7 t -115.38 74.23 4.14 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.638 0.733 . . . . 0.0 110.876 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -11.15 30.24 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.656 2.237 . . . . 0.0 112.323 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.01 -43.1 97.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.153 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 18.5 p -116.51 -25.81 7.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.71 77.0 1.12 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.471 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.719 HD23 ' CE1' ' A' ' 392' ' ' PHE . 5.4 tp -167.6 121.8 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 0.0 110.888 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -83.11 162.72 21.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.841 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.719 ' CE1' HD23 ' A' ' 390' ' ' LEU . 45.3 m-85 -144.14 169.58 17.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -113.87 -42.12 3.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 -83.98 151.71 24.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -89.12 -28.3 20.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.58 -26.58 23.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.878 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 14.5 tpt85 -81.94 -33.08 30.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.569 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -72.41 -29.97 64.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 95.9 p -67.58 -49.79 61.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.884 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -56.22 -26.19 50.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.947 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -88.9 -60.57 1.92 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.856 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 398' ' ' MET . 91.2 t -52.0 -38.07 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.128 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -68.14 -31.17 70.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 21.0 t -52.06 -30.67 26.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -75.89 -37.71 58.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -71.2 -61.44 1.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -78.72 66.5 3.32 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.505 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 26.7 p -170.15 176.97 4.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.932 0.396 . . . . 0.0 110.892 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 34.8 m -74.08 141.03 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.098 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -83.81 106.63 2.87 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.512 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 86.22 1.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.805 0.336 . . . . 0.0 110.91 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 12.9 p -87.05 60.12 6.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -73.14 -70.11 1.28 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.502 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 121.23 7.93 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.677 2.251 . . . . 0.0 112.334 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 22.3 t -77.01 133.15 39.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 17.6 m -127.82 177.68 6.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.531 179.951 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 1.8 t -53.18 -62.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 0.0 110.871 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 54.4 m -54.34 113.62 1.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.852 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 143.68 -133.82 5.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 35.3 p -133.9 144.4 48.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 0.0 110.855 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.7 t -96.1 65.49 2.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.916 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -175.32 166.54 38.09 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.476 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -124.51 163.81 21.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.9 0.381 . . . . 0.0 110.859 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -105.86 160.67 25.33 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.568 0.699 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -19.64 36.03 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.686 2.257 . . . . 0.0 112.356 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -140.27 129.28 23.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 35.8 p -159.61 174.19 14.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.832 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.9 t -117.25 74.25 7.68 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.653 0.74 . . . . 0.0 110.929 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -11.21 30.44 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.717 2.278 . . . . 0.0 112.353 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 93.4 t -64.23 -42.9 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.101 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.41 -25.53 7.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.46 76.02 1.03 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.481 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.669 HD23 ' CE1' ' A' ' 392' ' ' PHE . 4.4 tp -166.88 113.54 0.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.805 0.336 . . . . 0.0 110.962 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 76.9 mtt-85 -72.78 165.73 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.811 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.669 ' CE1' HD23 ' A' ' 390' ' ' LEU . 34.5 m-85 -148.14 164.76 32.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -116.1 -34.94 4.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -91.01 130.33 36.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -73.62 -29.77 62.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -82.6 -26.44 32.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.884 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -82.46 -38.45 23.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.501 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -69.39 -28.63 66.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 2.2 t -69.57 -26.14 64.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -84.05 -26.14 29.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -89.32 -55.49 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 398' ' ' MET . 92.1 t -52.99 -34.63 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.142 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -68.23 -30.8 69.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.1 t -52.03 -30.18 24.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -82.84 -53.99 5.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -57.24 116.6 3.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.856 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.416 ' O ' HG13 ' A' ' 409' ' ' VAL . . . 150.8 -54.03 0.48 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.514 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 58.6 m -52.4 109.06 0.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.924 0.393 . . . . 0.0 110.878 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 407' ' ' GLY . 29.1 m -99.25 139.85 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.16 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 82.6 120.49 0.64 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.509 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -104.08 -65.03 1.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 0.0 110.891 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 45.5 t -72.26 -65.98 0.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 168.55 -74.28 0.13 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.483 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -18.78 36.51 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.669 2.246 . . . . 0.0 112.342 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 67.1 m -99.95 62.75 1.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.862 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 61.9 p -56.93 132.08 51.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 CA-C-O 119.135 -0.814 . . . . 0.0 112.475 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 1.9 m -83.26 136.02 34.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.858 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 6.9 t -83.68 -31.17 26.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 93.01 -152.49 21.0 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.51 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 71.5 m -104.19 -46.26 4.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.358 . . . . 0.0 110.882 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 4.3 p -125.99 156.3 40.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.866 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -153.68 65.65 0.33 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.438 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -170.95 137.25 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.917 0.389 . . . . 0.0 110.901 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -146.12 160.65 42.3 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.551 0.691 . . . . 0.0 110.918 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -17.31 37.81 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.699 2.266 . . . . 0.0 112.362 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -129.48 122.18 28.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.907 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 41.9 p -147.15 156.49 43.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.621 ' SG ' HG22 ' A' ' 402' ' ' VAL . 14.2 t -116.13 74.32 5.45 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.652 0.739 . . . . 0.0 110.851 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -10.28 28.18 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.686 2.257 . . . . 0.0 112.342 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' VAL . . . . . 0.582 HG11 ' CB ' ' A' ' 405' ' ' HIS . 75.1 t -64.8 -43.84 96.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.096 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.7 p -116.48 -25.58 7.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.868 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 103.51 78.31 1.26 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.498 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.803 HD23 ' CE1' ' A' ' 392' ' ' PHE . 5.6 tp -168.61 134.32 1.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.801 0.334 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -93.38 163.28 13.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.803 ' CE1' HD23 ' A' ' 390' ' ' LEU . 39.1 m-85 -146.11 169.87 17.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.91 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -116.61 -38.77 3.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -84.48 152.67 23.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.825 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.1 -31.17 18.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -82.73 -26.98 31.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -80.95 -40.69 24.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.554 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -67.27 -31.65 72.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 70.3 p -68.15 -56.71 7.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -55.43 -26.27 40.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.937 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -82.94 -63.39 1.37 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.893 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.621 HG22 ' SG ' ' A' ' 385' ' ' CYS . 96.1 t -52.05 -34.98 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 44.3 mtm-85 -62.41 -34.07 76.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 7.3 m -52.08 -31.97 32.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.868 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' HIS . . . . . 0.582 ' CB ' HG11 ' A' ' 387' ' ' VAL . 45.3 m-70 -79.86 -49.74 11.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.819 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -74.28 80.31 1.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.838 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -108.5 -65.9 0.58 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.508 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 29.0 t -88.12 130.29 35.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 0.0 110.892 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.28 173.98 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.138 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 110.66 -115.24 3.97 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.553 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -77.08 138.51 39.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.812 0.339 . . . . 0.0 110.895 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 3.7 p -160.18 176.65 11.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 79.61 173.23 44.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.452 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 174.08 10.07 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.686 2.257 . . . . 0.0 112.317 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 2.6 p -117.19 87.38 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.843 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 66.4 m -106.51 173.24 6.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.822 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 CA-C-O 119.1 -0.833 . . . . 0.0 112.54 -179.961 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 4.9 t -95.29 -65.56 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 0.0 110.857 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 75.6 m -78.8 -59.34 2.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.88 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 105.3 -178.89 23.64 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.507 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 23.0 p -171.34 137.75 1.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 110.831 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 36.5 t -103.23 83.93 2.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.875 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -129.52 150.56 18.98 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.545 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -157.25 143.56 17.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 110.871 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 4.7 mttm 63.1 160.6 0.12 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.516 0.674 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -18.35 37.12 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.701 2.267 . . . . 0.0 112.335 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -137.93 109.27 6.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.974 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 83.1 p -131.34 161.54 32.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.626 ' SG ' HG22 ' A' ' 402' ' ' VAL . 15.0 t -114.36 74.21 2.92 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.655 0.741 . . . . 0.0 110.915 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -9.74 26.87 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 0.0 112.38 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.23 -44.21 95.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.108 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.8 p -116.42 -25.57 7.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 103.69 78.58 1.27 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.499 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.793 HD23 ' CE1' ' A' ' 392' ' ' PHE . 3.7 tp -168.59 135.29 1.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.803 0.335 . . . . 0.0 110.89 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -91.85 165.08 13.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.793 ' CE1' HD23 ' A' ' 390' ' ' LEU . 34.6 m-85 -148.6 161.44 41.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.9 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -110.38 -35.26 6.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -88.73 151.01 22.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -89.08 -28.22 20.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -85.06 -26.41 26.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.921 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 15.0 ttp85 -81.89 -34.81 29.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.523 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -73.22 -29.39 62.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 28.3 t -67.99 -58.62 4.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.801 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -54.82 -26.98 38.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -82.38 -65.07 1.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.626 HG22 ' SG ' ' A' ' 385' ' ' CYS . 94.8 t -52.29 -29.57 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 16.0 mmt85 -76.89 -35.26 57.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 15.7 t -52.59 -29.61 26.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -65.1 -69.53 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.853 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.92 -29.1 59.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -97.69 54.3 1.24 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.476 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 11.7 t -171.96 152.81 3.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.952 0.406 . . . . 0.0 110.849 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 30.9 m -72.3 -176.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.135 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 110.58 -76.37 0.22 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.9 139.08 45.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.802 0.334 . . . . 0.0 110.898 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 63.8 p -113.65 77.05 1.02 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 64.01 173.83 3.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.461 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -29.0 24.48 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.696 2.264 . . . . 0.0 112.373 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 2.2 m 58.47 37.5 25.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.871 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 93.3 p -145.68 153.04 40.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.811 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 CA-C-O 119.107 -0.829 . . . . 0.0 112.484 -179.971 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 88.8 p -130.06 175.01 9.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.909 0.385 . . . . 0.0 110.861 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 1.4 p -164.34 155.05 15.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.826 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 93.93 151.39 28.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.53 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 58.1 43.27 21.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.943 0.402 . . . . 0.0 110.879 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 6.0 m -90.66 -29.99 17.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.863 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -129.2 90.24 0.31 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.476 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -101.74 30.29 4.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 110.927 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 37.0 mttt -89.49 160.66 41.54 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.589 0.709 . . . . 0.0 110.89 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -19.69 35.92 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.639 2.226 . . . . 0.0 112.358 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -138.17 123.04 18.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -157.12 168.23 28.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.887 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.2 t -115.62 74.31 4.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.615 0.721 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.85 -10.44 28.48 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.687 2.258 . . . . 0.0 112.322 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.4 t -64.76 -43.38 96.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.127 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 18.1 p -116.48 -25.7 7.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.61 77.34 1.11 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.65 HD23 ' CE1' ' A' ' 392' ' ' PHE . 3.6 tp -168.06 115.61 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -72.36 165.51 24.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.849 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.65 ' CE1' HD23 ' A' ' 390' ' ' LEU . 36.5 m-85 -148.35 152.7 37.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -105.54 -32.39 8.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -93.7 146.3 23.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.11 -32.15 17.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -75.51 -26.78 58.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.61 -51.78 7.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.447 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -55.7 -28.86 57.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 30.9 t -70.65 -25.53 63.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -88.24 -25.62 22.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -88.89 -56.15 3.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 398' ' ' MET . 92.2 t -53.97 -57.59 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.111 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -52.93 -33.71 51.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.6 t -52.05 -30.11 24.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.893 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -70.67 -41.03 72.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -71.34 96.87 1.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 150.53 -29.84 1.05 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.559 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 17.1 t -78.12 -26.96 48.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.905 0.383 . . . . 0.0 110.855 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 32.8 t 58.54 70.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.104 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -147.14 40.11 1.02 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.537 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -139.8 155.77 47.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 110.937 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 17.3 t -94.4 74.47 3.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 167.27 69.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.513 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 101.71 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.683 2.256 . . . . 0.0 112.352 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 7.1 t -103.29 68.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.826 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 1.9 t -90.04 -50.36 6.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 CA-C-O 119.13 -0.817 . . . . 0.0 112.492 179.998 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.881 0.372 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 48.0 t -144.87 168.35 20.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.405 ' SG ' HG22 ' A' ' 402' ' ' VAL . 12.7 t -113.66 74.29 2.33 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.617 0.722 . . . . 0.0 110.888 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -11.29 30.47 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.671 2.247 . . . . 0.0 112.356 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.66 -43.56 98.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.43 -25.55 7.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.14 77.18 1.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.698 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 4.0 tp -168.06 108.64 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.919 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 50.0 mtt85 -66.68 163.81 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.698 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 42.4 m-85 -148.26 147.64 29.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -98.15 -34.06 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -90.15 144.9 25.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.863 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp -89.11 -26.23 21.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -84.15 -28.96 27.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.881 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -80.01 -38.38 32.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.47 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -68.53 -28.61 67.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 23.2 t -70.23 -25.64 63.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.825 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -86.41 -26.01 24.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -89.15 -56.63 3.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 398' ' ' MET . 92.0 t -52.67 -35.46 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.111 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 -68.0 -31.26 70.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 9.6 m -52.05 -30.18 24.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.893 0.378 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.8 p -132.79 179.77 5.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.852 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 10.6 t -127.43 74.69 77.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.631 0.729 . . . . 0.0 110.883 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -8.99 25.01 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.696 2.264 . . . . 0.0 112.354 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.0 t -67.39 -41.41 86.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.131 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.44 -25.51 7.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.38 73.75 0.94 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.481 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.627 HD23 ' O ' ' A' ' 391' ' ' ARG . 5.3 tt -168.53 106.06 0.46 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.782 0.325 . . . . 0.0 110.919 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.627 ' O ' HD23 ' A' ' 390' ' ' LEU . 56.6 mtm180 -64.87 164.8 11.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.607 ' CE1' HD22 ' A' ' 390' ' ' LEU . 7.6 m-85 -139.51 151.87 46.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -103.98 -29.76 10.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -91.75 147.14 23.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -86.95 -25.93 24.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -85.78 -51.6 6.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -57.06 -46.94 82.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.501 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.3 OUTLIER -53.92 -36.57 62.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.933 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 29.0 t -70.0 -25.66 63.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.839 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -82.94 -25.96 31.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -90.81 -55.59 3.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 398' ' ' MET . 93.8 t -52.84 -29.89 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -76.94 -32.44 57.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 59.0 m -52.01 -30.12 23.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.851 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.898 0.38 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 9.6 p -123.75 173.2 8.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.857 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.0 t -113.51 74.75 2.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.704 . . . . 0.0 110.862 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -8.61 24.04 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.691 2.261 . . . . 0.0 112.389 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 91.5 t -66.72 -43.92 89.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.2 p -116.46 -25.4 7.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.36 77.27 1.08 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.506 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.706 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 9.9 tp -167.72 109.81 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.793 0.33 . . . . 0.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -69.05 163.98 23.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.706 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 53.0 m-85 -151.13 141.69 22.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.2 tttp -91.84 -35.38 14.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -83.05 143.07 30.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.02 -25.88 21.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -83.91 -47.74 10.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 33.8 mmt-85 -60.2 -48.01 83.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.473 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -55.49 -27.97 51.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 6.3 t -70.35 -25.54 63.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.851 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -85.94 -25.92 25.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -89.5 -55.98 3.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.837 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 398' ' ' MET . 73.8 t -54.04 -27.31 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -77.27 -30.54 54.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 8.7 t -52.09 -30.16 24.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.829 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.914 0.388 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.8 p -138.92 169.55 17.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.916 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.5 t -113.87 74.7 2.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.594 0.712 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -8.63 24.1 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.651 2.234 . . . . 0.0 112.357 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.7 t -67.56 -41.88 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.55 -25.52 7.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.74 74.65 0.94 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.439 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.597 HD23 ' CE1' ' A' ' 392' ' ' PHE . 3.3 tp -168.73 105.7 0.43 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.787 0.327 . . . . 0.0 110.98 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -67.18 163.5 20.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.597 ' CE1' HD23 ' A' ' 390' ' ' LEU . 7.7 m-85 -139.48 149.33 43.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.853 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -100.91 -29.68 12.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -93.01 144.82 24.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.64 -25.98 23.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -90.13 -28.23 19.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.856 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -82.71 -30.2 29.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.523 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.2 OUTLIER -71.28 -32.61 68.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 60.1 p -69.16 -25.39 64.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -80.85 -25.99 37.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -92.03 -54.71 3.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.866 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 398' ' ' MET . 94.9 t -51.98 -39.62 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -70.56 -28.84 65.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.839 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 9.3 t -52.11 -30.12 24.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 179.959 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.871 0.367 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 67.1 m -117.58 170.52 8.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.864 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.545 ' SG ' HG22 ' A' ' 402' ' ' VAL . 9.6 t -113.48 75.05 2.34 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.685 0.755 . . . . 0.0 110.919 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -8.7 24.28 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.679 2.253 . . . . 0.0 112.37 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.8 t -67.32 -41.43 86.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.12 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 20.8 p -116.83 -26.64 6.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.85 74.57 0.93 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.537 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 391' ' ' ARG . 5.2 tt -169.03 112.42 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.901 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.657 ' O ' HD23 ' A' ' 390' ' ' LEU . 34.0 mtp180 -65.97 159.47 25.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.841 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.639 ' CE1' HD22 ' A' ' 390' ' ' LEU . 7.4 m-85 -140.15 140.44 35.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -92.44 -28.92 16.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 44.8 mmt-85 -93.89 143.05 26.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -88.57 -26.1 22.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -89.18 -37.19 15.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -70.35 -34.02 72.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.896 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.478 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.2 OUTLIER -71.38 -26.23 62.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 56.1 m -70.03 -26.31 63.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -85.86 -26.15 25.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -88.47 -56.5 3.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.865 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.545 HG22 ' SG ' ' A' ' 385' ' ' CYS . 64.8 t -53.99 -27.38 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.098 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -75.06 -31.31 61.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.4 t -52.15 -30.07 24.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 179.983 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.861 0.362 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 12.9 p -132.06 179.6 5.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.822 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.9 t -124.63 74.74 63.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.599 0.714 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -8.67 24.2 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.693 2.262 . . . . 0.0 112.341 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 81.5 t -67.19 -42.81 88.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -116.47 -25.57 7.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.35 76.07 1.0 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.494 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.629 HD23 ' CE1' ' A' ' 392' ' ' PHE . 4.1 tp -168.98 106.33 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.901 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 62.5 mtt85 -70.05 160.58 31.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.629 ' CE1' HD23 ' A' ' 390' ' ' LEU . 13.5 m-85 -137.6 160.96 37.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 32.7 mmtm -103.91 -37.92 7.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 23.5 mmt85 -87.29 146.08 26.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -89.1 -26.93 21.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -90.3 -27.91 19.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -83.7 -35.86 24.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.517 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -57.71 -30.59 65.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 15.4 m -68.54 -42.58 78.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.838 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -54.53 -27.28 37.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -95.77 -57.43 2.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.802 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 398' ' ' MET . 95.8 t -53.55 -56.79 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -54.43 -33.42 59.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.6 t -52.04 -30.16 24.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.888 179.936 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.909 0.385 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 48.1 t -143.16 168.8 18.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.7 t -113.54 74.65 2.3 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.615 0.721 . . . . 0.0 110.832 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -8.65 24.14 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.745 2.297 . . . . 0.0 112.309 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 405' ' ' HIS . 47.3 t -67.21 -43.33 88.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -116.31 -25.48 7.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.57 77.61 1.13 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.727 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 5.6 tp -168.61 112.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 110.883 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -72.52 167.0 21.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.727 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 53.6 m-85 -150.66 146.67 26.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.76 -35.47 10.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -86.28 146.29 26.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -88.8 -26.02 21.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.12 -38.28 20.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.878 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -69.37 -45.31 69.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.479 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -57.72 -32.15 67.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 31.0 t -71.2 -24.28 62.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.857 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -84.28 -21.78 30.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.948 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -96.37 -55.79 2.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.833 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 398' ' ' MET . 64.5 t -54.07 -27.17 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -36.9 85.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 6.5 t -51.91 -30.31 23.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.595 ' HB3' HG11 ' A' ' 387' ' ' VAL . 65.6 m-70 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.845 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.952 0.406 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 4.5 p -153.16 172.67 16.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.857 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.409 ' SG ' HG22 ' A' ' 402' ' ' VAL . 19.2 t -117.44 74.94 8.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.593 0.711 . . . . 0.0 110.895 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -8.65 24.14 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.642 2.228 . . . . 0.0 112.371 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 99.7 t -66.43 -44.32 90.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.16 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.4 p -116.51 -25.49 7.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 107.49 77.35 1.04 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.527 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.681 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 8.4 tp -168.01 104.11 0.47 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.832 0.349 . . . . 0.0 110.939 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -66.54 167.4 10.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.681 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 57.8 m-85 -150.71 177.61 9.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -125.15 -37.39 2.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -92.32 134.9 34.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.92 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -79.07 -24.43 43.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -85.0 -28.62 25.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -85.77 -46.24 10.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.655 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.4 OUTLIER -58.78 -33.49 70.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 12.7 p -63.7 -44.59 93.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -59.72 -26.13 65.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.937 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -88.46 -59.4 2.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.837 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 398' ' ' MET . 38.8 t -51.66 -38.36 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.127 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -57.63 -32.21 67.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 8.4 t -54.08 -29.03 42.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.853 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.938 0.399 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 45.6 t -126.66 169.41 13.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.854 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 29.3 t -113.37 75.25 2.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.623 0.725 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -8.55 23.88 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.656 2.237 . . . . 0.0 112.323 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . 0.617 HG11 ' HB3' ' A' ' 405' ' ' HIS . 23.8 t -65.99 -46.0 89.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.134 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -116.42 -25.55 7.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 107.11 80.53 1.31 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.53 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.677 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 11.0 tp -168.43 110.88 0.56 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.797 0.332 . . . . 0.0 110.956 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -71.55 164.33 26.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.677 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 54.6 m-85 -151.44 134.1 15.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -89.84 -26.14 20.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 29.0 mtm-85 -88.03 148.71 24.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.93 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -89.02 -25.15 22.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.56 -55.5 3.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -52.08 -46.74 65.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.502 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.3 OUTLIER -54.46 -36.47 64.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 40.0 t -72.02 -23.47 61.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -82.51 -22.85 34.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.908 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -96.53 -55.52 2.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.816 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 398' ' ' MET . 64.7 t -53.31 -28.03 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.36 -37.61 88.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 8.4 m -51.72 -31.04 24.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.617 ' HB3' HG11 ' A' ' 387' ' ' VAL . 55.2 m-70 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.87 0.366 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 53.0 p -165.53 -179.75 5.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.8 t -124.59 74.12 62.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.639 0.733 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 -12.3 32.74 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.694 2.263 . . . . 0.0 112.361 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 91.8 t -62.7 -43.16 98.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.134 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.38 -25.5 7.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.926 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.32 75.48 0.97 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.734 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 6.3 tp -165.81 108.4 0.78 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.909 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -73.74 161.57 30.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.734 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 60.7 m-85 -142.52 170.09 16.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.88 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -110.96 -45.53 3.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -82.83 148.77 27.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -89.11 -25.87 21.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -88.79 -26.2 21.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -84.41 -33.72 23.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.553 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -66.36 -28.75 68.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.82 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.1 t -68.49 -44.49 74.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.824 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -55.41 -26.26 40.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.934 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -95.24 -58.87 2.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.828 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 398' ' ' MET . 92.2 t -52.67 -56.86 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -53.47 -34.58 58.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.5 t -52.09 -30.13 24.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.828 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.95 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.893 0.377 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 45.2 p -124.28 173.51 8.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.859 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 25.0 t -113.36 75.87 2.49 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.663 0.744 . . . . 0.0 110.889 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -8.56 23.91 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.729 2.286 . . . . 0.0 112.356 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.61 -44.64 89.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.2 p -116.36 -25.3 7.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.63 77.39 1.07 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.493 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.648 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 13.1 tp -167.57 106.69 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.771 0.32 . . . . 0.0 110.92 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 39.0 mtt180 -68.05 164.79 19.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.648 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 65.8 m-85 -152.78 159.14 43.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.19 -32.06 5.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.94 109.52 16.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -59.82 -25.42 64.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -84.79 -42.08 15.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.879 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -68.55 -46.91 68.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.461 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -55.82 -29.83 60.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 5.5 p -70.86 -23.96 62.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -86.75 -25.46 24.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -91.26 -56.53 3.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 398' ' ' MET . 96.9 t -51.8 -40.48 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.164 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -70.26 -28.96 65.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.9 t -52.3 -29.73 24.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.835 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 179.984 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.906 0.384 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 24.3 p -143.77 167.45 22.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.459 ' SG ' HG22 ' A' ' 402' ' ' VAL . 11.1 t -114.75 74.23 3.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.59 0.709 . . . . 0.0 110.907 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -12.81 33.67 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.63 2.22 . . . . 0.0 112.396 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.18 -42.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.075 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 19.0 p -116.51 -25.89 7.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.95 75.55 1.02 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.495 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 391' ' ' ARG . 5.2 tt -166.68 110.3 0.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.817 0.342 . . . . 0.0 110.894 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.635 ' O ' HD23 ' A' ' 390' ' ' LEU . 49.7 mtm180 -65.28 161.65 19.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.837 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.618 ' CE1' HD22 ' A' ' 390' ' ' LEU . 7.3 m-85 -140.62 153.4 46.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.852 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -105.68 -29.27 10.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 27.6 mtt-85 -101.32 148.96 24.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -89.04 -26.15 21.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -83.86 -35.49 24.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.848 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -73.01 -38.9 66.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.458 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -69.91 -27.19 64.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.4 t -69.82 -26.42 64.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.847 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -87.7 -26.26 23.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.957 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -87.58 -57.77 2.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.459 HG22 ' SG ' ' A' ' 385' ' ' CYS . 66.5 t -52.3 -36.72 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -66.14 -31.58 72.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.1 t -52.13 -30.1 25.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.84 0.353 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 82.8 p -161.1 170.56 20.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.417 ' SG ' HG22 ' A' ' 402' ' ' VAL . 12.6 t -113.66 74.16 2.3 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.571 0.7 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -11.72 31.43 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.712 2.275 . . . . 0.0 112.334 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.36 -43.13 98.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.138 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.7 p -116.48 -25.56 7.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.38 75.83 0.99 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.681 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 7.4 tp -167.23 104.71 0.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.819 0.342 . . . . 0.0 110.919 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 12.4 mtp85 -72.77 161.47 30.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.681 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 56.1 m-85 -142.77 173.38 11.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -109.92 -48.02 3.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.926 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 10.4 mmp_? -78.26 150.62 33.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -89.09 -29.12 19.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.832 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -89.81 -26.67 20.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.54 -33.55 36.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.598 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -68.88 -29.72 68.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 37.5 t -66.86 -42.87 84.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -55.68 -26.2 43.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -95.35 -55.27 3.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.854 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 398' ' ' MET . 73.6 t -53.55 -32.83 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.139 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -68.73 -29.97 68.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.82 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 5.0 m -52.09 -30.13 24.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.816 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.854 179.994 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.918 0.389 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 91.2 p -152.64 171.37 18.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.819 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.5 t -115.17 74.25 3.79 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.666 0.746 . . . . 0.0 110.91 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -11.33 30.66 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.707 2.272 . . . . 0.0 112.346 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.89 -43.16 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.8 p -116.44 -25.71 7.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.58 76.54 1.06 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.487 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.692 HD23 ' CE1' ' A' ' 392' ' ' PHE . 4.1 tp -166.83 113.36 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.786 0.326 . . . . 0.0 110.907 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -73.96 160.03 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.692 ' CE1' HD23 ' A' ' 390' ' ' LEU . 46.3 m-85 -142.51 164.17 30.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.826 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -113.63 -37.27 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -83.75 144.48 29.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.822 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -27.77 20.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -85.41 -27.83 25.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -80.87 -48.45 12.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.508 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -55.64 -30.74 61.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 32.9 t -69.7 -26.31 64.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -81.89 -26.36 34.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.845 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -90.24 -54.98 3.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 398' ' ' MET . 91.9 t -53.65 -27.79 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.172 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -78.07 -31.3 50.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.845 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.7 t -52.17 -30.04 25.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.927 0.394 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 44.2 t -160.09 167.55 27.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.6 t -113.63 74.37 2.32 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.602 0.715 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -11.76 31.45 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.657 2.238 . . . . 0.0 112.324 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.5 t -63.66 -42.43 96.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.7 p -116.47 -25.56 7.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.22 75.06 0.98 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.5 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.779 HD23 ' CE1' ' A' ' 392' ' ' PHE . 4.5 tp -166.58 109.51 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.846 0.355 . . . . 0.0 110.89 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 39.9 mtp85 -72.66 160.67 31.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.878 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.779 ' CE1' HD23 ' A' ' 390' ' ' LEU . 40.0 m-85 -143.64 154.23 43.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -99.67 -38.24 8.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -83.94 145.21 28.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -89.05 -27.99 20.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.893 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -86.81 -26.2 24.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -81.83 -35.62 29.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.858 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.521 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -70.98 -28.79 64.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 2.3 t -68.73 -26.29 65.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -82.89 -26.32 31.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.93 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -89.12 -54.31 4.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 398' ' ' MET . 89.5 t -53.19 -35.68 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.147 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 27.9 mtm-85 -68.5 -29.24 67.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.898 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 5.6 m -52.01 -30.11 23.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.852 179.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.884 0.373 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 2.3 p -157.94 164.91 36.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.849 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.48 ' SG ' HG22 ' A' ' 402' ' ' VAL . 11.7 t -115.38 74.23 4.14 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.638 0.733 . . . . 0.0 110.876 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -11.15 30.24 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.656 2.237 . . . . 0.0 112.323 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.01 -43.1 97.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.153 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 18.5 p -116.51 -25.81 7.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.71 77.0 1.12 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.471 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.719 HD23 ' CE1' ' A' ' 392' ' ' PHE . 5.4 tp -167.6 121.8 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 0.0 110.888 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -83.11 162.72 21.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.841 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.719 ' CE1' HD23 ' A' ' 390' ' ' LEU . 45.3 m-85 -144.14 169.58 17.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -113.87 -42.12 3.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 -83.98 151.71 24.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -89.12 -28.3 20.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.58 -26.58 23.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.878 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 14.5 tpt85 -81.94 -33.08 30.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.569 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -72.41 -29.97 64.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 95.9 p -67.58 -49.79 61.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.884 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -56.22 -26.19 50.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.947 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -88.9 -60.57 1.92 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.856 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 398' ' ' MET . 91.2 t -52.0 -38.07 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.128 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -68.14 -31.17 70.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 21.0 t -52.06 -30.67 26.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.859 179.982 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.897 0.38 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 35.8 p -159.61 174.19 14.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.832 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.9 t -117.25 74.25 7.68 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.653 0.74 . . . . 0.0 110.929 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -11.21 30.44 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.717 2.278 . . . . 0.0 112.353 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 93.4 t -64.23 -42.9 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.101 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.41 -25.53 7.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.46 76.02 1.03 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.481 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.669 HD23 ' CE1' ' A' ' 392' ' ' PHE . 4.4 tp -166.88 113.54 0.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.805 0.336 . . . . 0.0 110.962 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 76.9 mtt-85 -72.78 165.73 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.811 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.669 ' CE1' HD23 ' A' ' 390' ' ' LEU . 34.5 m-85 -148.14 164.76 32.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -116.1 -34.94 4.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -91.01 130.33 36.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -73.62 -29.77 62.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -82.6 -26.44 32.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.884 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -82.46 -38.45 23.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.501 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -69.39 -28.63 66.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 2.2 t -69.57 -26.14 64.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -84.05 -26.14 29.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -89.32 -55.49 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 398' ' ' MET . 92.1 t -52.99 -34.63 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.142 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -68.23 -30.8 69.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.1 t -52.03 -30.18 24.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.971 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.861 0.362 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 41.9 p -147.15 156.49 43.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.621 ' SG ' HG22 ' A' ' 402' ' ' VAL . 14.2 t -116.13 74.32 5.45 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.652 0.739 . . . . 0.0 110.851 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -10.28 28.18 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.686 2.257 . . . . 0.0 112.342 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . 0.582 HG11 ' CB ' ' A' ' 405' ' ' HIS . 75.1 t -64.8 -43.84 96.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.096 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.7 p -116.48 -25.58 7.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.868 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 103.51 78.31 1.26 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.498 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.803 HD23 ' CE1' ' A' ' 392' ' ' PHE . 5.6 tp -168.61 134.32 1.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.801 0.334 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -93.38 163.28 13.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.803 ' CE1' HD23 ' A' ' 390' ' ' LEU . 39.1 m-85 -146.11 169.87 17.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.91 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -116.61 -38.77 3.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -84.48 152.67 23.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.825 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.1 -31.17 18.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -82.73 -26.98 31.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -80.95 -40.69 24.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.554 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -67.27 -31.65 72.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 70.3 p -68.15 -56.71 7.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -55.43 -26.27 40.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.937 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -82.94 -63.39 1.37 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.893 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.621 HG22 ' SG ' ' A' ' 385' ' ' CYS . 96.1 t -52.05 -34.98 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 44.3 mtm-85 -62.41 -34.07 76.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 7.3 m -52.08 -31.97 32.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.868 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . 0.582 ' CB ' HG11 ' A' ' 387' ' ' VAL . 45.3 m-70 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.819 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.892 0.377 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 83.1 p -131.34 161.54 32.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.626 ' SG ' HG22 ' A' ' 402' ' ' VAL . 15.0 t -114.36 74.21 2.92 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.655 0.741 . . . . 0.0 110.915 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -9.74 26.87 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 0.0 112.38 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.23 -44.21 95.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.108 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.8 p -116.42 -25.57 7.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 103.69 78.58 1.27 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.499 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.793 HD23 ' CE1' ' A' ' 392' ' ' PHE . 3.7 tp -168.59 135.29 1.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.803 0.335 . . . . 0.0 110.89 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -91.85 165.08 13.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.793 ' CE1' HD23 ' A' ' 390' ' ' LEU . 34.6 m-85 -148.6 161.44 41.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.9 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -110.38 -35.26 6.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -88.73 151.01 22.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -89.08 -28.22 20.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -85.06 -26.41 26.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.921 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 15.0 ttp85 -81.89 -34.81 29.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.523 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -73.22 -29.39 62.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 28.3 t -67.99 -58.62 4.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.801 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -54.82 -26.98 38.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -82.38 -65.07 1.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.626 HG22 ' SG ' ' A' ' 385' ' ' CYS . 94.8 t -52.29 -29.57 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 16.0 mmt85 -76.89 -35.26 57.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 15.7 t -52.59 -29.61 26.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.853 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.899 0.381 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -157.12 168.23 28.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.887 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.2 t -115.62 74.31 4.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.615 0.721 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.85 -10.44 28.48 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.687 2.258 . . . . 0.0 112.322 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.4 t -64.76 -43.38 96.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.127 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 18.1 p -116.48 -25.7 7.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.61 77.34 1.11 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.65 HD23 ' CE1' ' A' ' 392' ' ' PHE . 3.6 tp -168.06 115.61 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -72.36 165.51 24.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.849 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.65 ' CE1' HD23 ' A' ' 390' ' ' LEU . 36.5 m-85 -148.35 152.7 37.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -105.54 -32.39 8.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -93.7 146.3 23.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.11 -32.15 17.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -75.51 -26.78 58.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.61 -51.78 7.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.447 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -55.7 -28.86 57.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 30.9 t -70.65 -25.53 63.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -88.24 -25.62 22.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -88.89 -56.15 3.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 398' ' ' MET . 92.2 t -53.97 -57.59 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.111 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -52.93 -33.71 51.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.6 t -52.05 -30.11 24.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.893 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 179.974 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 91.5 p -129.95 118.42 21.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.918 0.39 . . . . 0.0 110.834 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 4.9 t -60.18 -70.14 0.18 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.861 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 103.18 51.15 1.01 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.517 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 66.1 p -149.23 133.2 17.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.891 0.377 . . . . 0.0 110.836 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 4.7 m -58.7 -31.78 68.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 173.41 89.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.529 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -144.77 140.5 28.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.893 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp 59.63 73.69 0.64 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.575 0.702 . . . . 0.0 110.848 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -13.1 34.13 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.662 2.241 . . . . 0.0 112.36 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -123.32 108.74 13.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 48.0 t -144.87 168.35 20.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.405 ' SG ' HG22 ' A' ' 402' ' ' VAL . 12.7 t -113.66 74.29 2.33 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.617 0.722 . . . . 0.0 110.888 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -11.29 30.47 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.671 2.247 . . . . 0.0 112.356 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.66 -43.56 98.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.43 -25.55 7.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.14 77.18 1.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.698 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 4.0 tp -168.06 108.64 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.919 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 50.0 mtt85 -66.68 163.81 18.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.698 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 42.4 m-85 -148.26 147.64 29.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -98.15 -34.06 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -90.15 144.9 25.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.863 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp -89.11 -26.23 21.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -84.15 -28.96 27.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.881 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -80.01 -38.38 32.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.47 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -68.53 -28.61 67.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 23.2 t -70.23 -25.64 63.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.825 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -86.41 -26.01 24.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -89.15 -56.63 3.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 398' ' ' MET . 92.0 t -52.67 -35.46 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.111 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 -68.0 -31.26 70.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 9.6 m -52.05 -30.18 24.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -79.27 -64.86 1.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -79.3 85.51 5.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -82.67 126.25 7.36 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.463 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 12.6 t -156.48 132.3 9.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.872 0.368 . . . . 0.0 110.895 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 11.2 p -172.16 147.36 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.14 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 170.82 59.98 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.462 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.05 160.22 0.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.772 0.32 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 72.7 p -72.43 163.34 28.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -74.33 170.97 53.23 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.476 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 107.11 1.78 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.644 2.229 . . . . 0.0 112.344 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 4.8 m -72.48 153.42 41.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.871 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 7.4 t -56.24 158.86 3.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 CA-C-O 119.141 -0.81 . . . . 0.0 112.471 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 38.8 m -89.87 177.41 6.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.902 0.382 . . . . 0.0 110.843 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 1.3 t -127.75 169.48 13.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.906 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 107.78 -48.71 0.92 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 37.7 m -103.48 44.44 1.02 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 0.0 110.834 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 74.9 m -87.68 98.52 11.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.864 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 172.68 156.9 13.27 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.482 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -79.12 137.24 37.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.935 0.398 . . . . 0.0 110.914 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.04 73.72 12.1 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.53 0.681 . . . . 0.0 110.843 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -15.6 37.18 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.709 2.273 . . . . 0.0 112.344 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -111.42 76.27 0.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.935 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.8 p -132.79 179.77 5.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.852 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 10.6 t -127.43 74.69 77.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.631 0.729 . . . . 0.0 110.883 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -8.99 25.01 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.696 2.264 . . . . 0.0 112.354 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.0 t -67.39 -41.41 86.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.131 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.44 -25.51 7.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.38 73.75 0.94 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.481 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.627 HD23 ' O ' ' A' ' 391' ' ' ARG . 5.3 tt -168.53 106.06 0.46 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.782 0.325 . . . . 0.0 110.919 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.627 ' O ' HD23 ' A' ' 390' ' ' LEU . 56.6 mtm180 -64.87 164.8 11.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.859 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.607 ' CE1' HD22 ' A' ' 390' ' ' LEU . 7.6 m-85 -139.51 151.87 46.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -103.98 -29.76 10.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -91.75 147.14 23.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -86.95 -25.93 24.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -85.78 -51.6 6.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -57.06 -46.94 82.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.501 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.3 OUTLIER -53.92 -36.57 62.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.933 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 29.0 t -70.0 -25.66 63.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.839 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -82.94 -25.96 31.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -90.81 -55.59 3.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 398' ' ' MET . 93.8 t -52.84 -29.89 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -76.94 -32.44 57.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 59.0 m -52.01 -30.12 23.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -75.02 -60.78 2.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.851 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -76.87 80.92 3.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.812 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -88.63 -107.93 1.06 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.521 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 80.6 p -119.32 47.61 1.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.871 0.367 . . . . 0.0 110.813 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 76.0 t -119.55 94.49 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.16 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -139.08 116.62 1.27 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.482 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -90.65 -45.75 8.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.893 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 78.0 p -62.43 145.79 53.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.839 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 93.8 167.69 37.83 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.427 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -45.08 1.71 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.691 2.26 . . . . 0.0 112.332 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 20.1 t -100.58 139.99 35.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.843 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 39.5 t -63.17 -31.9 73.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.861 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 CA-C-O 119.151 -0.805 . . . . 0.0 112.503 180.0 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 11.2 p -98.81 138.97 35.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.856 0.36 . . . . 0.0 110.833 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 48.2 m -88.24 86.47 7.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 71.08 92.31 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.499 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 67.2 p -77.3 152.85 34.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.853 0.358 . . . . 0.0 110.904 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 3.0 t -113.38 170.27 8.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.868 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 73.5 -151.46 44.91 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.488 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -159.73 114.25 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 110.889 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -154.56 73.74 5.97 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.577 0.703 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -16.48 37.32 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.696 2.264 . . . . 0.0 112.356 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -107.47 80.9 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 9.6 p -123.75 173.2 8.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.857 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 17.0 t -113.51 74.75 2.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.704 . . . . 0.0 110.862 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -8.61 24.04 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.691 2.261 . . . . 0.0 112.389 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 91.5 t -66.72 -43.92 89.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.2 p -116.46 -25.4 7.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.36 77.27 1.08 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.506 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.706 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 9.9 tp -167.72 109.81 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.793 0.33 . . . . 0.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -69.05 163.98 23.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.706 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 53.0 m-85 -151.13 141.69 22.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.2 tttp -91.84 -35.38 14.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -83.05 143.07 30.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.02 -25.88 21.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.884 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -83.91 -47.74 10.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 33.8 mmt-85 -60.2 -48.01 83.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.473 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -55.49 -27.97 51.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 6.3 t -70.35 -25.54 63.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.851 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -85.94 -25.92 25.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -89.5 -55.98 3.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.837 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 398' ' ' MET . 73.8 t -54.04 -27.31 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -77.27 -30.54 54.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 8.7 t -52.09 -30.16 24.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -79.37 -48.53 13.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.829 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -87.3 74.44 9.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.862 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -110.09 -104.63 2.86 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.487 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 3.9 t -52.05 -38.08 55.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.891 0.377 . . . . 0.0 110.841 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 65.6 t -82.21 142.66 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.143 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 111.4 -35.27 4.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.479 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -132.18 178.25 6.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.799 0.333 . . . . 0.0 110.879 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 3.0 m 54.19 27.99 8.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -160.62 -75.25 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.473 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 128.12 15.58 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.697 2.264 . . . . 0.0 112.352 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 11.2 p -89.42 74.47 7.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 31.8 t -97.15 -59.22 1.84 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 CA-C-O 119.157 -0.802 . . . . 0.0 112.499 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 11.4 t -164.62 127.4 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.888 0.375 . . . . 0.0 110.832 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 4.1 m -106.51 -42.09 5.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.88 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 173.18 -107.09 0.24 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.511 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 26.5 m -142.75 160.45 40.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.846 0.355 . . . . 0.0 110.854 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 68.6 p -156.19 128.77 7.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.873 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 79.99 -139.36 21.21 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.487 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -126.84 53.41 1.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.76 74.12 63.91 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 0.0 110.866 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -14.08 35.34 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.676 2.251 . . . . 0.0 112.31 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -112.73 84.84 2.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.8 p -138.92 169.55 17.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.916 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.5 t -113.87 74.7 2.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.594 0.712 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -8.63 24.1 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.651 2.234 . . . . 0.0 112.357 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.7 t -67.56 -41.88 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.55 -25.52 7.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.74 74.65 0.94 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.439 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.597 HD23 ' CE1' ' A' ' 392' ' ' PHE . 3.3 tp -168.73 105.7 0.43 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.787 0.327 . . . . 0.0 110.98 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -67.18 163.5 20.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.597 ' CE1' HD23 ' A' ' 390' ' ' LEU . 7.7 m-85 -139.48 149.33 43.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.853 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -100.91 -29.68 12.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -93.01 144.82 24.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.64 -25.98 23.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -90.13 -28.23 19.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.856 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -82.71 -30.2 29.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.523 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.2 OUTLIER -71.28 -32.61 68.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 60.1 p -69.16 -25.39 64.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -80.85 -25.99 37.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -92.03 -54.71 3.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.866 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 398' ' ' MET . 94.9 t -51.98 -39.62 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -70.56 -28.84 65.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.839 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 9.3 t -52.11 -30.12 24.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.812 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -80.01 -56.26 4.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -53.61 -37.6 63.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -87.79 156.94 28.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.523 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 24.5 m -116.74 72.54 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.936 0.398 . . . . 0.0 110.843 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.7 p -54.18 -27.85 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.171 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 168.82 -162.47 36.24 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.502 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -119.8 34.46 5.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.785 0.326 . . . . 0.0 110.837 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 1.5 t -71.16 96.01 1.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.843 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 93.87 -178.13 37.5 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 178.04 4.96 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.719 2.28 . . . . 0.0 112.316 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 7.5 t -102.41 143.22 32.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.826 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 66.8 p -94.47 164.28 13.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.862 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 119.158 -0.801 . . . . 0.0 112.526 -179.965 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 3.6 t 56.04 30.67 16.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 0.0 110.825 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 22.0 t -126.52 32.9 5.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 89.34 121.99 2.09 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.491 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 13.7 m -114.5 66.31 0.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.836 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 2.3 m -97.51 -41.66 8.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.9 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 75.67 -177.31 49.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.449 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -97.23 75.53 2.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.924 0.393 . . . . 0.0 110.937 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -160.7 74.03 2.77 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.603 0.716 . . . . 0.0 110.886 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -16.01 37.13 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.639 2.226 . . . . 0.0 112.358 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -105.04 80.69 1.64 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 67.1 m -117.58 170.52 8.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.864 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.545 ' SG ' HG22 ' A' ' 402' ' ' VAL . 9.6 t -113.48 75.05 2.34 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.685 0.755 . . . . 0.0 110.919 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -8.7 24.28 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.679 2.253 . . . . 0.0 112.37 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.8 t -67.32 -41.43 86.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.12 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 20.8 p -116.83 -26.64 6.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.85 74.57 0.93 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.537 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 391' ' ' ARG . 5.2 tt -169.03 112.42 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.901 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.657 ' O ' HD23 ' A' ' 390' ' ' LEU . 34.0 mtp180 -65.97 159.47 25.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.841 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.639 ' CE1' HD22 ' A' ' 390' ' ' LEU . 7.4 m-85 -140.15 140.44 35.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.859 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -92.44 -28.92 16.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 44.8 mmt-85 -93.89 143.05 26.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -88.57 -26.1 22.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -89.18 -37.19 15.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -70.35 -34.02 72.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.896 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.478 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.2 OUTLIER -71.38 -26.23 62.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 56.1 m -70.03 -26.31 63.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -85.86 -26.15 25.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -88.47 -56.5 3.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.865 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.545 HG22 ' SG ' ' A' ' 385' ' ' CYS . 64.8 t -53.99 -27.38 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.098 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -75.06 -31.31 61.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.4 t -52.15 -30.07 24.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -77.5 -63.9 1.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -86.46 71.04 10.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -76.9 -64.07 2.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.492 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 2.6 p -80.46 100.31 8.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 0.0 110.866 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 21.9 t -70.83 93.83 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.144 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -158.62 48.71 0.42 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.472 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -59.69 99.13 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.761 0.315 . . . . 0.0 110.881 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.87 126.9 16.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 176.61 -75.41 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.489 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 93.79 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.654 2.236 . . . . 0.0 112.362 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 19.5 t -89.42 83.09 6.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.806 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 1.3 t -77.78 175.85 9.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.833 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 CA-C-O 119.172 -0.793 . . . . 0.0 112.506 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 8.5 t -117.58 116.34 26.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.853 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 1.7 p -79.63 146.8 32.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.845 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -179.33 -134.99 2.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.49 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 1.9 t -115.98 -39.75 3.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.888 0.375 . . . . 0.0 110.87 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 3.1 m -97.04 -45.68 6.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.845 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 84.48 164.87 38.55 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.487 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -84.86 -26.83 27.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.894 0.378 . . . . 0.0 110.882 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.08 74.44 58.05 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.576 0.703 . . . . 0.0 110.915 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 -8.77 24.43 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.65 2.233 . . . . 0.0 112.31 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -112.46 68.33 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.901 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 12.9 p -132.06 179.6 5.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.822 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.9 t -124.63 74.74 63.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.599 0.714 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -8.67 24.2 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.693 2.262 . . . . 0.0 112.341 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 81.5 t -67.19 -42.81 88.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -116.47 -25.57 7.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.35 76.07 1.0 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.494 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.629 HD23 ' CE1' ' A' ' 392' ' ' PHE . 4.1 tp -168.98 106.33 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.858 0.361 . . . . 0.0 110.901 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 62.5 mtt85 -70.05 160.58 31.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.629 ' CE1' HD23 ' A' ' 390' ' ' LEU . 13.5 m-85 -137.6 160.96 37.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 32.7 mmtm -103.91 -37.92 7.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 23.5 mmt85 -87.29 146.08 26.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -89.1 -26.93 21.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -90.3 -27.91 19.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -83.7 -35.86 24.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.517 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -57.71 -30.59 65.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 15.4 m -68.54 -42.58 78.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.838 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -54.53 -27.28 37.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -95.77 -57.43 2.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.802 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 398' ' ' MET . 95.8 t -53.55 -56.79 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -54.43 -33.42 59.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.6 t -52.04 -30.16 24.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -72.03 -38.93 69.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -80.18 72.92 7.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.822 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 178.99 134.43 2.13 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.471 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 35.8 t -96.69 145.5 25.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.882 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.24 28.41 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.161 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -104.0 -75.14 1.03 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.38 175.12 8.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 0.0 110.886 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 3.5 p -73.06 -58.99 2.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.866 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 155.85 73.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.481 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 168.37 21.68 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.713 2.275 . . . . 0.0 112.313 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 12.9 p 52.19 34.9 15.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.822 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 3.0 m -76.63 -26.62 55.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.844 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 CA-C-O 119.125 -0.819 . . . . 0.0 112.494 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.456 -0.257 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 5.4 p -74.78 144.44 43.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.879 0.371 . . . . 0.0 110.868 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 46.8 t -131.78 -68.7 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.837 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 166.6 96.41 0.11 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.531 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 4.7 m -64.47 139.05 58.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 0.0 110.883 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.6 t -74.29 80.51 1.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -139.7 23.21 2.8 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.475 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -69.99 120.62 15.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.927 0.394 . . . . 0.0 110.868 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 4.4 mmtm 56.79 73.71 0.77 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.589 0.709 . . . . 0.0 110.854 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -13.74 35.01 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.641 2.227 . . . . 0.0 112.344 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -122.22 101.91 7.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 48.1 t -143.16 168.8 18.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.867 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.7 t -113.54 74.65 2.3 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.615 0.721 . . . . 0.0 110.832 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -8.65 24.14 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.745 2.297 . . . . 0.0 112.309 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 405' ' ' HIS . 47.3 t -67.21 -43.33 88.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -116.31 -25.48 7.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.57 77.61 1.13 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.727 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 5.6 tp -168.61 112.97 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 110.883 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -72.52 167.0 21.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.727 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 53.6 m-85 -150.66 146.67 26.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.76 -35.47 10.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -86.28 146.29 26.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -88.8 -26.02 21.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.12 -38.28 20.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.878 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -69.37 -45.31 69.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.479 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -57.72 -32.15 67.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 31.0 t -71.2 -24.28 62.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.857 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -84.28 -21.78 30.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.948 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -96.37 -55.79 2.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.833 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 398' ' ' MET . 64.5 t -54.07 -27.17 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -36.9 85.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 6.5 t -51.91 -30.31 23.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.595 ' HB3' HG11 ' A' ' 387' ' ' VAL . 65.6 m-70 -91.24 46.68 1.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.845 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -75.64 160.64 29.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.845 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 143.91 126.08 1.94 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.528 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 30.0 m -58.41 158.29 7.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 0.0 110.871 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 39.9 t -93.75 120.21 42.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.102 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 102.99 58.56 0.75 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -90.08 119.81 30.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.839 0.352 . . . . 0.0 110.897 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 7.7 t 57.84 31.84 21.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -84.11 166.35 42.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.494 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 139.26 39.74 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.735 2.29 . . . . 0.0 112.302 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 41.9 t -91.05 -36.19 14.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 19.8 p -72.71 -65.7 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 CA-C-O 119.123 -0.821 . . . . 0.0 112.513 179.996 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.471 -0.251 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 9.9 m -73.53 114.78 12.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.87 0.367 . . . . 0.0 110.899 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 44.4 m -87.78 72.44 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 86.41 -144.06 19.68 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.473 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 12.2 m -103.08 163.89 11.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.9 0.381 . . . . 0.0 110.824 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 12.0 t -93.18 151.77 19.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 110.26 161.81 18.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.488 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -63.77 130.85 45.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.908 0.385 . . . . 0.0 110.881 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -120.14 74.0 20.57 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.562 0.696 . . . . 0.0 110.929 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 -14.31 36.05 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.692 2.261 . . . . 0.0 112.334 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -119.68 108.53 14.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 4.5 p -153.16 172.67 16.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.857 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.409 ' SG ' HG22 ' A' ' 402' ' ' VAL . 19.2 t -117.44 74.94 8.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.593 0.711 . . . . 0.0 110.895 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -8.65 24.14 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.642 2.228 . . . . 0.0 112.371 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 99.7 t -66.43 -44.32 90.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.16 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.4 p -116.51 -25.49 7.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 107.49 77.35 1.04 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.527 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.681 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 8.4 tp -168.01 104.11 0.47 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.832 0.349 . . . . 0.0 110.939 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -66.54 167.4 10.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.681 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 57.8 m-85 -150.71 177.61 9.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -125.15 -37.39 2.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -92.32 134.9 34.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.92 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -79.07 -24.43 43.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -85.0 -28.62 25.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -85.77 -46.24 10.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.655 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.4 OUTLIER -58.78 -33.49 70.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 12.7 p -63.7 -44.59 93.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -59.72 -26.13 65.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.937 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -88.46 -59.4 2.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.837 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 398' ' ' MET . 38.8 t -51.66 -38.36 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.127 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -57.63 -32.21 67.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 8.4 t -54.08 -29.03 42.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.853 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -85.75 -50.12 7.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -71.27 82.12 0.74 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -99.27 -143.42 14.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.442 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 49.7 m -103.05 86.7 2.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 0.0 110.894 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 47.9 t -146.82 136.15 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.145 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 80.04 -164.27 48.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.467 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -89.17 152.55 21.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.786 0.327 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 1.2 p -103.99 -60.22 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.803 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -156.93 -173.42 25.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.492 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -175.32 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.662 2.241 . . . . 0.0 112.345 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 4.7 p 55.24 26.89 8.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.82 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 11.6 m -128.27 159.31 35.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 CA-C-O 119.143 -0.809 . . . . 0.0 112.468 -179.948 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 30.0 t -155.13 107.87 2.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.869 0.366 . . . . 0.0 110.835 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 48.8 m -87.08 -68.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -162.16 -94.63 0.1 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.486 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 58.9 p -80.49 -32.23 37.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 110.833 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 51.3 m -156.84 146.35 20.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -112.89 160.99 12.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.431 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -101.52 100.47 10.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.923 0.392 . . . . 0.0 110.935 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -168.46 73.57 0.83 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.559 0.695 . . . . 0.0 110.87 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -16.29 37.57 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.722 2.281 . . . . 0.0 112.33 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -110.93 89.43 3.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 45.6 t -126.66 169.41 13.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.854 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 29.3 t -113.37 75.25 2.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.623 0.725 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -8.55 23.88 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.656 2.237 . . . . 0.0 112.323 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . 0.617 HG11 ' HB3' ' A' ' 405' ' ' HIS . 23.8 t -65.99 -46.0 89.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.134 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.5 p -116.42 -25.55 7.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 107.11 80.53 1.31 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.53 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.677 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 11.0 tp -168.43 110.88 0.56 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.797 0.332 . . . . 0.0 110.956 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -71.55 164.33 26.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.677 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 54.6 m-85 -151.44 134.1 15.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -89.84 -26.14 20.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 29.0 mtm-85 -88.03 148.71 24.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.93 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -89.02 -25.15 22.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.56 -55.5 3.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -52.08 -46.74 65.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.502 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.3 OUTLIER -54.46 -36.47 64.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 40.0 t -72.02 -23.47 61.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -82.51 -22.85 34.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.908 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -96.53 -55.52 2.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.816 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 398' ' ' MET . 64.7 t -53.31 -28.03 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.36 -37.61 88.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 8.4 m -51.72 -31.04 24.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.617 ' HB3' HG11 ' A' ' 387' ' ' VAL . 55.2 m-70 -92.03 -28.86 16.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -67.92 -42.86 80.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -111.92 -179.14 19.97 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 5.1 t -121.9 53.32 1.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.923 0.392 . . . . 0.0 110.896 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.53 -26.96 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.132 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -100.84 -93.52 2.16 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.45 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -106.25 166.82 10.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.776 0.322 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 29.5 p -83.08 92.53 7.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -68.48 -168.95 5.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.515 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -17.54 37.75 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.647 2.231 . . . . 0.0 112.355 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 12.9 p -161.71 142.71 10.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.835 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 88.6 p -103.42 81.92 1.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.837 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 CA-C-O 119.145 -0.808 . . . . 0.0 112.475 -179.982 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 6.2 m -66.98 -62.11 1.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.927 0.394 . . . . 0.0 110.855 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 3.6 p -76.47 170.83 15.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -171.83 -114.84 0.34 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.503 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 2.2 p -84.35 -42.97 15.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.921 0.391 . . . . 0.0 110.891 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 7.4 m -73.4 163.56 27.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.892 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -90.16 -159.56 35.65 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.51 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -95.81 -57.5 2.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.914 0.388 . . . . 0.0 110.872 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -83.82 160.69 57.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.611 0.72 . . . . 0.0 110.873 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -17.15 37.61 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.645 2.23 . . . . 0.0 112.36 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -141.48 128.53 20.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.957 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 53.0 p -165.53 -179.75 5.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.8 t -124.59 74.12 62.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.639 0.733 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 -12.3 32.74 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.694 2.263 . . . . 0.0 112.361 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 91.8 t -62.7 -43.16 98.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.134 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.38 -25.5 7.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.926 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.32 75.48 0.97 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.734 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 6.3 tp -165.81 108.4 0.78 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.909 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -73.74 161.57 30.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.734 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 60.7 m-85 -142.52 170.09 16.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.88 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -110.96 -45.53 3.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -82.83 148.77 27.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -89.11 -25.87 21.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -88.79 -26.2 21.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -84.41 -33.72 23.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.553 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -66.36 -28.75 68.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.82 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.1 t -68.49 -44.49 74.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.824 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -55.41 -26.26 40.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.934 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -95.24 -58.87 2.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.828 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 398' ' ' MET . 92.2 t -52.67 -56.86 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -53.47 -34.58 58.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.5 t -52.09 -30.13 24.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.828 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -69.77 -64.53 0.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -79.1 112.89 16.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 168.81 97.61 0.11 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.472 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 1.6 m -75.18 85.01 2.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.371 . . . . 0.0 110.861 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 12.2 p -97.76 -30.41 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -111.07 -68.5 0.56 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.454 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.81 81.39 8.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.763 0.316 . . . . 0.0 110.896 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 5.3 t -68.15 -35.96 78.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.861 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 131.67 -73.16 0.47 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.494 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 102.43 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.708 2.272 . . . . 0.0 112.319 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.1 m -142.61 144.88 33.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 38.9 m -54.31 131.79 42.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.819 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.464 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 8.6 m -151.88 139.79 20.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.874 0.369 . . . . 0.0 110.881 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 11.4 t -56.65 -51.29 69.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.899 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 138.25 127.38 2.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 3.0 m -103.97 108.84 20.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 0.0 110.872 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 17.4 p -100.4 68.29 1.38 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -137.28 178.49 18.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.509 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -82.17 109.13 16.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -142.2 73.92 21.34 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.58 0.705 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -15.68 37.27 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.662 2.241 . . . . 0.0 112.31 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -101.59 77.02 1.71 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.872 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 45.2 p -124.28 173.51 8.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.859 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 25.0 t -113.36 75.87 2.49 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.663 0.744 . . . . 0.0 110.889 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -8.56 23.91 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.729 2.286 . . . . 0.0 112.356 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.61 -44.64 89.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.2 p -116.36 -25.3 7.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.63 77.39 1.07 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.493 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.648 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 13.1 tp -167.57 106.69 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.771 0.32 . . . . 0.0 110.92 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 39.0 mtt180 -68.05 164.79 19.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.648 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 65.8 m-85 -152.78 159.14 43.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.19 -32.06 5.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.94 109.52 16.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -59.82 -25.42 64.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -84.79 -42.08 15.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.879 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -68.55 -46.91 68.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.461 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -55.82 -29.83 60.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 5.5 p -70.86 -23.96 62.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -86.75 -25.46 24.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -91.26 -56.53 3.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 398' ' ' MET . 96.9 t -51.8 -40.48 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.164 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -70.26 -28.96 65.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.9 t -52.3 -29.73 24.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.835 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -77.58 -65.94 0.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -76.01 108.54 8.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -135.1 -42.52 0.12 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.449 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 10.4 p -59.1 143.51 48.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.899 0.38 . . . . 0.0 110.872 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 10.1 p -62.66 140.82 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.132 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -166.02 -58.38 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.504 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 33.2 tttm 58.37 37.48 25.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.778 0.323 . . . . 0.0 110.873 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 6.1 p -112.47 108.98 18.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.829 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 139.67 -71.56 0.44 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.496 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 143.3 50.17 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.732 2.288 . . . . 0.0 112.305 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 67.3 m -102.11 62.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.855 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 16.2 p -162.34 171.59 16.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 CA-C-O 119.18 -0.789 . . . . 0.0 112.453 -179.966 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 2.8 p -61.61 -55.98 24.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.389 . . . . 0.0 110.858 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 72.8 m -90.51 -179.31 5.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.825 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -162.28 -43.57 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.478 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 18.9 t -153.39 142.9 21.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.894 0.378 . . . . 0.0 110.876 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 37.6 t -98.82 -43.38 6.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 165.69 71.18 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.452 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -56.61 132.9 53.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 110.927 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -104.43 160.7 25.15 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.613 0.72 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -20.7 34.3 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.638 2.225 . . . . 0.0 112.332 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -126.98 110.5 13.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.951 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 24.3 p -143.77 167.45 22.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.459 ' SG ' HG22 ' A' ' 402' ' ' VAL . 11.1 t -114.75 74.23 3.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.59 0.709 . . . . 0.0 110.907 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -12.81 33.67 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.63 2.22 . . . . 0.0 112.396 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.18 -42.77 96.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.075 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 19.0 p -116.51 -25.89 7.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.95 75.55 1.02 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.495 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 391' ' ' ARG . 5.2 tt -166.68 110.3 0.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.817 0.342 . . . . 0.0 110.894 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.635 ' O ' HD23 ' A' ' 390' ' ' LEU . 49.7 mtm180 -65.28 161.65 19.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.837 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.618 ' CE1' HD22 ' A' ' 390' ' ' LEU . 7.3 m-85 -140.62 153.4 46.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.852 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -105.68 -29.27 10.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 27.6 mtt-85 -101.32 148.96 24.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -89.04 -26.15 21.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -83.86 -35.49 24.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.848 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -73.01 -38.9 66.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.458 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -69.91 -27.19 64.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.4 t -69.82 -26.42 64.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.847 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -87.7 -26.26 23.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.957 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -87.58 -57.77 2.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.459 HG22 ' SG ' ' A' ' 385' ' ' CYS . 66.5 t -52.3 -36.72 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -66.14 -31.58 72.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.1 t -52.13 -30.1 25.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -79.09 -46.8 17.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -57.85 -34.98 70.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -80.78 -35.85 23.97 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.444 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 6.1 m -71.86 136.71 47.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 110.852 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.78 142.73 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.121 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -137.2 -111.15 1.04 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.481 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -91.91 -51.76 5.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.759 0.314 . . . . 0.0 110.897 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.83 178.93 0.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -132.17 -167.51 11.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.464 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 138.83 38.89 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.678 2.252 . . . . 0.0 112.372 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 3.6 m -131.89 92.35 3.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 96.5 p -63.74 123.6 19.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.844 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 CA-C-O 119.168 -0.795 . . . . 0.0 112.475 -179.98 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 86.4 p -71.8 -33.76 68.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 110.842 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 17.9 p -90.35 63.17 5.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.816 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 168.24 -115.01 0.59 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.432 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 30.2 m -159.67 162.36 35.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.855 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 4.4 m -97.66 -65.29 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 111.47 -156.33 15.63 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.551 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -129.48 126.41 38.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 0.0 110.906 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -81.37 160.72 64.37 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.616 0.722 . . . . 0.0 110.859 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -16.77 37.45 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.69 2.26 . . . . 0.0 112.315 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -133.83 124.11 25.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 82.8 p -161.1 170.56 20.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.417 ' SG ' HG22 ' A' ' 402' ' ' VAL . 12.6 t -113.66 74.16 2.3 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.571 0.7 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -11.72 31.43 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.712 2.275 . . . . 0.0 112.334 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.36 -43.13 98.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.138 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.7 p -116.48 -25.56 7.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 106.38 75.83 0.99 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.681 HD23 ' CZ ' ' A' ' 392' ' ' PHE . 7.4 tp -167.23 104.71 0.54 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.819 0.342 . . . . 0.0 110.919 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 12.4 mtp85 -72.77 161.47 30.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.681 ' CZ ' HD23 ' A' ' 390' ' ' LEU . 56.1 m-85 -142.77 173.38 11.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -109.92 -48.02 3.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.926 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 10.4 mmp_? -78.26 150.62 33.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -89.09 -29.12 19.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.832 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -89.81 -26.67 20.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.54 -33.55 36.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.598 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -68.88 -29.72 68.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 37.5 t -66.86 -42.87 84.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -55.68 -26.2 43.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -95.35 -55.27 3.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.854 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 398' ' ' MET . 73.6 t -53.55 -32.83 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.139 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -68.73 -29.97 68.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.82 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 5.0 m -52.09 -30.13 24.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.816 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -85.35 54.03 2.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -88.24 135.42 33.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 135.21 -49.08 0.91 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.534 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 4.2 m 54.59 28.61 10.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.899 0.381 . . . . 0.0 110.852 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.52 142.25 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.123 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 97.1 71.38 1.06 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.501 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -118.69 124.48 47.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.0 110.926 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 12.9 t -127.99 120.65 28.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.861 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 89.6 72.19 1.26 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.464 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 143.23 50.36 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.7 2.267 . . . . 0.0 112.322 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 73.6 m -104.04 -33.42 8.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 48.1 p -122.89 -176.47 3.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.838 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 CA-C-O 119.158 -0.801 . . . . 0.0 112.522 179.981 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 4.6 m -136.99 127.76 27.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.918 0.389 . . . . 0.0 110.836 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 5.7 t -115.38 130.04 56.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.832 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -146.7 78.12 0.24 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.477 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 60.5 p -53.37 126.6 21.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 0.0 110.878 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 2.7 t -113.79 95.49 5.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 97.93 133.45 7.93 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.529 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -124.39 132.84 53.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.916 0.389 . . . . 0.0 110.926 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 30.1 mttp -87.68 160.64 46.94 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.542 0.687 . . . . 0.0 110.936 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -18.41 37.17 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.681 2.254 . . . . 0.0 112.336 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -136.06 120.11 17.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.876 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 91.2 p -152.64 171.37 18.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.819 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.5 t -115.17 74.25 3.79 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.666 0.746 . . . . 0.0 110.91 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -11.33 30.66 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.707 2.272 . . . . 0.0 112.346 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.89 -43.16 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.8 p -116.44 -25.71 7.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.58 76.54 1.06 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.487 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.692 HD23 ' CE1' ' A' ' 392' ' ' PHE . 4.1 tp -166.83 113.36 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.786 0.326 . . . . 0.0 110.907 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 56.7 mtt85 -73.96 160.03 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.692 ' CE1' HD23 ' A' ' 390' ' ' LEU . 46.3 m-85 -142.51 164.17 30.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.826 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -113.63 -37.27 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -83.75 144.48 29.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.822 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.08 -27.77 20.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -85.41 -27.83 25.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -80.87 -48.45 12.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.508 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -55.64 -30.74 61.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 32.9 t -69.7 -26.31 64.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -81.89 -26.36 34.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.845 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -90.24 -54.98 3.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 398' ' ' MET . 91.9 t -53.65 -27.79 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.172 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -78.07 -31.3 50.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.845 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.7 t -52.17 -30.04 25.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -76.83 -35.72 57.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.87 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.88 111.11 4.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.892 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 91.6 106.49 1.49 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.456 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 8.6 t -81.34 161.59 23.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.912 0.387 . . . . 0.0 110.836 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 14.9 p -84.87 -31.5 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.132 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -58.49 -64.08 4.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.474 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -77.46 -179.74 5.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.753 0.311 . . . . 0.0 110.899 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 1.4 t -122.87 167.04 14.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.862 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -154.07 176.64 31.88 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.51 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 91.82 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.637 2.225 . . . . 0.0 112.356 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.6 p -126.72 106.26 9.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.868 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 3.5 m -133.47 109.1 9.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 CA-C-O 119.138 -0.812 . . . . 0.0 112.477 -179.943 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 1.2 m -86.92 144.15 27.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.92 0.39 . . . . 0.0 110.883 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 63.3 p -172.6 160.08 4.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.832 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 80.4 60.52 2.35 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.481 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 3.6 t -112.59 -39.72 4.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.37 . . . . 0.0 110.892 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 16.2 m -80.53 93.23 6.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.855 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 168.33 65.93 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.499 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.23 139.23 35.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 110.868 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 36.0 mttm -108.49 160.65 26.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.557 0.694 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -16.98 37.91 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.655 2.236 . . . . 0.0 112.372 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -137.44 125.23 22.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 44.2 t -160.09 167.55 27.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.6 t -113.63 74.37 2.32 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.602 0.715 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -11.76 31.45 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.657 2.238 . . . . 0.0 112.324 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.5 t -63.66 -42.43 96.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.7 p -116.47 -25.56 7.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.22 75.06 0.98 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.5 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.779 HD23 ' CE1' ' A' ' 392' ' ' PHE . 4.5 tp -166.58 109.51 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.846 0.355 . . . . 0.0 110.89 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 39.9 mtp85 -72.66 160.67 31.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.878 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.779 ' CE1' HD23 ' A' ' 390' ' ' LEU . 40.0 m-85 -143.64 154.23 43.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -99.67 -38.24 8.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -83.94 145.21 28.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -89.05 -27.99 20.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.893 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -86.81 -26.2 24.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -81.83 -35.62 29.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.858 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.521 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -70.98 -28.79 64.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 2.3 t -68.73 -26.29 65.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -82.89 -26.32 31.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.93 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -89.12 -54.31 4.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 398' ' ' MET . 89.5 t -53.19 -35.68 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.147 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 27.9 mtm-85 -68.5 -29.24 67.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.898 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 5.6 m -52.01 -30.11 23.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -85.21 -32.61 22.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.852 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -69.38 112.65 6.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.816 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -163.8 -94.62 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.474 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 3.3 p -118.74 64.99 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.902 0.382 . . . . 0.0 110.847 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 17.6 m -131.69 156.19 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 168.87 -131.3 2.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -129.29 -44.07 1.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.789 0.328 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 25.8 m 60.45 26.67 16.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.851 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -110.53 -175.13 20.54 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.467 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 103.41 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.692 2.261 . . . . 0.0 112.352 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 3.0 t -129.66 113.23 14.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.854 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 58.1 p -124.08 29.03 6.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.871 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 CA-C-O 119.171 -0.794 . . . . 0.0 112.476 -179.946 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 26.8 t -110.83 66.65 0.63 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.83 0.348 . . . . 0.0 110.833 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 5.3 m -78.22 -50.92 11.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 137.32 -143.89 15.22 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.549 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 9.5 m -76.79 163.98 26.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.862 0.363 . . . . 0.0 110.829 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.8 p -86.63 -47.32 9.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.881 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -104.71 19.59 41.26 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.448 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 55.92 32.72 20.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.909 0.385 . . . . 0.0 110.88 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -150.27 160.65 32.76 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.623 0.725 . . . . 0.0 110.858 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -20.26 34.85 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.671 2.247 . . . . 0.0 112.34 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -142.87 134.71 26.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.952 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 2.3 p -157.94 164.91 36.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.849 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.48 ' SG ' HG22 ' A' ' 402' ' ' VAL . 11.7 t -115.38 74.23 4.14 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.638 0.733 . . . . 0.0 110.876 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -11.15 30.24 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.656 2.237 . . . . 0.0 112.323 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.01 -43.1 97.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.153 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 18.5 p -116.51 -25.81 7.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 104.71 77.0 1.12 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.471 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.719 HD23 ' CE1' ' A' ' 392' ' ' PHE . 5.4 tp -167.6 121.8 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 0.0 110.888 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -83.11 162.72 21.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.841 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.719 ' CE1' HD23 ' A' ' 390' ' ' LEU . 45.3 m-85 -144.14 169.58 17.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.89 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -113.87 -42.12 3.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 -83.98 151.71 24.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -89.12 -28.3 20.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.58 -26.58 23.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.878 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 14.5 tpt85 -81.94 -33.08 30.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.569 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -72.41 -29.97 64.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 95.9 p -67.58 -49.79 61.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.884 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -56.22 -26.19 50.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.947 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -88.9 -60.57 1.92 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.856 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 398' ' ' MET . 91.2 t -52.0 -38.07 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.128 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -68.14 -31.17 70.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 21.0 t -52.06 -30.67 26.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -75.89 -37.71 58.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -71.2 -61.44 1.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -78.72 66.5 3.32 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.505 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 26.7 p -170.15 176.97 4.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.932 0.396 . . . . 0.0 110.892 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 34.8 m -74.08 141.03 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.098 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -83.81 106.63 2.87 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.512 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 86.22 1.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.805 0.336 . . . . 0.0 110.91 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 12.9 p -87.05 60.12 6.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -73.14 -70.11 1.28 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.502 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 121.23 7.93 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.677 2.251 . . . . 0.0 112.334 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 22.3 t -77.01 133.15 39.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 17.6 m -127.82 177.68 6.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.531 179.951 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 1.8 t -53.18 -62.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 0.0 110.871 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 54.4 m -54.34 113.62 1.34 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.852 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 143.68 -133.82 5.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 35.3 p -133.9 144.4 48.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 0.0 110.855 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.7 t -96.1 65.49 2.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.916 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -175.32 166.54 38.09 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.476 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -124.51 163.81 21.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.9 0.381 . . . . 0.0 110.859 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -105.86 160.67 25.33 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.568 0.699 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -19.64 36.03 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.686 2.257 . . . . 0.0 112.356 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -140.27 129.28 23.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 35.8 p -159.61 174.19 14.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.832 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 11.9 t -117.25 74.25 7.68 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.653 0.74 . . . . 0.0 110.929 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -11.21 30.44 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.717 2.278 . . . . 0.0 112.353 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 93.4 t -64.23 -42.9 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.101 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.41 -25.53 7.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.46 76.02 1.03 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.481 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.669 HD23 ' CE1' ' A' ' 392' ' ' PHE . 4.4 tp -166.88 113.54 0.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.805 0.336 . . . . 0.0 110.962 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 76.9 mtt-85 -72.78 165.73 24.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.811 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.669 ' CE1' HD23 ' A' ' 390' ' ' LEU . 34.5 m-85 -148.14 164.76 32.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -116.1 -34.94 4.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -91.01 130.33 36.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -73.62 -29.77 62.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -82.6 -26.44 32.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.884 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -82.46 -38.45 23.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.501 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -69.39 -28.63 66.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 2.2 t -69.57 -26.14 64.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -84.05 -26.14 29.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -89.32 -55.49 3.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 398' ' ' MET . 92.1 t -52.99 -34.63 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.142 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -68.23 -30.8 69.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.1 t -52.03 -30.18 24.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -82.84 -53.99 5.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -57.24 116.6 3.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.856 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.416 ' O ' HG13 ' A' ' 409' ' ' VAL . . . 150.8 -54.03 0.48 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.514 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 58.6 m -52.4 109.06 0.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.924 0.393 . . . . 0.0 110.878 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 407' ' ' GLY . 29.1 m -99.25 139.85 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.16 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 82.6 120.49 0.64 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.509 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -104.08 -65.03 1.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 0.0 110.891 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 45.5 t -72.26 -65.98 0.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 168.55 -74.28 0.13 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.483 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -18.78 36.51 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.669 2.246 . . . . 0.0 112.342 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 67.1 m -99.95 62.75 1.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.862 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 61.9 p -56.93 132.08 51.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 CA-C-O 119.135 -0.814 . . . . 0.0 112.475 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 1.9 m -83.26 136.02 34.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.858 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 6.9 t -83.68 -31.17 26.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 93.01 -152.49 21.0 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.51 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 71.5 m -104.19 -46.26 4.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.358 . . . . 0.0 110.882 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 4.3 p -125.99 156.3 40.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.866 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -153.68 65.65 0.33 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.438 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -170.95 137.25 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.917 0.389 . . . . 0.0 110.901 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -146.12 160.65 42.3 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.551 0.691 . . . . 0.0 110.918 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -17.31 37.81 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.699 2.266 . . . . 0.0 112.362 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -129.48 122.18 28.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.907 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 41.9 p -147.15 156.49 43.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.621 ' SG ' HG22 ' A' ' 402' ' ' VAL . 14.2 t -116.13 74.32 5.45 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.652 0.739 . . . . 0.0 110.851 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -10.28 28.18 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.686 2.257 . . . . 0.0 112.342 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . 0.582 HG11 ' CB ' ' A' ' 405' ' ' HIS . 75.1 t -64.8 -43.84 96.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.096 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.7 p -116.48 -25.58 7.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.868 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 103.51 78.31 1.26 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.498 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.803 HD23 ' CE1' ' A' ' 392' ' ' PHE . 5.6 tp -168.61 134.32 1.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.801 0.334 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -93.38 163.28 13.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.803 ' CE1' HD23 ' A' ' 390' ' ' LEU . 39.1 m-85 -146.11 169.87 17.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.91 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -116.61 -38.77 3.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -84.48 152.67 23.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.825 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.1 -31.17 18.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -82.73 -26.98 31.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -80.95 -40.69 24.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.554 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -67.27 -31.65 72.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 70.3 p -68.15 -56.71 7.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -55.43 -26.27 40.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.937 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -82.94 -63.39 1.37 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.893 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.621 HG22 ' SG ' ' A' ' 385' ' ' CYS . 96.1 t -52.05 -34.98 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 44.3 mtm-85 -62.41 -34.07 76.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 7.3 m -52.08 -31.97 32.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.868 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . 0.582 ' CB ' HG11 ' A' ' 387' ' ' VAL . 45.3 m-70 -79.86 -49.74 11.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.819 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -74.28 80.31 1.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.838 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -108.5 -65.9 0.58 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.508 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 29.0 t -88.12 130.29 35.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 0.0 110.892 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.28 173.98 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.138 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 110.66 -115.24 3.97 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.553 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -77.08 138.51 39.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.812 0.339 . . . . 0.0 110.895 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 3.7 p -160.18 176.65 11.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 79.61 173.23 44.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.452 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 174.08 10.07 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.686 2.257 . . . . 0.0 112.317 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 2.6 p -117.19 87.38 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.843 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 66.4 m -106.51 173.24 6.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.822 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 CA-C-O 119.1 -0.833 . . . . 0.0 112.54 -179.961 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 4.9 t -95.29 -65.56 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 0.0 110.857 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 75.6 m -78.8 -59.34 2.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.88 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 105.3 -178.89 23.64 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.507 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 23.0 p -171.34 137.75 1.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 110.831 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 36.5 t -103.23 83.93 2.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.875 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -129.52 150.56 18.98 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.545 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -157.25 143.56 17.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 110.871 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 4.7 mttm 63.1 160.6 0.12 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.516 0.674 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -18.35 37.12 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.701 2.267 . . . . 0.0 112.335 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -137.93 109.27 6.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.974 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 83.1 p -131.34 161.54 32.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.626 ' SG ' HG22 ' A' ' 402' ' ' VAL . 15.0 t -114.36 74.21 2.92 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.655 0.741 . . . . 0.0 110.915 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -9.74 26.87 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 0.0 112.38 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.23 -44.21 95.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.108 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 17.8 p -116.42 -25.57 7.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 103.69 78.58 1.27 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.499 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.793 HD23 ' CE1' ' A' ' 392' ' ' PHE . 3.7 tp -168.59 135.29 1.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.803 0.335 . . . . 0.0 110.89 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -91.85 165.08 13.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.793 ' CE1' HD23 ' A' ' 390' ' ' LEU . 34.6 m-85 -148.6 161.44 41.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.9 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -110.38 -35.26 6.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -88.73 151.01 22.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -89.08 -28.22 20.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -85.06 -26.41 26.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.921 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 15.0 ttp85 -81.89 -34.81 29.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.523 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.0 OUTLIER -73.22 -29.39 62.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 28.3 t -67.99 -58.62 4.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.801 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -54.82 -26.98 38.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -82.38 -65.07 1.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.626 HG22 ' SG ' ' A' ' 385' ' ' CYS . 94.8 t -52.29 -29.57 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 16.0 mmt85 -76.89 -35.26 57.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 15.7 t -52.59 -29.61 26.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.862 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -65.1 -69.53 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.853 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.92 -29.1 59.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -97.69 54.3 1.24 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.476 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 11.7 t -171.96 152.81 3.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.952 0.406 . . . . 0.0 110.849 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 30.9 m -72.3 -176.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.135 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . 110.58 -76.37 0.22 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.9 139.08 45.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.802 0.334 . . . . 0.0 110.898 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 63.8 p -113.65 77.05 1.02 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.861 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 64.01 173.83 3.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.461 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -29.0 24.48 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.696 2.264 . . . . 0.0 112.373 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 2.2 m 58.47 37.5 25.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.871 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 93.3 p -145.68 153.04 40.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.811 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 CA-C-O 119.107 -0.829 . . . . 0.0 112.484 -179.971 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 88.8 p -130.06 175.01 9.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.909 0.385 . . . . 0.0 110.861 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' SER . . . . . . . . . . . . . 1.4 p -164.34 155.05 15.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.826 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 93.93 151.39 28.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.53 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 58.1 43.27 21.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.943 0.402 . . . . 0.0 110.879 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 6.0 m -90.66 -29.99 17.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.863 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -129.2 90.24 0.31 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.476 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -101.74 30.29 4.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 110.927 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 37.0 mttt -89.49 160.66 41.54 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.589 0.709 . . . . 0.0 110.89 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -19.69 35.92 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.639 2.226 . . . . 0.0 112.358 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -138.17 123.04 18.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -157.12 168.23 28.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.887 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 12.2 t -115.62 74.31 4.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.615 0.721 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.85 -10.44 28.48 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.687 2.258 . . . . 0.0 112.322 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' VAL . . . . . . . . . . . . . 92.4 t -64.76 -43.38 96.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.127 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' CYS . . . . . . . . . . . . . 18.1 p -116.48 -25.7 7.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 105.61 77.34 1.11 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.65 HD23 ' CE1' ' A' ' 392' ' ' PHE . 3.6 tp -168.06 115.61 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -72.36 165.51 24.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.849 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.65 ' CE1' HD23 ' A' ' 390' ' ' LEU . 36.5 m-85 -148.35 152.7 37.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -105.54 -32.39 8.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -93.7 146.3 23.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.11 -32.15 17.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -75.51 -26.78 58.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.61 -51.78 7.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.858 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.447 ' O ' HG23 ' A' ' 402' ' ' VAL . 0.1 OUTLIER -55.7 -28.86 57.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 30.9 t -70.65 -25.53 63.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -88.24 -25.62 22.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -88.89 -56.15 3.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 398' ' ' MET . 92.2 t -53.97 -57.59 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.111 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -52.93 -33.71 51.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.6 t -52.05 -30.11 24.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.893 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -70.67 -41.03 72.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -71.34 96.87 1.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 150.53 -29.84 1.05 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.559 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 17.1 t -78.12 -26.96 48.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.905 0.383 . . . . 0.0 110.855 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . . . . . . . . . 32.8 t 58.54 70.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.104 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . . . . . . . . . . . -147.14 40.11 1.02 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.537 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -139.8 155.77 47.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 110.937 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' SER . . . . . . . . . . . . . 17.3 t -94.4 74.47 3.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 167.27 69.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.513 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 101.71 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.683 2.256 . . . . 0.0 112.352 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 7.1 t -103.29 68.74 0.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.826 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' SER . . . . . . . . . . . . . 1.9 t -90.04 -50.36 6.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 CA-C-O 119.13 -0.817 . . . . 0.0 112.492 179.998 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_